known_doi,retrieved_doi,score,query_be
10.1073/pnas.0507415102,10.1073/pnas.0507415102,80.304695,"Gabriel, G. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host, Proc Natl Acad Sci USA, 2005, 102, 18590, 18595, DOI: 10.1073/pnas.0507415102, PMID: 16339318"
10.1128/jvi.02790-15,10.1128/jvi.02790-15,73.58942,"Hanson, A. Identification of Stabilizing Mutations in an H5 Hemagglutinin Influenza Virus Protein, J Virol, 2015, 90, 2981, 2992, DOI: 10.1128/JVI.02790-15, PMID: 26719265"
10.1128/jvi.74.24.11825-11831.2000,10.1128/jvi.74.24.11825-11831.2000,104.69582,"Suzuki, Y. Sialic acid species as a determinant of the host range of influenza A viruses, J Virol, 2000, 74, 11825, 11831, DOI: 10.1128/JVI.74.24.11825-11831.2000, PMID: 11090182"
10.1073/pnas.201401198,10.1073/pnas.201401198,133.79997,"Ha, Y, Stevens, DJ, Skehel, JJ, Wiley, DC. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs, Proc Natl Acad Sci USA, 2001, 98, 11181, 11186, DOI: 10.1073/pnas.201401198, PMID: 11562490"
10.1146/annurev.micro.59.030804.121059,10.1146/annurev.micro.59.030804.121059,118.79603,"Parrish, CR, Kawaoka, Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses, Annu Rev Microbiol, 2005, 59, 553, 586, DOI: 10.1146/annurev.micro.59.030804.121059, PMID: 16153179"
10.1016/j.vetmic.2016.02.027,10.1016/j.vetmic.2016.02.027,74.612045,"Zhao, Y. Adaptive amino acid substitutions enhance the virulence of a novel human H7N9 influenza virus in mice, Vet Microbiol, 2016, 187, 8, 14, DOI: 10.1016/j.vetmic.2016.02.027, PMID: 27066703"
10.3389/fmicb.2017.01763,10.3389/fmicb.2017.01763,69.05049,"Zhang, C. Amino Acid Substitutions Associated with Avian H5N6 Influenza A Virus Adaptation to Mice, Front Microbiol, 2017, 8, 1763, DOI: 10.3389/fmicb.2017.01763, PMID: 28966609"
10.1038/srep15928,10.1038/srep15928,85.37035,"Sang, X. Adaptation of H9N2 AIV in guinea pigs enables efficient transmission by direct contact and inefficient transmission by respiratory droplets, Sci Rep, 2015, 5, 15928, DOI: 10.1038/srep15928, PMID: 26552719"
10.1371/journal.pone.0040752,10.1371/journal.pone.0040752,108.658714,"Wang, J. Mouse-adapted H9N2 influenza A virus PB2 protein M147L and E627K mutations are critical for high virulence, PLoS One, 2012, 7, e40752, DOI: 10.1371/journal.pone.0040752, PMID: 22808250"
10.1016/j.meegid.2011.07.025,10.1016/j.meegid.2011.07.025,81.13213,"Zhang, Z. Multiple amino acid substitutions involved in enhanced pathogenicity of LPAI H9N2 in mice, Infect Genet Evol, 2011, 11, 1790, 1797, DOI: 10.1016/j.meegid.2011.07.025, PMID: 21896338"
10.3389/fmicb.2019.00018,10.3389/fmicb.2019.00018,91.48154,"Zhao, Z. A Novel Reassortant Avian H7N6 Influenza Virus Is Transmissible in Guinea Pigs via Respiratory Droplets, Front Microbiol, 2019, 10, 18, DOI: 10.3389/fmicb.2019.00018, PMID: 30723462"
10.1073/pnas.172393399,10.1073/pnas.172393399,62.042732,"Hoffmann, E. Rescue of influenza B virus from eight plasmids, Proc Natl Acad Sci USA, 2002, 99, 11411, 11416, DOI: 10.1073/pnas.172393399, PMID: 12172012"
10.1007/s007050170002,10.1007/s007050170002,94.27951,"Hoffmann, E, Stech, J, Guan, Y, Webster, RG, Perez, DR. Universal primer set for the full-length amplification of all influenza A viruses, Arch Virol, 2001, 146, 2275, 2289, DOI: 10.1007/s007050170002, PMID: 11811679"
10.1128/jvi.03024-13,10.1128/jvi.03024-13,136.74135,"Zhao, Z. PB2-588I enhances 2009 H1N1 pandemic influenza virus virulence by increasing viral replication and exacerbating PB2 inhibition of beta interferon expression, J Virol, 2014, 88, 2260, 2267, DOI: 10.1128/JVI.03024-13, PMID: 24335306"
10.1038/s41598-017-16139-1,10.1038/s41598-017-16139-1,78.294846,"Zhao, Z. Avian Influenza H5N6 Viruses Exhibit Differing Pathogenicities and Transmissibilities in Mammals, Sci Rep, 2017, 7, 16280, DOI: 10.1038/s41598-017-16139-1, PMID: 29176564"
10.1006/viro.1994.1615,10.1006/viro.1994.1615,129.30257,"Connor, RJ, Kawaoka, Y, Webster, RG, Paulson, JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates, Virology, 1994, 205, 17, 23, DOI: 10.1006/viro.1994.1615, PMID: 7975212"
10.1128/jvi.74.18.8502-8512.2000,10.1128/jvi.74.18.8502-8512.2000,130.17313,"Matrosovich, M. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals, J Virol, 2000, 74, 8502, 8512, DOI: 10.1128/JVI.74.18.8502-8512.2000, PMID: 10954551"
10.1038/s41598-018-26658-0,10.1038/s41598-018-26658-0,87.486336,"Zhao, Z. Author Correction: Avian Influenza H5N6 Viruses Exhibit Differing Pathogenicities and Transmissibilities in Mammals, Sci Rep, 2018, 8, 9084, DOI: 10.1038/s41598-018-26658-0, PMID: 29884792"
10.1016/0042-6822(89)90249-3,10.1016/0042-6822(89)90249-3,125.87833,"Rogers, GN, D’Souza, BL. Receptor binding properties of human and animal H1 influenza virus isolates, Virology, 1989, 173, 317, 322, DOI: 10.1016/0042-6822(89)90249-3, PMID: 2815586"
10.1128/jvi.73.2.1146-1155.1999,10.1128/jvi.73.2.1146-1155.1999,156.30096,"Matrosovich, M, Zhou, N, Kawaoka, Y, Webster, R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties, J Virol, 1999, 73, 1146, 1155, PMID: 9882316"
10.1016/j.coviro.2012.03.003,10.1016/j.coviro.2012.03.003,85.77766,"Imai, M, Kawaoka, Y. The role of receptor binding specificity in interspecies transmission of influenza viruses, Curr Opin Virol, 2012, 2, 160, 167, DOI: 10.1016/j.coviro.2012.03.003, PMID: 22445963"
10.1038/nature12476,10.1038/nature12476,61.73004,"Richard, M. Limited airborne transmission of H7N9 influenza A virus between ferrets, Nature, 2013, 501, 560, 563, DOI: 10.1038/nature12476, PMID: 23925116"
10.1016/j.chom.2016.10.022,10.1016/j.chom.2016.10.022,63.62074,"Bi, Y. Genesis, Evolution and Prevalence of H5N6 Avian Influenza Viruses in China, Cell Host Microbe, 2016, 20, 810, 821, DOI: 10.1016/j.chom.2016.10.022, PMID: 27916476"
10.1128/jvi.00943-14,10.1128/jvi.00943-14,76.233765,"Zhong, L. Molecular mechanism of the airborne transmissibility of H9N2 avian influenza A viruses in chickens, J Virol, 2014, 88, 9568, 9578, DOI: 10.1128/JVI.00943-14, PMID: 24920791"
10.1016/j.vetmic.2018.08.002,10.1016/j.vetmic.2018.08.002,134.17108,"Su, H, Yang, X, Wang, S, Shi, H, Liu, X. Effect of annexin II-mediated conversion of plasmin from plasminogen on airborne transmission of H9N2 avian influenza virus, Vet Microbiol, 2018, 223, 100, 106, DOI: 10.1016/j.vetmic.2018.08.002, PMID: 30173734"
10.1371/journal.pone.0175267,10.1371/journal.pone.0175267,137.64635,"Mancera Gracia, JC, Van den Hoecke, S, Saelens, X, Van Reeth, K. Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine, PLoS One, 2017, 12, e0175267, DOI: 10.1371/journal.pone.0175267, PMID: 28384328"
10.3390/v10110653,10.3390/v10110653,188.21075,"Kamiki, Haruhiko, Matsugo, Hiromichi, Kobayashi, Tomoya, Ishida, Hiroho, Takenaka-Uema, Akiko, Murakami, Shin, Horimoto, Taisuke. A PB1-K577E Mutation in H9N2 Influenza Virus Increases Polymerase Activity and Pathogenicity in Mice, Viruses, 2018, 10, 11, 653, DOI: 10.3390/v10110653"
10.1007/s12275-015-5329-4,10.1007/s12275-015-5329-4,73.9615,"Park, KJ. Molecular characterization of mammalian-adapted Korean-type avian H9N2 virus and evaluation of its virulence in mice, J Microbiol, 2015, 53, 570, 577, DOI: 10.1007/s12275-015-5329-4, PMID: 26224460"
10.1371/journal.ppat.1007919,10.1371/journal.ppat.1007919,108.79559,"Arai, Y. PB2 mutations arising during H9N2 influenza evolution in the Middle East confer enhanced replication and growth in mammals, PLoS Pathog, 2019, 15, e1007919, DOI: 10.1371/journal.ppat.1007919, PMID: 31265471"
10.1007/s12250-018-0072-8,10.1007/s12250-018-0072-8,114.80433,"Zhang, J. The D253N Mutation in the Polymerase Basic 2 Gene in Avian Influenza (H9N2) Virus Contributes to the Pathogenesis of the Virus in Mammalian Hosts, Virol Sin, 2018, 33, 531, 537, DOI: 10.1007/s12250-018-0072-8, PMID: 30569291"
10.1128/jvi.01775-14,10.1128/jvi.01775-14,73.79981,"Liu, Q. Virulence determinants in the PB2 gene of a mouse-adapted H9N2 virus, J Virol, 2015, 89, 877, 882, DOI: 10.1128/JVI.01775-14, PMID: 25339773"
10.1016/j.vetmic.2015.02.016,10.1016/j.vetmic.2015.02.016,83.22093,"Chen, Q. Adaptive amino acid substitutions enhance the virulence of an H7N7 avian influenza virus isolated from wild waterfowl in mice, Vet Microbiol, 2015, 177, 18, 24, DOI: 10.1016/j.vetmic.2015.02.016, PMID: 25769645"
10.1126/science.1062882,10.1126/science.1062882,110.03469,"Hatta, M, Gao, P, Halfmann, P, Kawaoka, Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses, Science, 2001, 293, 1840, 1842, DOI: 10.1126/science.1062882, PMID: 11546875"
10.1038/srep19474,10.1038/srep19474,84.84464,"Xiao, C. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses, Sci Rep, 2016, 6, 19474, DOI: 10.1038/srep19474, PMID: 26782141"
10.1128/jvi.00883-16,10.1128/jvi.00883-16,105.42125,"Xu, G. Prevailing PA Mutation K356R in Avian Influenza H9N2 Virus Increases Mammalian Replication and Pathogenicity, J Virol, 2016, 90, 8105, 8114, DOI: 10.1128/JVI.00883-16, PMID: 27384648"
10.1016/j.jinf.2013.08.001,10.1016/j.jinf.2013.08.001,119.86931,"Xu, W. PA-356R is a unique signature of the avian influenza A (H7N9) viruses with bird-to-human transmissibility: potential implication for animal surveillances, J Infect, 2013, 67, 490, 494, DOI: 10.1016/j.jinf.2013.08.001, PMID: 23933287"
10.1007/s00705-016-2872-1,10.1007/s00705-016-2872-1,83.35828,"Fang, S. Genomic characterization of influenza A (H7N9) viruses isolated in Shenzhen, Southern China, during the second epidemic wave, Arch Virol, 2016, 161, 2117, 2132, DOI: 10.1007/s00705-016-2872-1, PMID: 27169600"
10.1128/jvi.01557-17,10.1128/jvi.01557-17,95.9393,"Zhong, G. et al. Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence. J Virol 92, 10.1128/JVI.01557-17 (2018)."
10.1007/s11270-014-2292-3,10.1007/s11270-014-2292-3,106.37718,"Miao, T, Pan, TA. Multiphysics Model for Evaluating Electrokinetic Remediation of Nuclear Waste-Contaminated Soils, Water, Air, & Soil Pollution, 2015, 226, 3, 77, DOI: 10.1007/s11270-014-2292-3"
10.1016/j.chemosphere.2019.125112,10.1016/j.chemosphere.2019.125112,169.31383,"Chen, L, Long, C, Wang, D, Yang, J. Phytoremediation of cadmium (Cd) and uranium (U) contaminated soils by, Brassica juncea L. enhanced with exogenous application of plant growth regulators, Chemosphere, 2020, 242, 125112, DOI: 10.1016/j.chemosphere.2019.125112"
10.1016/j.ecoenv.2019.04.081,10.1016/j.ecoenv.2019.04.081,170.89603,"Navarro-León, E, Oviedo-Silva, J, Ruiz, JM, Blasco, B. Possible role of HMA4a TILLING mutants of, Brassica rapa in cadmium phytoremediation programs, Ecotoxicology and Environmental Safety, 2019, 180, 88, 94, DOI: 10.1016/j.ecoenv.2019.04.081, PMID: 31078020"
10.1016/j.net.2016.01.017,10.1016/j.net.2016.01.017,94.65127,"Kim, IG, Kim, SS, Kim, GN, Han, GS, Choi, GW. Reduction of Radioactive Waste from Remediation of Uranium-Contaminated Soil, Nuclear Engineering and Technology, 2017, 48, 840, 846, DOI: 10.1016/j.net.2016.01.017"
10.1080/02757540.2018.1452915,10.1080/02757540.2018.1452915,90.07143,"Yu, Y, Liu, M, Yang, J. Characteristics of vanadium adsorption on and desorption from humic acid, Chemistry and Ecology, 2018, 34, 6, 548, 564, DOI: 10.1080/02757540.2018.1452915"
10.1016/j.chemosphere.2019.05.233,10.1016/j.chemosphere.2019.05.233,136.41273,"Sun, Z, Wu, B, Guo, P, Wang, S, Guo, S. Enhanced electrokinetic remediation and simulation of cadmium-contaminated soil by superimposed electric field, Chemosphere, 2019, 233, 17, 24, DOI: 10.1016/j.chemosphere.2019.05.233, PMID: 31163304"
10.1016/j.jhazmat.2018.11.109,10.1016/j.jhazmat.2018.11.109,84.7555,"Xia, Z. Remediation of cadmium, lead and zinc in contaminated soil with CETSA and MA/AA, Journal of Hazardous Materials, 2019, 366, 177, 183, DOI: 10.1016/j.jhazmat.2018.11.109, PMID: 30522084"
10.1038/s41598-019-42029-9,10.1038/s41598-019-42029-9,145.1873,"Usman, K, Al-Ghouti, MA, Abu-Dieyeh, MH. The assessment of cadmium, chromium, copper, and nickel tolerance and bioaccumulation by shrub plant Tetraena qataranse, Scientific Reports, 2019, 9, 1, 5658, DOI: 10.1038/s41598-019-42029-9, PMID: 30948781"
10.1080/09593330.2012.715757,10.1080/09593330.2012.715757,108.18461,"Almaroai, YA. Role of chelating agents on release kinetics of metals and their uptake by maize from chromated copper arsenate-contaminated soil, Environmental Technology, 2013, 34, 6, 747, 755, DOI: 10.1080/09593330.2012.715757, PMID: 23837326"
10.1016/j.jhazmat.2013.08.069,10.1016/j.jhazmat.2013.08.069,93.35008,"Zhang, T. Chelant extraction of heavy metals from contaminated soils using new selective EDTA derivatives, Journal of Hazardous Materials, 2013, 262, 464, 471, DOI: 10.1016/j.jhazmat.2013.08.069, PMID: 24076482"
10.1023/a:1004356007312,10.1023/a:1004356007312,45.5458,"Jones, DL. Organic acids in the rhizosphere -a critical review, Plant and Soil, 1998, 205, 1, 25, 44, DOI: 10.1023/A:1004356007312"
10.1023/a:1004325817420,10.1023/a:1004325817420,91.99325,"Cieśliński, G, Van Rees, KC, Szmigielska, AM, Krishnamurti, GS, Huang, PM. Low-molecular-weight organic acids in rhizosphere soils of durum wheat and their effect on cadmium bioaccumulation, Plant and Soil, 1998, 203, 1, 109, 117, DOI: 10.1023/A:1004325817420"
10.1023/a:1022371130939,10.1023/a:1022371130939,125.8209,"Hinsinger, P, Plassard, C, Tang, C, Jaillard, B. Origins of root-mediated pH changes in the rhizosphere and their responses to environmental constraints: A review, Plant and Soil, 2003, 248, 1/2, 43, 59, DOI: 10.1023/A:1022371130939"
10.1016/s0045-6535(02)00225-4,10.1016/s0045-6535(02)00225-4,141.23514,"Wu, LH, Luo, YM, Christie, P, Wong, MH. Effects of EDTA and low molecular weight organic acids on soil solution properties of a heavy metal polluted soil, Chemosphere, 2003, 50, 6, 819, 822, DOI: 10.1016/S0045-6535(02)00225-4, PMID: 12688497"
10.1016/j.envpol.2007.11.015,10.1016/j.envpol.2007.11.015,94.91428,"Leštan, D, Luo, C, Li, X. The use of chelating agents in the remediation of metal-contaminated soils: A review, Environmental Pollution, 2008, 153, 1, 3, 13, DOI: 10.1016/j.envpol.2007.11.015, PMID: 18155817"
10.15244/pjoes/81207,10.15244/pjoes/81207,116.00895,"Bian, XG, Cui, J, Tang, BP, Yang, L. Chelant-Induced Phytoextraction of Heavy Metals from Contaminated Soils: A Review, Polish journal of environmental studies, 2018, 27, 6, 2417, 2424, DOI: 10.15244/pjoes/81207"
10.1016/j.chemosphere.2008.11.007,10.1016/j.chemosphere.2008.11.007,91.87345,"Saifullah, ME. EDTA-assisted Pb phytoextraction, Chemosphere, 2009, 74, 10, 1279, 1291, DOI: 10.1016/j.chemosphere.2008.11.007, PMID: 19121533"
10.1016/j.biortech.2010.08.006,10.1016/j.biortech.2010.08.006,172.36789,"Zhao, SL, Lian, F, Duo, L. EDTA-assisted phytoextraction of heavy metals by turfgrass from municipal solid waste compost using permeable barriers and associated potential leaching risk, Bioresource Technology, 2011, 102, 2, 621, 626, DOI: 10.1016/j.biortech.2010.08.006, PMID: 20797852"
10.1016/j.chemosphere.2011.01.007,10.1016/j.chemosphere.2011.01.007,122.83072,"Sillanpa, MET, Kurniawan, TA, Lo, WH. Degradation of chelating agents in aqueous solution using advanced oxidation process (AOP), Chemosphere, 2011, 83, 11, 1443, 1460, DOI: 10.1016/j.chemosphere.2011.01.007, PMID: 21349569"
10.1016/j.envpol.2006.02.012,10.1016/j.envpol.2006.02.012,156.85867,"Luo, CL, Shen, ZG, Lou, LQ, Li, XD. EDDS and EDTA-enhanced phytoextraction of metals from artificially contaminated soil and residual effects of chelant compounds, Environmental Pollution, 2006, 144, 3, 862, 871, DOI: 10.1016/j.envpol.2006.02.012, PMID: 16616805"
10.2134/jeq2003.5000,10.2134/jeq2003.5000,159.32938,"Grcman, H, Vodnik, D, Velikonja-Bolta, S, Lestan, D. Ethylenediaminedissuccinate as a new chelate for environmentally safe enhanced lead phytoextraction, Journal of Environmental Quality, 2003, 32, 32, 500, 506, DOI: 10.2134/jeq2003.5000, PMID: 12708673"
10.1016/j.jhazmat.2013.09.063,10.1016/j.jhazmat.2013.09.063,102.26714,"Yang, J. Leaching characteristics of vanadium in mine tailings and soils near a vanadium titanomagnetite mining site, Journal of Hazardous Materials, 2014, 264, 498, 504, DOI: 10.1016/j.jhazmat.2013.09.063, PMID: 24268537"
10.1016/j.chemosphere.2013.01.116,10.1016/j.chemosphere.2013.01.116,135.96495,"Lan, JC. Efficiency of biodegradable EDDS, NTA and APAM on enhancing the phytoextraction of cadmium by, Siegesbeckia orientalis L. grown in Cd-contaminated soils, Chemosphere, 2013, 91, 9, 1362, 1367, DOI: 10.1016/j.chemosphere.2013.01.116, PMID: 23466280"
10.1080/15226514.2018.1474435,10.1080/15226514.2018.1474435,130.53418,"Shen, JC, Zhang, ZH, Liu, R, Wang, ZH. Ecological restoration of eroded karst utilizing pioneer moss and vascular plant species with selection based on vegetation diversity and underlying soil chemistry, International Journal of Phytoremediation, 2018, 20, 14, 1369, 1379, DOI: 10.1080/15226514.2018.1474435, PMID: 30652488"
10.2136/sssabookser5.3.c34,10.2136/sssabookser5.3.c34,88.38909,"Nelson, D. W. & Sommers, L. E. Total carbon, organic carbon and organic matter. In: Sparks, D. L. et al. (eds). Methods of soil analysis: SSSA, Madison, Wisconsin. pp. 961–1010 (1996)."
10.1007/s11356-013-1917-1,10.1007/s11356-013-1917-1,152.16989,"Yang, J, Teng, Y, Zuo, R, Song, L. Comparison of bioavailable vanadium in alfalfa rhizosphere soil extracted by an improved BCR procedure and EDTA, HCl, and NaNO, 3 single extractions in a pot experiment with V–Cd treatments, Environmental Science and Pollution Research, 2013, 22, 12, 8833, 8842, DOI: 10.1007/s11356-013-1917-1, PMID: 23807559"
10.1007/s11270-015-2684-z,10.1007/s11270-015-2684-z,105.54451,"Elrashidi, MA, Seybold, CA, Wysocki, DA. Effects of Annual Precipitation on Heavy Metals in Runoff from Soils in the US Great Plains, Water, Air, & Soil Pollution, 2015, 226, 12, 417, DOI: 10.1007/s11270-015-2684-z"
10.1016/j.jhazmat.2010.05.065,10.1016/j.jhazmat.2010.05.065,158.20433,"Li, JH. Ethyllactate-EDTA composite system enhances the remediation of the cadmium-contaminated soil by Autochthonous Willow (Salix x aureo-pendula CL ‘J1011’) in the lower reaches of the Yangtze River, Journal of Hazardous Materials, 2010, 181, 1-3, 673, 678, DOI: 10.1016/j.jhazmat.2010.05.065, PMID: 20554378"
10.1007/s11356-015-4396-8,10.1007/s11356-015-4396-8,118.92693,"Afshan, S. Citric acid enhances the phytoextraction of chromium, plant growth, and photosynthesis by alleviating the oxidative damages in, Brassica napus L, Environmental Pollution, 2015, 22, 15, 11679, 11689"
10.1016/j.chemosphere.2007.01.062,10.1016/j.chemosphere.2007.01.062,154.36958,"Evangelou, MW, Ebel, M, Schaeffer, A. Chelate assisted phytoextraction of heavy metals from soil. Effect, mechanism, toxicity, and fate of chelating agents, Chemosphere, 2007, 68, 6, 989, 1003, DOI: 10.1016/j.chemosphere.2007.01.062, PMID: 17349677"
10.1093/jxb/erq281,10.1093/jxb/erq281,95.75372,"Lux, A, Martinka, M, Vaculík, M, White, PJ. Root responses to cadmium in the rhizosphere:a review, Journal of Experimental Botany, 2011, 62, 1, 21, 37, DOI: 10.1093/jxb/erq281, PMID: 20855455"
10.1016/j.chemosphere.2012.11.044,10.1016/j.chemosphere.2012.11.044,128.09428,"Jagetiya, B, Sharma, A. Optimization of chelators to enhance uraium uptake from tailings for phytoremediation, Chemosphere, 2013, 91, 5, 692, 696, DOI: 10.1016/j.chemosphere.2012.11.044, PMID: 23267730"
10.1016/j.ecoenv.2014.03.007,10.1016/j.ecoenv.2014.03.007,87.72594,"Ehsan, S. Citric acid assisted phytoremediation of cadmium by, Brassica napus L, Ecotoxicology and Environmental Safety, 2014, 106, 164, 172, DOI: 10.1016/j.ecoenv.2014.03.007, PMID: 24840879"
10.1080/15226514.2018.1501336,10.1080/15226514.2018.1501336,127.120605,"Moslehi, A, Feizian, M, Higueras, P, Eisvand, HR. Assessment of EDDS and vermicompost for the phytoextraction of Cd and Pb by sunflower (, Helianthus annuus L.), International Journal of Phytoremediation, 2019, 21, 3, 191, 199, DOI: 10.1080/15226514.2018.1501336, PMID: 30663886"
10.1080/15320383.2019.1613957,10.1080/15320383.2019.1613957,127.77027,"Chen, L, Wang, D, Zeng, C, Long, C. Improving Cobalt Phytoextraction by, Astragalus Sinicus L. Grown in Co-Contaminated Soils Using Biodegradable Chelators, Soil and Sediment Contamination: An International Journal, 2019, 28, 5, 461, 472, DOI: 10.1080/15320383.2019.1613957"
10.1016/j.ecoenv.2017.09.070,10.1016/j.ecoenv.2017.09.070,173.31345,"Farhangi-Abriz, S, Ghassemi-Golezani, K. How can salicylic acid and jasmonic acid mitigate salt toxicity in soybean plants, Ecotoxicology and Environmental Safety, 2018, 147, 1, 1010, 1016, DOI: 10.1016/j.ecoenv.2017.09.070, PMID: 29976003"
10.1016/j.chemosphere.2007.02.058,10.1016/j.chemosphere.2007.02.058,172.88792,"Quartacci, MF, Irtelli, B, Baker, AJ, Navariizzo, F. The use of NTA and EDDS for enhanced phytoextraction of metals from a multiply contaminated soil by, Brassica carinata, Chemosphere, 2007, 68, 10, 1920, 1928, DOI: 10.1016/j.chemosphere.2007.02.058, PMID: 17418884"
10.1016/j.chemosphere.2012.08.061,10.1016/j.chemosphere.2012.08.061,115.289604,"Ghnaya, T. Implication of organic acids in the long-distance transport and the accumulation of lead in, Sesuvium portulacastrum and, Brassica juncea, Chemosphere, 2013, 90, 4, 1449, 1454, DOI: 10.1016/j.chemosphere.2012.08.061, PMID: 23026160"
10.1016/j.ecoenv.2016.05.036,10.1016/j.ecoenv.2016.05.036,96.13506,"Zhang, H. Comparison of chelates for enhancing, Ricinus communis L. phytoremediation of Cd and Pb contaminated soil, Ecotoxicology and Environmental Safety, 2017, 133, 57, 62, DOI: 10.1016/j.ecoenv.2016.05.036"
10.1016/j.jenvrad.2018.12.023,10.1016/j.jenvrad.2018.12.023,94.997856,"Hu, N. Enhancement of repeated applications of chelates on phytoremediation of uranium contaminated soil by, Macleaya cordata, Journal of Environmental Radioactivity, 2019, 199, 58, 65, DOI: 10.1016/j.jenvrad.2018.12.023, PMID: 30685639"
10.1016/j.jenvman.2012.12.028,10.1016/j.jenvman.2012.12.028,116.306595,"Hseu, ZY, Jien, SH, Wang, SH, Deng, HW. Using EDDS and NTA for enhanced phytoextraction of Cd by water spinach, Ecotoxicology and Environmental Safety, 2013, 117, 58, 64"
10.1016/j.jhazmat.2011.10.026,10.1016/j.jhazmat.2011.10.026,131.13742,"Lozano, JC, Blanco, RP, Tome, FV, Calvo, CP. Enhancing radium solubilization in soils by citrate, EDTA, and EDDS chelating amendments, Journal of Hazardous Materials, 2013, 198, 224, 231, DOI: 10.1016/j.jhazmat.2011.10.026"
10.1007/s11356-014-3803-x,10.1007/s11356-014-3803-x,104.60973,"Li, CW. Phytoextraction of uranium from contaminated soil by, Macleaya cordata before and after application of EDDS and CA, Environmental Science and Pollution Research, 2014, 22, 8, 6155, 6163, DOI: 10.1007/s11356-014-3803-x, PMID: 25399528"
10.3171/sup.2005.102.s_supplement.0081,10.3171/jns.2005.102.s_supplement.0207,67.96694,"Liu, K-D. Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients, J. neurosurgery, 2005, 102, 81, 86, DOI: 10.3171/sup.2005.102.s_supplement.0081"
10.3171/2012.8.gks121066,10.3171/2012.8.gks121066,61.35184,"Lee, C-C. Brainstem cavernous malformations: the role of gamma knife surgery, J. neurosurgery, 2012, 117, 164, 169, DOI: 10.3171/2012.8.GKS121066"
10.1007/bf01405501,10.1007/bf01405501,72.41323,"Frischi, J. Cavernous malformations of the brain stem. a review of 139 cases, Acta Neurochir (Wien), 1994, 130, 35, 46, DOI: 10.1007/BF01405501, PMID: 7725941"
10.3171/jns.1999.90.1.0050,10.3171/jns.1999.90.1.0050,75.59896,"Porter, RW. Cavernous malformations of the brainstem: experience with 100 patients, J. neurosurgery, 1999, 90, 50, 58, DOI: 10.3171/jns.1999.90.1.0050"
10.1227/00006123-199305000-00005,10.1097/00006123-199305000-00005,119.86345,"Robinson, JR, Jr, Awad, IA, Magdinec, M, Paranandi, L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain, Neurosurgery, 1993, 32, 730, 736, DOI: 10.1227/00006123-199305000-00005, PMID: 8492847"
10.1179/016164105x39914,10.1179/016164105x39914,81.79147,"Cantu, C. Predictive factors for intracerebral hemorrhage in patients with cavernous angiomas, Neurol. research, 2005, 27, 314, 318, DOI: 10.1179/016164105X39914"
10.3171/jns.1995.83.5.0820,10.3171/jns.1995.83.5.0820,113.95393,"Kondziolka, D, Lunsford, LD, Kestle, JR. The natural history of cerebral cavernous malformations, J. neurosurgery, 1995, 83, 820, 824, DOI: 10.3171/jns.1995.83.5.0820"
10.1227/00006123-199906000-00007,10.1227/00006123-199906000-00007,75.343895,"Moriarity, JL. The natural history of cavernous malformations: a prospective study of 68 patients, Neurosurgery, 1999, 44, 1166, 1173, PMID: 10371615"
10.1227/01.neu.0000159644.04757.45,10.1227/01.neu.0000159644.04757.45,96.14116,"Ferroli, P. Brainstem cavernomas: long-term results of microsurgical resection in 52 patients, Neurosurgery, 2005, 56, 1203, 1214, DOI: 10.1227/01.NEU.0000159644.04757.45, PMID: 15918936"
10.1016/s1042-3680(18)30574-6,10.1016/s1042-3680(18)30574-6,90.70626,"Isamat, F, Conesa, G. Cavernous angiomas of the brain stem, Neurosurg. Clin, 1993, 4, 507, 518, DOI: 10.1016/S1042-3680(18)30574-6"
10.1016/j.neuchi.2007.03.003,10.1016/j.neuchi.2007.03.003,51.356304,"Nataf, F. Brainstem cavernomas: surgical experience at the ch sainte-anne general hospital, Neuro-Chirurgie, 2007, 53, 192, 201, DOI: 10.1016/j.neuchi.2007.03.003, PMID: 17499815"
10.1136/jnnp.72.3.351,10.1136/jnnp.72.3.351,110.72755,"Sandalcioglu, I, Wiedemayer, H, Secer, S, Asgari, S, Stolke, D. Surgical removal of brain stem cavernous malfor-mations: surgical indications, technical considerations, and results, J. Neurol. Neurosurg. & Psychiatry, 2002, 72, 351, 355, DOI: 10.1136/jnnp.72.3.351, PMID: 11861694"
10.1016/s0090-3019(03)00187-3,10.1016/s0090-3019(03)00187-3,109.73875,"Wang, C-c, Liu, A, Zhang, J-t, Sun, B, Zhao, Y-l. Surgical management of brain-stem cavernous malformations: report of 137 cases, Surg. neurology, 2003, 59, 444, 454, DOI: 10.1016/S0090-3019(03)00187-3"
10.3171/2010.6.focus10128,10.3171/2010.6.focus10128,106.77479,"Abla, AA, Turner, JD, Mitha, AP, Lekovic, G, Spetzler, RF. Surgical approaches to brainstem cavernous malformations, Neurosurg. focus, 2010, 29, E8, DOI: 10.3171/2010.6.FOCUS10128"
10.1159/000100121,10.1159/000100121,110.14561,"Kondziolka, D, Flickinger, J. C. & Lunsford, L. D. Radiosurgery for cavernous malformations. In Radiosurgery and Pathological Fundamentals, 20, 220–230 (Karger Publishers, 2007)."
10.3171/jns.1995.83.5.0825,10.3171/jns.1995.83.5.0825,120.55639,"Kondziolka, D, Lunsford, LD, Flickinger, JC, Kestle, JR. Reduction of hemorrhage risk after stereotactic radio-surgery for cavernous malformations, J. neurosurgery, 1995, 83, 825, 831, DOI: 10.3171/jns.1995.83.5.0825"
10.1097/00006123-200101000-00007,10.1227/00006123-200101000-00007,69.488945,"Kupersmith, MJ. Natural history of brainstem cavernous malformations, Neurosurgery, 2001, 48, 47, 54, PMID: 11152360"
10.1097/00006123-199804000-00031,10.1097/00006123-199804000-00031,129.82628,"Gewirtz, RJ, Steinberg, GK, Crowley, R, Levy, RP. Pathological changes in surgically resected angiographically occult vascular malformations after radiation, Neurosurgery, 1998, 42, 738, 741, DOI: 10.1097/00006123-199804000-00031, PMID: 9574637"
10.3171/sup.2005.102.s_supplement.0056,10.3171/jns.2005.102.s_supplement.0056,158.69057,"Nyáry, I, Major, O, Hanzély, Z, Szeifert, GT. Histopathological findings in a surgically resected thalamic cavernous hemangioma 1 year after 40-gy irradiation, J. neurosurgery, 2005, 102, 56, 58, DOI: 10.3171/sup.2005.102.s_supplement.0056"
10.4103/2152-7806.157071,10.4103/2152-7806.157071,96.63,"Kida, Y. Radiosurgery for symptomatic cavernous malformations: A multi-institutional retrospective study in japan, Surg. neurology international, 2015, 6, S249, DOI: 10.4103/2152-7806.157071"
10.1055/s-2000-11378,10.1055/s-2000-11378,38.91696,"Liák, R. Gammakniferadiosurgeryofthebrainstemcavernomas, min-MinimallyInvasive Neurosurg, 2000, 43, 201, 207, DOI: 10.1055/s-2000-11378"
10.1159/000163380,10.1159/000163380,128.6972,"Kida, Y. Radiosurgery for cavernous malformations in basal ganglia, thalamus and brainstem. In Japanese Experience with Gamma Knife Radiosurgery, 22, 31–37 (Karger Publishers, 2009)."
10.3171/2010.3.jns091156,10.3171/2010.3.jns091156,93.07227,"Nagy, G. Stereotactic radiosurgery for deep-seated cavernous malformations: a move toward more active, early intervention, J. neurosurgery, 2010, 113, 691, 699, DOI: 10.3171/2010.3.JNS091156"
10.3171/2010.7.focus10151,10.3171/2010.7.focus10151,83.04264,"Monaco, EA. Stereotactic radiosurgery for the treatment of symptomatic brainstem cavernous malformations, Neurosurg. focus, 2010, 29, E11, DOI: 10.3171/2010.7.FOCUS10151"
10.1016/s0090-3019(96)00425-9,10.1016/s0090-3019(96)00425-9,72.66955,"Kim, D-S, Park, Y-G, Choi, J-U, Chung, S-S, Lee, K-C. An analysis of the natural history of cavernous malfor-mations, Surg. neurology, 1997, 48, 9, 17, DOI: 10.1016/S0090-3019(96)00425-9"
10.1227/neu.0b013e3181eb5032,10.1227/neu.0b013e3181eb5032,75.52329,"Menzler, K. Epileptogenicity of cavernomas depends on (archi-) cortical localization, Neurosurgery, 2010, 67, 918, 924, DOI: 10.1227/NEU.0b013e3181eb5032, PMID: 20881556"
10.1097/00006123-199607000-00007,10.1097/00006123-199607000-00007,101.49272,"Casazza, M. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome, Neurosurgery, 1996, 39, 26, 34, DOI: 10.1097/00006123-199607000-00007, PMID: 8805137"
10.1111/j.1528-1167.2009.02397.x,10.1111/j.1528-1167.2009.02397.x,120.595215,"Kwan, P. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ilae commission on therapeutic strategies, Epilepsia, 2010, 51, 1069, 1077, DOI: 10.1111/j.1528-1167.2009.02397.x, PMID: 19889013"
10.1038/nrd2467,10.1038/nrd2467,90.16852,"Supuran, CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Discov 2008; 7: 168–81. PMID: 18167490"
10.1038/nrd2467,10.1038/nrd2467,91.09233,"Supuran, CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168–81. PMID: 18167490"
10.3109/14756366.2015.1122001,10.3109/14756366.2015.1122001,81.21761,"Supuran, CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016; 31: 345–60. PMID: 26619898"
10.2174/138161208783877910,10.2174/138161208783877910,71.35264,"Supuran, CT. Editorial. Carbonic anhydrases as drug targets. Curr Pharm Des 2008; 14: 601–2. PMID: 18336304"
10.1042/bcj20160115,10.1042/bcj20160115,71.09136,"Supuran, CT. Structure and function of carbonic anhydrases. Biochem J 2016; 473: 2023–32. PMID: 27407171"
10.3390/metabo7030048,10.3390/metabo7030048,84.29616,"Supuran, CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites 2017; 7: 48."
10.1080/17460441.2017.1253677,10.1080/17460441.2017.1253677,83.941795,"Supuran, CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Exp Opin Drug Discov 2017; 12: 61–88."
10.1080/13543776.2018.1523897,10.1080/13543776.2018.1523897,80.81105,"Supuran, CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018; 28: 709–12. PMID: 30217119"
10.1080/17460441.2019.1651289,10.1080/17460441.2019.1651289,116.255745,"Nocentini, A, Supuran, CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 2019; 14: 1175–97. PMID: 31436118"
10.1002/anie.200701189,10.1002/anie.200701189,124.75182,"Köhler, K, Hillebrecht, A, Schulze Wischeler, J, et al. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Angew Chem Int Ed Engl 2007; 46: 7697–9. PMID: 17705204"
10.1080/13543784.2018.1548608,10.1080/13543784.2018.1548608,96.875275,"Supuran, CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018; 27: 963–70."
10.4155/fmc.14.68,10.4155/fmc.14.68,91.41842,"Carta, F, Supuran, CT, Scozzafava, A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem 2014; 6: 1149–65. PMID: 25078135"
10.1080/14756366.2018.1515933,10.1080/14756366.2018.1515933,112.41531,"Akocak, S, Lolak, N, Bua, S, Supuran, CT. Discovery of novel 1, 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. J Enzyme Inhibit Med Chem 2018; 33: 1575–80."
10.1021/jm101541x,10.1021/jm101541x,127.22339,"Pacchiano, F, Carta, F, McDonald, PC, et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011; 54: 1896–902. PMID: 21361354"
10.1039/c0cc02707c,10.1039/c0cc02707c,150.03372,"Pacchiano, F, Aggarwal, M, Avvaru, BS, et al. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. Chem Communicat 2010; 46: 8371–3."
10.1002/1521-3773(20020916)41:18<3338::aid-anie3338>3.0.co;2-7,10.1002/1521-3773(20020916)41:18<3338::aid-anie3338>3.0.co;2-7,85.21071,"Kimball, DB, Haley, MM. Triazenes: a versatile tool in organic synthesis. Angew Chem Int Ed 2002; 41: 3338–51."
10.1016/j.phrs.2007.08.003,10.1016/j.phrs.2007.08.003,91.11691,"Marchesi, F, Turriziani, M, Tortorelli, G, et al. Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res 2007; 56: 275–87. PMID: 17897837"
10.2174/1381612825666190617155749,10.2174/1381612825666190617155749,86.29245,"Francisco, AP, Mendes, E, Santos, AR, Perry, MJ. Anticancer triazenes: from bioprecursors to hybrid molecules. Curr Pharm Des 2019; 25: 1623–42. PMID: 31244412"
10.1016/s0223-5234(98)80033-0,10.1016/s0223-5234(98)80033-0,139.7215,"Supuran, CT, Scozzafava, A, Jurca, BC, Ilies, MA. Carbonic anhydrase inhibitors-Part 49: synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I. Eur J Med Chem 1998; 33: 83–93."
10.1016/j.bioorg.2018.02.015,10.1016/j.bioorg.2018.02.015,132.59395,"Lolak, N, Akocak, S, Bua, S, et al. Design and synthesis of novel 1, 3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors. Bioorg Chem 2018; 77: 542–7. PMID: 29462772"
10.3109/14756366.2013.806497,10.3109/14756366.2013.806497,121.709,"Bilginer, S, Unluer, E, Gul, HI, et al. Carbonic anhydrase inhibitors. Phenols incorporating 2-or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase. J Enzyme Inhibit Med Chem 2014; 29: 495–9."
10.1080/14756366.2016.1243536,10.1080/14756366.2016.1243536,94.09989,"Gul, HI, Mete, E, Eren, SE, et al. Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4, 5-dihydro-pyrazol-1-yl] benzenesulfonamides. J Enzyme Inhibit Med Chem 2017; 32: 169–75."
10.1080/14756366.2016.1244533,10.1080/14756366.2016.1244533,84.81143,"Gul, HI, Mete, E, Taslimi, P, et al. Synthesis, carbonic anhydrase I and II inhibition studies of the 1, 3, 5-trisubstituted-pyrazolines. J Enzyme Inhibit Med Chem 2017; 32: 189–92."
10.1016/j.bioorg.2019.103057,10.1016/j.bioorg.2019.103057,107.14148,"Gul, HI, Tugrak, M, Gul, M, et al. New phenolic Mannich bases with piperazines and their bioactivities. Bioorg Chem 2019; 90: 103057. PMID: 31226471"
10.1016/j.bioorg.2018.03.027,10.1016/j.bioorg.2018.03.027,182.41817,"Gul, HI, Yamali, C, Bulbuller, M, et al. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes. Bioorg Chem 2018; 78: 290–7. PMID: 29621641"
10.3109/14756366.2016.1149479,10.3109/14756366.2016.1149479,102.3869,"Ozgun, DO, Yamali, C, Gul, HI, et al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J Enzyme Inhibit Med Chem 2016; 31: 1498–501."
10.1111/cbdd.13149,10.1111/cbdd.13149,157.64905,"Yamali, C, Gul, HI, Ece, A, et al. Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes. Chem Biol Drug Des 2018; 91: 854–66. PMID: 29143485"
10.3109/14756366.2015.1126715,10.3109/14756366.2015.1126715,106.26263,"Yamali, C, Tugrak, M, Gul, HI, Tanc, M, et al. The inhibitory effects of phenolic Mannich bases on carbonic anhydrase I and II isoenzymes. J Enzyme Inhibit Med Chem 2016; 31: 1678–81."
10.1080/14756366.2019.1670657,10.1080/14756366.2019.1670657,112.12081,"Bilginer, S, Gul, HI, Erdal, FS, et al. Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2 (3H)-benzoxazolones. J Enzyme Inhibit Med Chem 2019; 34: 1722–9."
10.1080/14756366.2018.1530994,10.1080/14756366.2018.1530994,96.570885,"Canakci, D, Koyuncu, I, Lolak, N, et al. Synthesis and cytotoxic activities of novel copper and silver complexes of 1,3-diaryltriazene-substituted sulfonamides. J Enzyme Inhib Med Chem 2019; 34: 110–6. PMID: 30362387"
10.1021/jm301625s,10.1021/jm301625s,123.86423,"Tars, K, Vullo, D, Kazaks, A, et al. Sulfocoumarins (1,2-benzoxathiine 2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013; 56: 293–300. PMID: 23241068"
10.1016/j.jinorgbio.2011.11.017,10.1016/j.jinorgbio.2011.11.017,80.492,"De Simone, G, Supuran, CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012; 111: 117–29. PMID: 22192857"
10.1080/14756366.2018.1428572,10.1080/14756366.2018.1428572,92.02446,"Supuran, CT. Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018; 33: 485–95. PMID: 29390912"
10.1021/jm000296j,10.1021/jm000296j,149.79242,"Scozzafava, A, Menabuoni, L, Mincione, F, et al. Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. J Med Chem 2000; 43: 4542–51. PMID: 11087579"
10.1021/jm9901879,10.1021/jm9901879,147.06165,"Scozzafava, A, Briganti, F, Mincione, G, et al. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route. J Med Chem 1999; 42: 3690–700. PMID: 10479300"
10.1016/s0223-5234(99)80039-7,10.1016/s0223-5234(99)80039-7,133.24236,"Supuran, CT, Clare, BW. Carbonic anhydrase inhibitors. Part 57. Quantum chemical QSAR of a group of 1,3,4-thiadiazole and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties. Eur J Med Chem 1999; 34: 41–50."
10.1016/0223-5234(96)85163-4,10.1016/0223-5234(96)85163-4,154.12567,"Supuran, CT, Nicolae, A, Popescu, A. Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes. Eur J Med Chem 1996; 31: 431–8."
10.1016/j.bmcl.2011.05.071,10.1016/j.bmcl.2011.05.071,78.35519,"Sarikaya, SBÖ, Topal, F, Şentürk, M, et al. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011; 21: 4259–62. PMID: 21669522"
10.1016/j.bmc.2009.01.067,10.1016/j.bmc.2009.01.067,93.455376,"Sentürk, M, Gülçin, I, Daştan, A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009; 17: 3207–11. PMID: 19231207"
10.1016/s0223-5234(98)80042-1,10.1016/s0223-5234(98)80042-1,99.59885,"Supuran, CT, Ilies, MA, Scozzafava, A. Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives. Eur J Med Chem 1998; 33: 739–52."
10.1126/science.123.3191.309,10.1126/science.123.3191.309,57.10536,"Warburg, O. On the origin of cancer cells. Science 1956; 123: 309–14. PMID: 13298683"
10.1007/s10555-014-9531-3,10.1007/s10555-014-9531-3,101.622215,"Fais, S, Venturi, G, Gatenby, B. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastas Rev 2014; 33: 1095–108."
10.1038/nrc1478,10.1038/nrc1478,88.45285,"Gatenby, RA, Gillies, RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891–9. PMID: 15516961"
10.1126/science.1160809,10.1126/science.1160809,93.35759,"Vander Heiden, MG, Cantley, LC, Thompson, CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029–33. PMID: 19460998"
10.1038/nrc2981,10.1038/nrc2981,73.29105,"Cairns, RA, Harris, IS, Mak, TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85–95. PMID: 21258394"
10.1038/nrd3554,10.1038/nrd3554,95.41845,"Neri, D, Supuran, CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011; 10: 767–77. PMID: 21921921"
10.1038/s41568-018-0030-7,10.1038/s41568-018-0030-7,91.22604,"Gillies, RJ, Brown, JS, Anderson, ARA, Gatenby, RA. Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow. Nat Rev Cancer 2018; 18: 576–85. PMID: 29891961"
10.1016/j.molmed.2011.09.001,10.1016/j.molmed.2011.09.001,112.36433,"Fais, S, Fauvarque, M-O. TM9 and cannibalism: how to learn more about cancer by studying amoebae and invertebrates. Trends Mol Med 2012; 18: 4–5. PMID: 22001540"
10.3109/14756366.2016.1156105,10.3109/14756366.2016.1156105,46.634884,"Fais, S. A non-mainstream approach against cancer. J Enzyme Inhib Med Chem 2016; 31: 882–9. PMID: 26972280"
10.1038/s41568-018-0073-9,10.1038/s41568-018-0073-9,85.15788,"Fais, S, Overholtzer, M. Cell-in-cell phenomena in cancer. Nat Rev Cancer 2018; 18: 758–66. PMID: 30420767"
10.3390/metabo8010002,10.3390/metabo8010002,90.75404,"Iessi, E, Logozzi, M, Mizzoni, D, et al. Rethinking the combination of proton exchanger inhibitors in cancer therapy. Metabolites 2017; 8: 2."
10.4155/fmc.15.71,10.4155/fmc.15.71,82.15206,"Supuran, CT, Winum, J-Y. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem 2015; 7: 1407–14. PMID: 26230880"
10.4155/fmc.15.71,10.4155/fmc.15.71,82.15206,"Supuran, CT, Winum, JY. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem 2015; 7: 1407–14. PMID: 26230880"
10.1371/journal.pone.0088193,10.1371/journal.pone.0088193,102.47192,"Federici, C, Petrucci, F, Caimi, S, et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 2014; 9: e88193. PMID: 24516610"
10.1016/j.drup.2015.08.004,10.1016/j.drup.2015.08.004,111.949745,"Taylor, S, Spugnini, EP, Assaraf, YG, et al. Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updat 2015; 23: 69–78. PMID: 26341193"
10.1016/j.canlet.2017.06.036,10.1016/j.canlet.2017.06.036,95.30976,"Logozzi, M, Angelini, DF, Iessi, E, et al. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients. Cancer Lett 2017; 403: 318–29. PMID: 28694142"
10.3390/cancers10100370,10.3390/cancers10100370,128.83682,"Logozzi, M, Mizzoni, D, Angelini, D, et al. Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes. Cancers 2018; 10: 370."
10.1007/s10555-019-09783-8,10.1007/s10555-019-09783-8,107.238625,"Logozzi, M, Spugnini, E, Mizzoni, D, et al. Extracellular acidity and increased exosome release as key phenotypes of malignant tumors. Cancer Metastasis Rev 2019; 38: 93–101. PMID: 30715644"
10.1038/ncb1596,10.1038/ncb1596,98.85398,"Valadi, H, Ekström, K, Bossios, A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654–9. PMID: 17486113"
10.1093/nar/gks658,10.1093/nar/gks658,135.92897,"Nolte’tHoen, ENM, Buermans, HPJ, Waasdorp, M, et al. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 2012; 40: 9272–85. PMID: 22821563"
10.1016/j.canlet.2013.05.012,10.1016/j.canlet.2013.05.012,165.65692,"Canitano, A, Venturi, G, Borghi, M, et al. Exosomes released in vitro from Epstein–Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs. Cancer Lett 2013; 337: 193–9. PMID: 23684926"
10.1016/j.bbcan.2017.11.005,10.1016/j.bbcan.2017.11.005,88.38757,"Zhao, H, Achreja, A, Iessi, E, et al. The key role of extracellular vesicles in the metastatic process. Biochim Biophys Acta BBA -Rev Cancer 2018; 1869: 64–77."
10.3390/ijms19123968,10.3390/ijms19123968,105.78857,"Spugnini, E, Logozzi, M, Di Raimo, R, et al. A role of tumor-released exosomes in paracrine dissemination and metastasis. Int J Mol Sci 2018; 19: 3968."
10.1080/14756366.2017.1292263,10.1080/14756366.2017.1292263,121.1337,"Iessi, E, Logozzi, M, Lugini, L, et al. Acridine orange/exosomes increase the delivery and the effectiveness of acridine orange in human melanoma cells: a new prototype for theranostics of tumors. J Enzyme Inhib Med Chem 2017; 32: 648–57. PMID: 28262028"
10.1080/14756366.2017.1335310,10.1080/14756366.2017.1335310,80.98139,"Kusuzaki, K, Matsubara, T, Murata, H, et al. Natural extracellular nanovesicles and photodynamic molecules: is there a future for drug delivery? J Enzyme Inhib Med Chem 2017; 32: 908–16. PMID: 28708430"
10.1371/journal.pone.0005219,10.1371/journal.pone.0005219,104.38222,"Logozzi, M, De Milito, A, Lugini, L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009; 4: e5219. PMID: 19381331"
10.1074/jbc.m109.041152,10.1074/jbc.m109.041152,89.64545,"Parolini, I, Federici, C, Raggi, C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284: 34211–22. PMID: 19801663"
10.3390/cancers11030429,10.3390/cancers11030429,109.97054,"Rodríguez Zorrilla, S, Pérez-Sayans, M, Fais, S, et al. A pilot clinical study on the prognostic relevance of plasmatic exosomes levels in oral squamous cell carcinoma patients. Cancers 2019; 11: 429."
10.1080/14756366.2018.1538980,10.1080/14756366.2018.1538980,110.741554,"Logozzi, M, Capasso, C, Di Raimo, R, et al. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem 2019; 34: 272–8. PMID: 30734594"
10.1007/s12253-015-9935-6,10.1007/s12253-015-9935-6,90.616844,"Li, Y, Dong, M, Sheng, W, Huang, L. Roles of carbonic anhydrase IX in development of pancreatic cancer. Pathol Oncol Res 2016; 22: 277–86. PMID: 26224207"
10.1186/s13000-016-0495-1,10.1186/s13000-016-0495-1,116.150314,"Ambrosio, MR, Di Serio, C, Danza, G, et al. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer. Diagn Pathol 2016; 11: 45. PMID: 27225200"
10.1021/acs.biochem.6b00243,10.1021/acs.biochem.6b00243,78.45755,"Mahon, BP, Bhatt, A, Socorro, L, et al. The structure of carbonic anhydrase IX is adapted for low-pH catalysis. Biochemistry 2016; 55: 4642–53. PMID: 27439028"
10.1016/j.bbrc.2017.08.107,10.1016/j.bbrc.2017.08.107,67.730385,"Horie, K, Kawakami, K, Fujita, Y, et al. Exosomes expressing carbonic anhydrase 9 promote angiogenesis. Biochem Biophys Res Commun 2017; 492: 356–61. PMID: 28851650"
10.4149/bll_2016_038,10.4149/bll_2016_038,107.08524,"Rosenberg, V, Pastorekova, S, Zatovicova, M, et al. High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer. Bratisl Lek Listy 2016; 117: 201–4. PMID: 27075382"
10.1002/med.21497,10.1002/med.21497,111.8658,"Supuran, CT, Alterio, V, Di Fiore, A, et al. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med Res Rev 2018; 38: 1799–836. PMID: 29635752"
10.1080/14756366.2017.1411350,10.1080/14756366.2017.1411350,100.01426,"Lucarini, L, Magnelli, L, Schiavone, N, et al. Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma. J Enzyme Inhib Med Chem 2018; 33: 234–40. PMID: 29251173"
10.1111/neup.12485,10.1111/neup.12485,147.70157,"Cetin, B, Gonul, II, Gumusay, O, et al. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme: carbonic anhydrase IX and glioblastoma multiforme. Neuropathology 2018; 38: 457–62. PMID: 29952031"
10.1038/s41598-017-02169-2,10.1038/s41598-017-00957-4,95.0476,"Lin, C, Wong, BCK, Chen, H, et al. Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy. Sci Rep 2017; 7: 2019–23. PMID: 28515482"
10.3727/096504017x14965111926391,10.3727/096504017x14965111926391,148.82039,"Riemann, A, Güttler, A, Haupt, V, et al. Inhibition of carbonic anhydrase IX by ureidosulfonamide inhibitor U104 reduces prostate cancer cell growth, but does not modulate daunorubicin or cisplatin cytotoxicity. Oncol Res Featur Preclin Clin Cancer Ther 2018; 26: 191–200."
10.3390/cancers11071002,10.3390/cancers11071002,156.25691,"Hedlund, EE, McDonald, PC, Nemirovsky, O, et al. Harnessing induced essentiality: targeting carbonic anhydrase IX and angiogenesis reduces lung metastasis of triple negative breast cancer xenografts. Cancers 2019; 11: 1002."
10.1007/978-94-007-7359-2_11,10.1007/978-94-007-7359-2_11,149.85512,"Benej, M, Pastorekova, S, Pastorek, J. Carbonic anhydrase IX: regulation and role in cancer In, Frost, SC, McKenna, R, editors. Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications. Vol. 75 Dordrecht: Springer Netherlands; 2014 p. 199–219."
10.1007/s00109-017-1590-9,10.1007/s00109-017-1590-9,102.15734,"Andreucci, E, Peppicelli, S, Carta, F, et al. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis. J Mol Med 2017; 95: 1341–53. PMID: 28929255"
10.1093/intimm/dxh267,10.1093/intimm/dxh267,101.7251,"Caby, M-P, Lankar, D, Vincendeau-Scherrer, C, et al. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17: 879–87. PMID: 15908444"
10.1080/20013078.2018.1535750,10.1080/20013078.2018.1461450,89.01371,"Théry, C, Witwer, KW, Aikawa, E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7: 1535750. PMID: 30637094"
10.1002/0471143030.cb0322s30,10.1002/0471143030.cb0322s30,106.02254,"Théry, C, Amigorena, S, Raposo, G, Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; 30: 3.22.1–3.22.29."
10.1016/0042-6822(92)90464-z,10.1016/0042-6822(92)90464-z,109.518105,"Pastoreková, S, Závadová, Z, Košťál, M, et al. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992; 187: 620–6. PMID: 1312272"
10.3390/cancers11010118,10.3390/cancers11010118,123.37643,"Logozzi, M, Mizzoni, D, Di Raimo, R, et al. Oral administration of fermented papaya (FPP®) controls the growth of a murine melanoma through the in vivo induction of a natural antioxidant response. Cancers 2019; 11: 118."
10.1016/j.bmcl.2009.08.088,10.1016/j.bmcl.2009.08.088,146.59364,"Innocenti, A, Pastorekova, S, Pastorek, J, et al. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO 2 hydration at acidic pH values characteristic of solid tumors. Bioorg Med Chem Lett 2009; 19: 5825–8. PMID: 19751975"
10.1158/1535-7163.mct-11-0450,10.1158/1535-7163.mct-11-0450,128.58083,"Gozgit, JM, Wong, MJ, Moran, L, et al. Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Mol Cancer Ther 2012; 11: 690–9. PMID: 22238366"
10.1021/jm2006222,10.1021/jm2006222,127.98251,"Guagnano, V, Furet, P, Spanka, C, et al. Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-ylphenylamino] -pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase. J Med Chem 2011; 54: 7066–83. PMID: 21936542"
10.1158/0008-5472.can-11-3034,10.1158/0008-5472.can-11-3034,113.65168,"Gavine, PR, Mooney, L, Kilgour, E, et al. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res 2012; 72: 2045–56. PMID: 22369928"
10.1158/1535-7163.mct-11-0306,10.1158/1535-7163.mct-11-0306,95.96559,"Zhao, GS, Li, WY, Chen, DH, et al. A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models. Mol Cancer Ther 2011; 10: 2200–10. PMID: 21900693"
10.1158/1535-7163.mct-16-0589,10.1158/1535-7163.mct-16-0589,84.66991,"Perera, TPS, Jovcheva, E, Mevellec, L, et al. Discovery and pharmacological characterization of JNJ-42756493 (erdafitinib), a functionally selective smallmolecule FGFR family inhibitor. Mol Cancer Ther 2017; 16: 1010–20. PMID: 28341788"
10.1158/1535-7163.mct-14-0248,10.1158/1535-7163.mct-14-0248,105.13174,"Nakanishi, Y, Akiyama, N, Tsukaguchi, T, et al. The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor. Mol Cancer Ther 2014; 13: 2547–58. PMID: 25169980"
10.1039/c5ob00778j,10.1039/c5ob00778j,85.561356,"Liu, J, Peng, X, Dai, Y, et al. Design, synthesis and biological evaluation of novel FGFR inhibitors bearing indazole scaffold. Org Biomol Chem 2015; 13: 7643–54. PMID: 26080733"
10.1107/s1399004714027539,10.1107/s1399004714027539,89.29164,"Yosaatmadja, Y, Patterson, AV, Smaill, JB, Squire, CJ. The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition. Acta Crystallogr 2015; 71: 525–33."
10.1038/nrc2559,10.1038/nrc2559,76.47706,"Zhang, J, Yang, PL, Gray, NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009; 9: 28–39. PMID: 19104514"
10.1016/j.str.2014.09.019,10.1016/j.str.2014.09.019,121.226234,"Tucker, JA, Klein, T, Breed, J, et al. Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4. Structure 2014; 22: 1764–74. PMID: 25465127"
10.1021/cr00039a007,10.1021/cr00039a007,95.11536,"Miyaura, N, Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem Rev 1995; 95: 2457–85."
10.1021/acs.jmedchem.7b00360,10.1021/acs.jmedchem.7b00360,95.78849,"Ken, AB, Timothy, DO, Erik, V, et al. Discovery of the irreversible covalent FGFR inhibitor 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8 H)‑one (PRN1371) for the treatment of solid tumors. J Med Chem 2017; 60: 6516–27. PMID: 28665128"
10.1016/j.ejmech.2017.04.049,10.1016/j.ejmech.2017.04.049,90.66892,"Li, X, Guise, CP, Taghipouran, R, et al. 2-Oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitors. Eur J Med Chem 2017; 135: 531–43. PMID: 28521156"
10.1021/acs.jmedchem.8b01531,10.1021/acs.jmedchem.8b01531,86.26175,"Lu, X, Chen, H, Patterson, AV, et al. Fibroblast growth factor receptor 4 (FGFR4) selective inhibitors as hepatocellular carcinoma therapy: advances and prospects. J Med Chem 2019; 62: 2905–15. PMID: 30403487"
10.1016/j.ejmech.2013.01.029,10.1016/j.ejmech.2013.01.029,94.56714,"Costa, JS, Lopes, JPB, Russowsky, D, et al. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl-and butyrylcholinesterase inhibitors. Eur J Med Chem 2013; 62: 556–63. PMID: 23422935"
10.2174/1570159x13666150716165726,10.2174/1570159x13666150716165726,58.40109,"Vieira, THF, Guimaraes, IM, Silva, FR, Ribeiro, FM. Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol 2016; 14: 101–15. PMID: 26813123"
10.1080/14756366.2016.1210139,10.1080/14756366.2016.1210139,79.35795,"Wu, WY, Dai, YC, Li, NG, et al. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem 2017; 32: 572–87. PMID: 28133981"
10.2174/0929867321666141106122628,10.2174/0929867321666141106122628,106.80451,"Guzior, N, Wi.eckowska, A, Panek, D, Malawska, B. Recent development of multifunctional agents as potential drug candidates for the treatment of alzheimer’s disease. Curr Med Chem 2014; 22: 373–404."
10.1016/j.biotechadv.2016.12.005,10.1016/j.biotechadv.2016.12.005,81.086136,"Dey, A, Bhattacharya, R, Mukherjee, A, Pandey, DK. Natural products against Alzheimer's disease: pharmacotherapeutics and biotechnological interventions. Biotechnol Adv 2017; 35: 178–216. PMID: 28043897"
10.1021/jm501100b,10.1021/jm501100b,101.70442,"Vitaku, E, Smith, DT, Njardarson, JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem 2014; 57: 10257–74. PMID: 25255204"
10.1002/jbt.21581,10.1002/jbt.21581,108.559586,"Bosenbecker, J, Bareño, VDO, Difabio, R, et al. Synthesis and antioxidant activity of 3-(pyridin-2-yl,ethyl)-1,3-thiazinan(thiazolidin)-4-ones. J Biochem Mol Toxic 2014; 28: 425–32."
10.1111/cbdd.13009,10.1111/cbdd.13009,91.81461,"Bielenica, A, Sanna, G, Madeddu, S, et al. New thiourea and 1,3-thiazolidin-4-one derivatives effective on the HIV-1 virus. Chem Biol Drug Des 2017; 90: 883–91. PMID: 28434186"
10.1016/j.ejmech.2017.12.049,10.1016/j.ejmech.2017.12.049,102.48941,"Ansari, MF, Idrees, D, Hassan, MI, et al. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: targeting human carbonic anhydrase IX. Eur J Med Chem 2018; 144: 544–56. PMID: 29289880"
10.1016/j.ejmech.2016.08.057,10.1016/j.ejmech.2016.08.057,101.77353,"da Silva, DS, da Silva, CEH, Soares, MSP, et al. Thiazolidin-4-ones from 4-(methylthio)benzaldehyde and 4-(methylsulfonyl)benzaldehyde: synthesis, antiglioma activity and cytotoxicity. Eur J Med Chem 2016; 124: 574–82. PMID: 27614406"
10.1016/j.ejmech.2016.04.028,10.1016/j.ejmech.2016.04.028,104.93345,"Gouvêa, DP, Vasconcellos, FA, Berwaldt, GA, et al. 2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies. Eur J Med Chem 2016; 118: 259–65. PMID: 27131068"
10.1007/s00044-017-1837-6,10.1007/s00044-017-1837-6,110.520905,"Patel, NB, Patel, MD. Synthesis and evaluation of antibacterial and antifungal activities of 4-thiazolidinones and 2-azetidinones derivatives from chalcone. Med Chem Res 2017; 26: 1772–83."
10.1016/j.ejmech.2013.01.054,10.1016/j.ejmech.2013.01.054,113.41461,"Raza, S, Srivastava, SP, Srivastava, DS, et al. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Eur J Med Chem 2013; 63: 611–20. PMID: 23567949"
10.1016/j.ejmech.2017.11.097,10.1016/j.ejmech.2017.11.097,85.73143,"Solomon, VR, Pundir, S, Le, HT, Lee, H. Design and synthesis of novel quinacrine-[1,3]-thiazinan-4-one hybrids for their anti-breast cancer activity. Eur J Med Chem 2018; 143: 1028–38. PMID: 29232580"
10.1016/j.arabjc.2011.07.007,10.1016/j.arabjc.2011.07.007,84.248146,"Kumawat, MK, Singh, UP, Singh, B, et al. Synthesis and antimalarial activity evaluation of 3-(3-(7-chloroquinolin-4-ylamino)propyl)-1,3-thiazinan-4-one derivatives. Arab J Chem 2016; 9: 643–7."
10.24959/ophcj.14.814,10.24959/ophcj.14.814,109.532425,"Elenich, IP, Rassukana, YV, Khomutnik, YY, et al. Synthesis, the antioxidant and antibacterial activity of fluoroalkyl substituted thiazolidinones and thiazinanones incorporating an aminophosphonate or aminocarboxylate fragment. Zh Org Farm Khim 2014; 12: 45–8."
10.1016/j.exppara.2018.07.012,10.1016/j.exppara.2018.07.012,134.76465,"Zehetmeyr, FK, da Silva, M, Pereira, KM, et al. Ovicidal in vitro activity of 2-aryl-3-(2-morpholinoethyl)thiazolidin-4-ones and 2-aryl-3-(3-morpholino-propyl)thiazolidin-4-ones against Fasciola hepatica (Linnaeus, 1758). Exp Parasitol 2018; 192: 60–4. PMID: 30040962"
10.1055/s-0036-1590866,10.1055/s-0036-1590866,114.82689,"Drawanz, BB, Zimmer, GC, Rodrigues, LV, et al. 5,6,7,8-Tetrahydronaphthalen-1-amine as precursor for thiazolidinones and benzothiazepinones: synthesis and atropisomeric relationship. Synthesis 2017; 49: 5167–75."
10.1016/0006-2952(61)90145-9,10.1016/0006-2952(61)90145-9,76.726654,"Elmann, GL, Courtney, KD, Andres, V, Featherstone, RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95. PMID: 13726518"
10.1016/0003-2697(76)90527-3,10.1016/0003-2697(76)90527-3,96.84504,"Bradford, MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976; 72: 248–54. PMID: 942051"
10.1006/abio.1976.9999,10.1016/0003-2697(76)90527-3,96.84504,"Bradford, MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976; 72: 248–54. PMID: 942051"
10.1016/s0006-8993(99)01503-6,10.1016/s0006-8993(99)01503-6,170.80324,"Gottfried, C, Valentim, L, Salbego, C, et al. Regulation of protein phosphorylation in astrocyte cultures by external calcium ions: specific effects on the phosphorylation of glial fibrillary acidic protein (GFAP), vimentin and heat shock protein 27 (HSP27). Brain Res 1999; 833: 142–9. PMID: 10375689"
10.2174/1568026619666190128125912,10.2174/1568026619666190128125912,66.24,"Saxena, M, Dubey, R. Target enzyme in alzheimer's disease: acetylcholinesterase inhibitors. Curr Top Med Chem 2019; 19: 264–75. PMID: 30706815"
10.3389/fnagi.2019.00220,10.3389/fnagi.2019.00220,102.17595,"Jo, T, Nho, K, Saykin, AJ. Deep learning in alzheimer's disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci 2019; 11: 220. PMID: 31481890"
10.2147/ijn.s200490,10.2147/ijn.s200490,71.54497,"Tiwari, S, Atluri, V, Kaushik, A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 2019; 14: 5541–54. PMID: 31410002"
10.7861/clinmedicine.16-3-247,10.7861/clinmedicine.16-3-247,62.86604,"Briggs, R, Kennelly, SP, O'Neill, D. Drug treatments in Alzheimer's disease. Clin Med (Lond) 2016; 16: 247–53. PMID: 27251914"
10.1080/14756360701421294,10.1080/14756360701421294,81.34171,"Wiesner, J, Kříž, Z, Kuča, K, et al. Acetylcholinesterases-the structural similarities and differences. J Enzyme Inhib Med Chem 2007; 22: 417–24. PMID: 17847707"
10.1055/s-0031-1296772,10.1055/s-0031-1296772,88.407745,"Ozadali, K, Ozkannli, F, Erol, D, et al. Synthesis and biological activities of some thiazolidin-4-ones. Arzneimittelforschung 2006; 56: 678–81. PMID: 17225562"
10.1016/j.bmc.2014.01.010,10.1016/j.bmc.2014.01.010,80.05094,"Nam, SO, Park, DH, Lee, YH, et al. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014; 22: 1262–7. PMID: 24485122"
10.1016/j.bmcl.2007.04.015,10.1016/j.bmcl.2007.04.015,70.44367,"Tang, H, Ning, FX, Wei, YB, et al. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors. Bioorg Med Chem Lett 2007; 17: 3765–8. PMID: 17451950"
10.1111/jnc.13651,10.1111/jnc.13651,143.32954,"Anuncibay-Soto, B, Pérez-Rodríguez, D, Santos-GAldiano, M, Font, E, Regueiro-Purriños, M, Fernández-López, A. Post-ischemic salubrinal treatment results in a neuroprotective role in global cerebral ischemia, J Neurochem, 2016, 138, 295, 306, PMID: 27123756"
10.1111/jnc.14789,10.1111/jnc.14789,163.83458,"Font-Belmonte, E, Ugidos, IF, Santos-Galdiano, M, González-Rodríguez, P, Anuncibay-Soto, B, Pérez-Rodríguez, D, Gonzalo-Orden, M, Fernández-López, A. Post-ischemic salubrinal administration reduces necroptosis in a rat model of global cerebral ischemia, J Neurochem, 2019, doi: 10.1111/jnc.14789"
10.1038/s41418-017-0012-4,10.1038/cdd.2008.150,93.34657,"Galluzzi, L, Vitale, I, Aaronson, SA, Abrams, JM, Adam, D, Agostinis, P, Alnemri, ES, Altucci, L, Amelio, I, Andrews, DW, Annicchiarico-Petruzzelli, M, Antonov, AV, Arama, E, Baehrecke, EH, Barlev, NA, Bazan, NG, Bernassola, F, Bertrand, MJM, Bianchi, K, Blagosklonny, MV. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018, Cell Death Differ, 2018, 25, 486, 541, PMID: 29362479"
10.1016/j.cell.2017.03.020,10.1016/j.cell.2017.03.020,143.07864,"Gong, YN, Guy, C, Olauson, H, Becker, JU, Yang, M, Fitzgerald, P, Linkermann, A, Green, DR. ESCRT-III Acts downstream of MLKL to regulate necroptotic cell death and its consequences, Cell, 2017, 169, 286, 300.e16, PMID: 28388412"
10.1016/j.cell.2019.04.024,10.1016/j.cell.2019.04.024,90.25468,"Green, DR. The coming decade of cell death research: Five riddles, Cell, 2019, 177, 1094, 1107, PMID: 31100266"
10.1152/ajplung.00069.2018,10.1152/ajplung.00069.2018,149.43547,"Kim, H, Zamel, R, Bai, XH, Lu, C, Keshavjee, S, Keshavjee, S, Liu, M. Ischemia reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting, Am J Physiol Lung Cell Mol Physiol, 2018, 315, L595, 608, PMID: 30024306"
10.1016/j.brainres.2016.04.063,10.1016/j.brainres.2016.04.063,140.36568,"Logsdon, AF, Lucke-Wold, BP, Nguyen, L, Matsumoto, RR, Turner, RC, Rosen, CL, Huber, JD. Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury, Brain Res, 2016, 1643, 140, 151, PMID: 27131989"
10.1038/nrm2970,10.1038/nrm2970,129.00768,"Vandenabeele, P, Galluzzi, L, Vanden Berghe, T, Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion, Nat Rev Mol Cell Biol, 2018, 11, 700, 714"
10.1016/j.nbd.2014.04.002,10.1016/j.nbd.2014.04.002,154.53894,"Vieira, M, Fernandes, J, Carreto, L, Anuncibay-Soto, B, Santos, M, Han, J, Fernández-López, A, Duarte, CB, Carvalho, AL, Santos, AE. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3, Neurobiol Dis, 2018, 68, 26, 36"
10.1016/j.redox.2018.02.019,10.1016/j.redox.2018.02.019,156.57005,"Zhu, P, Hu, S, Jin, Q, Li, D, Tian, F, Toan, S, Li, Y, Zhou, H, Chen, Y. Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/MPTP pathway, Redox Biol, 2018, 16, 157, 168, PMID: 29502045"
10.1016/j.exger.2018.12.005,10.1016/j.exger.2018.12.005,179.59244,"Abraham, D, Feher, J, Scuderi, GL, Szabo, D, Dobolyi, A, Cservenak, M, Juhasz, J, Ligeti, B, Pongor, S, Gomez-Cabrera, MC, Vina, J, Higuchi, M, Suzuki, K, Boldogh, I, Radak, Z. Exercise and probiotics attenuate the development of Alzheimer’s disease in transgenic mice: Role of microbiome, Exp Gerontol, 2019, 115, 122, 131, PMID: 30529024"
10.3389/fnagi.2016.00256,10.3389/fnagi.2016.00256,154.42001,"Akbari, E, Asemi, Z, Daneshvar Kakhaki, R, Bahmani, F, Kouchaki, E, Tamtaji, OR, Hamidi, GA, Salami, M. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial, Front Aging Neurosci, 2016, 8, 256, PMID: 27891089"
10.1186/s12974-019-1494-4,10.1186/s12974-019-1494-4,107.72004,"Angelucci, F, Cechova, K, Amlerova, J, Hort, J. Antibiotics, gut microbiota, and Alzheimer’s disease, J Neuroinflammation, 2019, 16, 108, PMID: 31118068"
10.1139/apnm-2017-0648,10.1139/apnm-2017-0648,188.28671,"Athari Nik Azm, S, Djazayeri, A, Safa, M, Azami, K, Ahmadvand, B, Sabbaghziarani, F, Sharifzadeh, M, Vafa, M. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1–42) injected rats, Appl Physiol Nutr Metab, 2018, 43, 718, 726, PMID: 29462572"
10.3233/jad-161141,10.3233/jad-161141,67.84652,"Jiang, C, Li, G, Huang, P, Liu, Z, Zhao, B. The gut microbiota and Alzheimer’s disease, J Alzheimer’s Dis, 2017, 58, 1, 15, PMID: 28372330"
10.1186/s40168-019-0635-4,10.1186/s40168-019-0635-4,132.82884,"Liang, Y, Zhan, J, Liu, D, Luo, M, Han, J, Liu, X, Liu, C, Cheng, Z, Zhou, Z, Wang, P. Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota, Microbiome, 2019, 7, 19, PMID: 30744700"
10.1111/j.1365-2982.2010.01620.x,10.1111/j.1365-2982.2010.01620.x,120.09839,"Neufeld, KM, Kang, N, Bienenstock, J, Foster, JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice, Neurogastroenterol Motil, 2011, 23, 255, 264,e119, PMID: 21054680"
10.1016/j.phrs.2018.03.012,10.1016/j.phrs.2018.03.012,129.65326,"Pistollato, F, Iglesias, RC, Ruiz, R, Aparicio, S, Crespo, J, Lopez, LD, Manna, PP, Giampieri, F, Battino, M. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies, Pharmacol Res, 2018, 131, 32, 43, PMID: 29555333"
10.3920/bm2014.0177,10.3920/bm2014.0177,111.20379,"Wang, T, Hu, X, Liang, S, Li, W, Wu, X, Wang, L, Jin, F. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats, Benef Microbes, 2015, 6, 707, 717, PMID: 25869281"
10.1016/j.cbpc.2018.11.010,10.1016/j.cbpc.2018.11.010,94.105515,"Wang, X, Shen, M, Zhou, J, Jin, Y. Chlorpyrifos disturbs hepatic metabolism associated with oxidative stress and gut microbiota dysbiosis in adult zebrafish, Comp Biochem Physiol C Toxicol Pharmacol, 2019, 216, 19, 28, PMID: 30423371"
10.1002/hep.29327,10.1002/hep.29327,137.50018,"Yip, LY, Aw, CC, Lee, SH, Hong, YS, Ku, HC, Xu, WH, Chan, JMX, Cheong, EJY, Chng, KR, Ng, AHQ, Nagarajan, N, Mahendran, R, Lee, YK, Browne, ER, Chan, ECY. The liver–gut microbiota axis modulates hepatotoxicity of tacrine in the rat, Hepatology, 2018, 67, 282, 295, PMID: 28646502"
10.3389/fnagi.2018.00187,10.3389/fnagi.2018.00187,157.60895,"Zhang, H, Wang, Z, Li, Y, Han, J, Cui, C, Lu, C, Zhou, J, Cheong, L, Li, Y, Sun, T, Zhang, D, Su, X. Sex-based differences in gut microbiota composition in response to tuna oil and algae oil supplementation in a D-galactose-induced aging mouse model, Front Aging Neurosci, 2018, 10, 187, PMID: 29997496"
10.1021/jacs.8b08947,10.1021/jacs.8b08947,121.17163,"Abeyawardhane, DL, Fernández, RD, Heitger, DR, Crozier, MK, Wolver, J, Lucas, HR. Copper induced radical dimerization of α-synuclein requires histidine, J Am Chem Soc, 2018a, 140, 17086, 17094, PMID: 30422655"
10.1021/jacs.8b02013,10.1021/jacs.8b02013,121.03149,"Abeyawardhane, DL, Fernández, RD, Murgas, CJ, Heitger, DR, Forney, AK, Crozier, MK, Lucas, HR. Iron redox chemistry promotes antiparallel oligomerization of α-synuclein, J Am Chem Soc, 2018b, 140, 5028, 5032, PMID: 29608844"
10.1074/jbc.m600933200,10.1074/jbc.m600933200,163.10979,"Anderson, J, Walker, D, Goldstein, J, de Laat, R, Banducci, K, Caccavello, R, Barbour, R, Huang, J, Kling, K, Lee, M, Diep, L, Keim, P, Shen, X, Chataway, T, Schlossmacher, M, Seubert, P, Schenk, D, Sinha, S, Gai, W, Chilcote, T. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease, J Biol Chem, 2006, 281, 29739, 29752, PMID: 16847063"
10.1038/nature10324,10.1038/nature10324,117.03984,"Bartels, T, Choi, JG, Selkoe, DJ. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, 2011a, 477, 107, 110, PMID: 21841800"
10.1038/protex.2011.254,10.1038/protex.2011.254,88.88799,"Bartels, T, Choi, J, Kim, N, Selkoe, D. Non-denaturing purification of alpha-synuclein from erythrocytes, 2011b, Accessed on July 7, 2017, https://protocolexchange.researchsquare.com/article/nprot-2136/v1"
10.1007/s00401-010-0664-3,10.1007/s00401-010-0664-3,180.88353,"Beach, TG, Adler, CH, Sue, LI, Vedders, L, Lue, L, White Iii, CL, Akiyama, H, Caviness, JN, Shill, HA, Sabbagh, MN, Walker, DG. Arizona Parkinson’s Disease Consortium, Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders, Acta Neuropathol, 2010, 119, 689, 702, PMID: 20306269"
10.1016/j.neuron.2013.09.004,10.1016/j.neuron.2013.09.004,80.92145,"Bendor, JT, Logan, TP, Edwards, RH. The function of α-synuclein, Neuron, 2013, 79, 1044, 1066, PMID: 24050397"
10.1021/ja107842f,10.1021/ja107842f,119.24533,"Binolfi, A, Valiente-Gabioud, AA, Duran, R, Zweckstetter, M, Griesinger, C, Fernandez, CO. Exploring the structural details of Cu(I) binding to α-synuclein by NMR spectroscopy, J Am Chem Soc, 2011, 133, 194, 196, PMID: 21158432"
10.1038/ncomms3575,10.1038/ncomms3575,137.87547,"Bousset, L, Pieri, L, Ruiz-Arlandis, G, Gath, J, Jensen, PH, Habenstein, B, Madiona, K, Olieric, V, Böckmann, A, Meier, BH, Melki, R. Structural and functional characterization of two alpha-synuclein strains, Nat Commun, 2013, 4, 2575, PMID: 24108358"
10.1007/s00441-004-0956-9,10.1007/s00441-004-0956-9,126.523026,"Braak, H, Ghebremedhin, E, Rüb, U, Bratzke, H, Del Tredici, K. Stages in the development of Parkinson’s disease-related pathology, Cell Tissue Res, 2004, 318, 121, 134, PMID: 15338272"
10.1002/mds.21065,10.1002/mds.21065,145.56372,"Braak, H, Bohl, JR, Müller, CM, Rüb, U, de Vos, RA, Del Tredici, K. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered, Mov Disord, 2006, 21, 2042, 2051, PMID: 17078043"
10.3390/polym6102684,10.3390/polym6102684,120.75152,"Burger, VM, Gurry, T, Stultz, CM. Intrinsically disordered proteins: where computation meets experiment, Polymers, 2014, 6, 2684, 2719"
10.1038/nature12125,10.1038/nature12125,114.798355,"Burré, J, Vivona, S, Diao, J, Sharma, M, Brunger, AT, Südhof, TC. Properties of native brain α-synuclein, Nature, 2013, 498, E4, 6, discussion E6-7, PMID: 23765500"
10.1002/ana.25446,10.1002/ana.25446,178.3176,"Candelise, N, Schmitz, M, Llorens, F, Villar-Piqué, A, Cramm, M, Thom, T, da Silva Correia, SM, Eriton Gomes da Cunha, J, Möbius, W, Outeiro, TF, Álvarez, VG, Banchelli, M, D’Andrea, C, de Angelis, M, Zafar, S, Rabano, A, Matteini, P, Zerr, I. Seeding variability of different alpha synuclein strains in synucleinopathies, Ann Neurol, 2019, 85, 691, 703, PMID: 30805957"
10.1021/acschemneuro.9b00090,10.1021/acschemneuro.9b00090,128.25871,"Chakraborty, R, Chattopadhyay, K. Cryo-electron microscopy uncovers key residues within the core of alpha-synuclein fibrils, ACS Chem Neurosci, 2019, 10, 1135, 1136, PMID: 30785257"
10.1016/j.jmb.2018.06.012,10.1016/j.jmb.2018.06.012,88.07062,"Chen, J, Kriwacki, RW. Intrinsically disordered proteins: structure, function and therapeutics, J Mol Biol, 2018, 430, 2275, 2277, PMID: 29906412"
10.1073/pnas.1421204112,10.1073/pnas.1421204112,200.17006,"Chen, SW, Drakulic, S, Deas, E, Ouberai, M, Aprile, FA, Arranz, R, Ness, S, Roodveldt, C, Guilliams, T, De-Genst, EJ, Klenerman, D, Wood, NW, Knowles, TP, Alfonso, C, Rivas, G, Abramov, AY, Valpuesta, JM, Dobson, CM, Cremades, N. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation, Proc Natl Acad Sci U S A, 2015, 112, E1994, 2003, PMID: 25855634"
10.1111/jnc.13845,10.1111/jnc.13845,108.30532,"Corbillé, AG, Neunlist, M, Derkinderen, P. Cross-linking for the analysis of α-synuclein in the enteric nervous system, J Neurochem, 2016, 139, 839, 847, PMID: 27637918"
10.1111/j.1471-4159.2009.06324.x,10.1111/j.1471-4159.2009.06324.x,134.93994,"Danzer, KM, Krebs, SK, Wolff, M, Birk, G, Hengerer, B. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology, J Neurochem, 2009, 111, 192, 203, PMID: 19686384"
10.1021/acschemneuro.7b00446,10.1021/acschemneuro.7b00446,107.154366,"Cote, Y, Delarue, P, Scheraga, HA, Senet, P, Maisuradze, GG. From a highly disordered to a metastable state: uncovering insights of α-synuclein, ACS Chem Neurosci, 2018, 9, 1051, 1065, PMID: 29451381"
10.1016/j.neurobiolaging.2013.09.034,10.1016/j.neurobiolaging.2013.09.034,128.1383,"Davies, KM, Bohic, S, Carmona, A, Ortega, R, Cottam, V, Hare, DJ, Finberg, JP, Reyes, S, Halliday, GM, Mercer, JF, Double, KL. Copper pathology in vulnerable brain regions in Parkinson’s disease, Neurobiol Aging, 2014, 35, 858, 866, PMID: 24176624"
10.3389/fnins.2018.00623,10.3389/fnins.2018.00623,110.87153,"Dettmer, U. Rationally designed variants of α-synuclein illuminate its, in vivo structural properties in health and disease, Front Neurosci, 2018, 12, 623, PMID: 30319334"
10.1074/jbc.m112.403311,10.1074/jbc.m112.403311,130.71735,"Dettmer, U, Newman, AJ, Luth, ES, Bartels, T, Selkoe, D. In vivo cross-linking reveals principally oligomeric forms of α-synuclein and β-synuclein in neurons and non-neural cells, J Biol Chem, 2013, 288, 6371, 6385, PMID: 23319586"
10.1073/pnas.1505953112,10.1073/pnas.1505953112,157.26381,"Dettmer, U, Newman, AJ, von Saucken, VE, Bartels, T, Selkoe, D. KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity, Proc Natl Acad Sci U S A, 2015a, 112, 9596, 9601, PMID: 26153422"
10.1038/ncomms8314,10.1038/ncomms9008,151.20102,"Dettmer, U, Newman, AJ, Soldner, F, Luth, ES, Kim, NC, von Saucken, VE, Sanderson, JB, Jaenisch, R, Bartels, T, Selkoe, D. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation, Nat Commun, 2015b, 6, 7314, PMID: 26076669"
10.1074/jbc.m113.512459,10.1074/jbc.m113.512459,127.2915,"Dikiy, I, Eliezer, D. N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid-and Micelle-bound alpha-Synuclein and Increases Its Affinity for Physiological Membranes, J Biol Chem, 2014, 289, 3652, 3665, PMID: 24338013"
10.1016/j.sbi.2008.10.002,10.1016/j.sbi.2008.10.002,92.10243,"Dunker, AK, Silman, I, Uversky, VN, Sussman, JL. Function and structure of inherently disordered proteins, Curr Opin Struct Biol, 2008, 18, 756, 764, PMID: 18952168"
10.1074/jbc.m112.383711,10.1074/jbc.m112.383711,145.42896,"Fauvet, B, Fares, M, Samuel, F, Dikiy, I, Tandon, A, Eliezer, D, Lashuel, H. Characterization of semisynthetic and naturally N-alpha-acetylated alpha-synuclein, in vitro and in intact cells implications for aggregation and cellular properties of alpha-synuclein, J Biol Chem, 2012a, 287, 28243, 28262, PMID: 22718772"
10.1042/,10.1042/bst0300559,69.472984,"el-Agnaf, OM, Irvine, GB. Aggregation and neurotoxicity of α-synuclein and related peptides, Biochem Soc Trans, 2002, 30, 559, PMID: 12196137"
10.1074/jbc.m111.318949,10.1074/jbc.m111.318949,192.55591,"Fauvet, B, Mbefo, MK, Fares, MB, Desobry, C, Michael, S, Ardah, MT, Tsika, E, Coune, P, Prudent, M, Lion, N, Eliezer, D, Moore, DJ, Schneider, B, Aebischer, P, El-Agnaf, OM, Masliah, E, Lashuel, HA. α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer, J Biol Chem, 2012b, 287, 15345, 15364, PMID: 22315227"
10.1038/nrc1317,10.1038/nrc1317,73.76704,"Jordan, MA, Wilson, L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4: 253–65. PMID: 15057285"
10.1038/nrd3253,10.1038/nrd3253,97.174164,"Dumontet, C, Jordan, MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010; 9: 790–803. PMID: 20885410"
10.1016/j.ejmech.2014.09.051,10.1016/j.ejmech.2014.09.051,83.169266,"Kaur, R, Kaur, G, Gill, RK, et al. Recent developments in tubulin polymerization inhibitors: an overview. Eur J Med Chem 2014; 87: 89–124. PMID: 25240869"
10.1002/chin.199835328,10.1002/chin.199835328,87.49653,"Shi, Q, Chen, K, Morris-Natschke, SL, Lee, KH. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr Pharm Des 1998; 4: 219–48. PMID: 10197041"
10.2174/13895575112091394,10.2174/138955712804586648,100.58329,"Bukhari, SNA, Jasamai, M, Jantan, I. Synthesis and biological evaluation of chalcone derivatives (mini review). Mini Rev Med Chem 2012; 12: 1394–403. PMID: 22876958"
10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u,10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u,95.922104,"Jordan, A, Hadfield, JA, Lawrence, NJ, McGown, AT. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998; 18: 259–96. PMID: 9664292"
10.3390/molecules22081210,10.3390/molecules22081210,89.49513,"Gomes, MN, Muratov, EN, Pereira, M, et al. Chalcone derivatives: promising starting points for drug design. Molecules 2017; 22: 1210."
10.1021/acs.chemrev.7b00020,10.1021/acs.chemrev.7b00020,75.16188,"Zhuang, CL, Zhang, W, Sheng, CQ, et al. Chalcone: a privileged structure in medicinal chemistry. Chem Rev 2017; 117: 7762–810. PMID: 28488435"
10.1016/j.ejmech.2016.05.067,10.1002/chin.201641270,100.27145,"Mirzaei, H, Emami, S. Recent advances of cytotoxic chalconoids targeting tubulin polymerization: synthesis and biological activity. Eur J Med Chem 2016; 121: 610–39. PMID: 27318983"
10.1016/j.ejmech.2015.05.004,10.1016/j.ejmech.2015.05.004,85.69243,"Mahapatra, DM, Bharti, SK, Asati, V. Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 2015; 98: 69–114. PMID: 26005917"
10.2174/1871520615666150518093144,10.2174/1871520615666150518093144,62.62833,"Sharma, R, Kumar, R, Kodwani, R, et al. A review on mechanisms of anti tumor activity of chalcones. Anticancer Agents Med Chem 2015; 16: 200–11. PMID: 25980813"
10.1007/s00280-008-0802-y,10.1007/s00280-008-0802-y,113.115746,"Loa, J, Chow, P, Zhang, K. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother Pharmacol 2009; 63: 1007–16. PMID: 18766342"
10.1016/j.canlet.2014.08.041,10.1016/j.canlet.2014.08.041,135.8755,"Lee, JM, Lee, MS, Koh, D, et al. A new synthetic 2′-hydroxy-2,4,6-trimethoxy-5′,6′-naphthochalcone induces g2/m cell cycle arrest and apoptosis by disrupting the microtubular network of human colon cancer cells. Cancer Lett 2014; 354: 348–54. PMID: 25193463"
10.1016/s0960-894x(01)00617-5,10.1016/s0960-894x(01)00617-5,71.54342,"Pouget, C, Lauthier, F, Simon, A, et al. Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. Bioorg Med Chem Lett 2001; 11: 3095–7. PMID: 11720850"
10.1016/j.ejmech.2011.10.033,10.1016/j.ejmech.2011.10.033,82.980606,"Singh, P, Raj, R, Kumar, V, et al. 1,2,3-triazole tethered beta-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation. Eur J Med Chem 2012; 47: 594–600. PMID: 22071256"
10.1021/jf4034688,10.1021/jf4034688,113.07305,"Shin, SY, Kim, JH, Yoon, H, et al. Novel antimitotic activity of 2-hydroxy-4-methoxy-2′,3′-benzochalcone (hymnpro) through the inhibition of tubulin polymerization. J Agric Food Chem 2013; 61: 12588–97. PMID: 24308485"
10.1016/j.ejmech.2018.04.011,10.1016/j.ejmech.2018.04.011,83.47497,"Li, L, Jiang, SB, Li, XX, et al. Recent advances in trimethoxyphenyl (tmp) based tubulin inhibitors targeting the colchicine binding site. Eur J Med Chem 2018; 151: 482–94. PMID: 29649743"
10.1038/s41598-017-10972-0,10.1038/s41598-017-10972-0,126.79301,"Lindamulage, IK, Vu, HY, Karthikeyan, C, et al. Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and mrp1 function. Sci Rep 2017; 7: 10298. PMID: 28860494"
10.1111/cbdd.12776,10.1111/cbdd.12776,102.47085,"Konieczny, MT, Bulakowska, A, Pirska, D, et al. Influence of s-oxidation on cytotoxic activity of oxathiole-fused chalcones. Chem Biol Drug Des 2016; 88: 519–33. PMID: 27198732"
10.1111/cbdd.12296,10.1111/cbdd.12296,123.4757,"Konieczny, MT, Bulakowska, A, Polak, J, et al. Structural factors affecting cytotoxic activity of (e)-1-(benzo d 1,3 oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives. Chem Biol Drug Des 2014; 84: 86–91. PMID: 24476543"
10.1016/j.bmc.2010.02.012,10.1016/j.bmc.2010.02.012,73.91499,"Tu, HY, Huang, AM, Hour, TC, et al. Synthesis and biological evaluation of 2′,5′-dimethoxychalcone derivatives as microtubule-targeted anticancer agents. Bioorg Med Chem 2010; 18: 2089–98. PMID: 20199865"
10.1016/j.bmc.2014.02.028,10.1016/j.bmc.2014.02.028,79.8165,"Wang, G, Li, C, He, L, et al. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorg Med Chem 2014; 22: 2060–79. PMID: 24629450"
10.1016/j.ejmech.2014.10.075,10.1016/j.ejmech.2014.10.075,105.60719,"Konieczny, MT, Buɬakowska, A, Pirska, D, et al. Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin. Eur J Med Chem 2015; 89: 733–42. PMID: 25462279"
10.2174/0929867322666150114163732,10.2174/0929867322666150114163732,91.37653,"Ji, YT, Liu, YN, Liu, ZP. Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments. Curr Med Chem 2015; 22: 1348–60. PMID: 25620094"
10.1016/j.ejmech.2017.07.054,10.1016/j.ejmech.2017.07.054,81.29397,"Zhou, ZZ, Shi, XD, Feng, HF, et al. Discovery of 9h-purins as potential tubulin polymerization inhibitors: synthesis, biological evaluation and structure activity relationships. Eur J Med Chem 2017; 138: 1126–34. PMID: 28763647"
10.1080/14756366.2019.1594802,10.1080/14756366.2019.1594802,114.95632,"Ettari, R, Pallio, G, Pizzino, G, et al. Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma mm.1r cells. J Enzyme Inhib Med Chem 2019; 34: 1307–13. PMID: 31307247"
10.1002/jcc.21334,10.1002/jcc.21334,108.27183,"Trott, O, Olson, AJ. Software news and update autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455–61. PMID: 19499576"
10.1046/j.1365-2591.1997.00092.x,10.1046/j.1365-2591.1997.00092.x,108.31049,"Sjogren, U, Figdor, D, Persson, S, et al. Influence of infection at the time of root filling on the outcome of endodontic treatment of teeth with apical periodontitis. Int Endod J. 1997; 30(5): 297–7. PMID: 9477818"
10.1016/j.joen.2007.07.018,10.1016/j.joen.2007.07.018,80.02763,"Imura, N, Pinheiro, ET, Gomes, BP, et al. The outcome of endodontic treatment: a retrospective study of 2000 cases performed by a specialist. J Endod. 2007; 33(11): 1278–1282. PMID: 17963946"
10.1097/00004770-200112000-00021,10.1097/00004770-200112000-00021,93.54128,"Lazarski, MP, Walker, WA, 3rd, Flores, CM, et al. Epidemiological evaluation of the outcomes of nonsurgical root canal treatment in a large cohort of insured dental patients. J Endod. 2001; 27(12): 791–796. PMID: 11771594"
10.1111/j.1365-2591.1993.tb00765.x,10.1111/j.1365-2591.1993.tb00765.x,120.890625,"Smith, CS, Setchell, DJ, Harty, FJ. Factors influencing the success of conventional root canal therapy–a five-year retrospective study. Int Endod J. 1993; 26(6): 321–333. PMID: 8144241"
10.1016/s0099-2399(07)80180-4,10.1016/s0099-2399(07)80180-4,91.45948,"Sjogren, U, Hagglund, B, Sundqvist, G, et al. Factors affecting the long-term results of endodontic treatment. J Endod. 1990; 16(10): 498–504. PMID: 2084204"
10.1046/j.1365-2591.2003.00640.x,10.1046/j.1365-2591.2003.00640.x,96.893265,"Dugas, NN, Lawrence, HP, Teplitsky, PE, et al. Periapical health and treatment quality assessment of root-filled teeth in two Canadian populations. Int Endod J. 2003; 36(3): 181–192. PMID: 12657144"
10.14219/jada.archive.2005.0140,10.14219/jada.archive.2005.0140,83.77411,"Lin, LM, Rosenberg, PA, Lin, J. Do procedural errors cause endodontic treatment failure? J Am Dent Assoc. 2005; 136(2): 187–193. quiz 231 PMID: 15782522"
10.1111/j.1600-0579.2006.00397.x,10.1111/j.1600-0579.2006.00397.x,124.24609,"Lynch, CD, Burke, FM. Quality of root canal fillings performed by undergraduate dental students on single-rooted teeth. Eur J Dent Educ. 2006; 10(2): 67–72. PMID: 16634813"
10.1155/2014/751274,10.1155/2014/751274,103.475945,"Vukadinov, T, Blazic, L, Kantardzic, I, et al. Technical quality of root fillings performed by undergraduate students: a radiographic study. ScientificWorldJournal. 2014; 2014: 751274. PMID: 24672365"
10.22037/iej.v13i1.16800,10.14744/eej.2018.69775,53.696518,"Zambon da Silva, P, Carlos Ribeiro, F, Machado Barroso Xavier, J, et al. Radiographic evaluation of root canal treatment performed by undergraduate students, part I; iatrogenic errors. Iran Endod J. 2018; 13(1): 30–36. PMID: 29692832"
10.4103/0253-7176.116232,10.4103/0253-7176.116232,94.00603,"Charan, J, Biswas, T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013; 35(2): 121–126. PMID: 24049221"
10.1111/j.1365-2591.1987.tb00592.x,10.1111/j.1365-2591.1987.tb00592.x,96.86876,"Reit, C. The influence of observer calibration on radiographic periapical diagnosis. Int Endod J. 1987; 20(2): 75–81. PMID: 3471728"
10.1177/00220345860650031201,10.1177/00220345860650031201,94.550995,"Valachovic, RW, Douglass, CW, Berkey, CS, et al. Examiner reliability in dental radiography. J Dent Res. 1986; 65(3): 432–436. PMID: 3457049"
10.1177/00220345860650020701,10.1177/00220345860650020701,105.28764,"Hunt, RJ. Percent agreement, Pearson’s correlation, and kappa as measures of inter-examiner reliability. J Dent Res. 1986; 65(2): 128–130. PMID: 3455967"
10.1111/j.1365-2591.2006.01158.x,10.1111/j.1365-2591.2006.01158.x,128.27263,"Er, O, Sagsen, B, Maden, M, et al. Radiographic technical quality of root fillings performed by dental students in Turkey. Int Endod J. 2006; 39(11): 867–872. PMID: 17014524"
10.1111/j.1365-2591.2005.01008.x,10.1111/j.1365-2591.2005.01008.x,127.272575,"Eleftheriadis, GI, Lambrianidis, TP. Technical quality of root canal treatment and detection of iatrogenic errors in an undergraduate dental clinic. Int Endod J. 2005; 38(10): 725–734. PMID: 16164687"
10.2298/sgs1103139k,10.2298/sgs1103139k,104.38108,"Kulić, L, Nogo-Živanović, D, Krunic, J, et al. Radiological assessment of the quality of root canal fillings in teeth endodontically treated at students’ practical sessions. Serb Dent J. 2011; 58."
10.1016/0030-4220(71)90230-1,10.1016/0030-4220(71)90230-1,106.482506,"Schneider, SW. A comparison of canal preparations in straight and curved root canals. Oral Surg Oral Med Oral Pathol. 1971; 32(2): 271–275. PMID: 5284110"
10.1155/2015/673914,10.1155/2015/673914,100.19256,"Yousuf, W, Khan, M, Mehdi, H. Endodontic procedural errors: frequency, type of error, and the most frequently treated tooth. Int J Dent. 2015; 2015: 673914. PMID: 26347779"
10.1186/s12903-015-0137-0,10.1186/s12903-015-0137-0,116.2882,"Barbieri, N, Leonardi, DP, Baechtold, MS, et al. Influence of cervical preflaring on apical transportation in curved root canals instrumented by reciprocating file systems. BMC Oral Health. 2015; 15: 149. PMID: 26593244"
10.1111/j.1365-2591.2009.01679.x,10.1111/j.1365-2591.2009.01679.x,141.63014,"Balto, H, Al Khalifah, S, Al Mugairin, S, et al. Technical quality of root fillings performed by undergraduate students in Saudi Arabia. Int Endod J. 2010; 43(4): 292–300. PMID: 20487448"
10.1016/0030-4220(90)90217-g,10.1016/0030-4220(90)90217-g,129.17557,"Greene, KJ, Krell, KV. Clinical factors associated with ledged canals in maxillary and mandibular molars. Oral Surg Oral Med Oral Pathol. 1990; 70(4): 490–497. PMID: 2216387"
10.1034/j.1600-9657.2000.016005229.x,10.1034/j.1600-9657.2000.016005229.x,111.379776,"Kapalas, A, Lambrianidis, T. Factors associated with root canal ledging during instrumentation. Endod Dent Traumatol. 2000; 16(5): 229–231. PMID: 11202887"
10.1111/j.1365-2591.2010.01706.x,10.1111/j.1365-2591.2010.01706.x,111.26587,"Khabbaz, MG, Protogerou, E, Douka, E. Radiographic quality of root fillings performed by undergraduate students. Int Endod J. 2010; 43(6): 499–508. PMID: 20536578"
10.22037/iej.v13i1.18507,10.14744/eej.2018.69775,51.25568,"Hendi, SS, Karkehabadi, H, Eskandarloo, A. Iatrogenic errors during root canal instrumentation performed by dental students. Iran Endod J. 2018; 13(1): 126–131. PMID: 29692848"
10.1590/1678-775720130542,10.1590/1678-775720130542,145.5008,"Sousa, K, Andrade-Junior, CV, Silva, JM, et al. Comparison of the effects of tripleGates and gates-glidden burs on cervical dentin thickness and root canal area by using cone beam computed tomography. J appl oral sci. 2015; 23(2): 164–168. PMID: 26018308"
10.1016/s0099-2399(88)80196-1,10.1016/s0099-2399(88)80196-1,111.12835,"Walia, HM, Brantley, WA, Gerstein, H. An initial investigation of the bending and torsional properties of Nitinol root canal files. J Endod. 1988; 14(7): 346–351. PMID: 3251996"
10.1016/j.joen.2018.03.012,10.1016/j.joen.2018.03.012,108.56086,"Haug, SR, Solfjeld, AF, Ranheim, LE, et al. Impact of case difficulty on endodontic mishaps in an undergraduate student clinic. J Endod. 2018; 44(7): 1088–1095. PMID: 29803337"
10.1111/j.1747-4477.2010.00270.x,10.1111/j.1747-4477.2010.00270.x,101.27315,"Rafeek, RN, Smith, WA, Mankee, MS, et al. Radiographic evaluation of the technical quality of root canal fillings performed by dental students. Aust Endod J. 2012; 38(2): 64–69. PMID: 22827818"
10.1016/j.joen.2006.03.001,10.1016/j.joen.2006.03.001,113.32825,"Iqbal, MK, Kohli, MR, Kim, JS. A retrospective clinical study of incidence of root canal instrument separation in an endodontics graduate program: a PennEndo database study. J Endod. 2006; 32(11): 1048–1052. PMID: 17055904"
10.1016/j.jdent.2004.01.002,10.1016/j.jdent.2004.01.002,129.05592,"Barrieshi-Nusair, KM, Al-Omari, MA, Al-Hiyasat, AS. Radiographic technical quality of root canal treatment performed by dental students at the dental teaching center in Jordan. J Dent. 2004; 32(4): 301–307. PMID: 15053913"
10.7508/iej.2015.04.012,10.4103/1658-5984.171999,79.17395,"Alsulaimani, RS, Al-Manei, KK, Alsubait, SA, et al. Effects of clinical training and case difﬁculty on the radiographic quality of root canal ﬁllings performed by dental students in Saudi Arabia. Iran Endod J. 2015; 10: 268–273. PMID: 26523143"
10.20944/preprints201801.0110.v1,10.3390/metabo8010022,118.855194,"Aspatwar, A, Haapanen, S, Parkkila, S. An update on the metabolic roles of carbonic anhydrases in the model Alga Chlamydomonas reinhardtii. Metabolites 2018; 8: 22."
10.1007/978-94-007-7359-2_8,10.1007/978-94-007-7359-2_8,102.21724,"Aspatwar, A, Tolvanen, ME, Ortutay, C, Parkkila, S. Carbonic anhydrase related proteins: molecular biology and evolution. Subcell Biochem 2014; 75: 135–56. PMID: 24146378"
10.1021/cr200176r,10.1021/cr200176r,104.74598,"Alterio, V, Di Fiore, A, D'Ambrosio, K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012; 112: 4421–68. PMID: 22607219"
10.1016/j.cbpa.2010.06.161,10.1016/j.cbpa.2010.06.161,45.374928,"Gilmour, KM. Perspectives on carbonic anhydrase. Comp Biochem Physiol A Mol Integr Physiol 2010; 157: 193–7. PMID: 20541618"
10.3109/14756366.2012.737323,10.3109/14756366.2012.737323,92.29115,"Aggarwal, M, Boone, CD, Kondeti, B, McKenna, R. Structural annotation of human carbonic anhydrases. J Enzyme Inhib Med Chem 2013; 28: 267–77. PMID: 23137351"
10.1016/j.bmc.2013.07.044,10.1016/j.bmc.2013.07.044,147.68568,"Sethi, KK, Vullo, D, Verma, SM, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I II VII IX and XII with benzene sulfonamides incorporating 4567-tetrabromophthalimide moiety. Bioorg Med Chem 2013; 21: 5973–82. PMID: 23965175"
10.1016/j.ejmech.2017.03.026,10.1016/j.ejmech.2017.03.026,94.339,"Mboge, MY, Mahon, BP, Lamas, N, et al. Structure activity study of carbonic anhydrase IX: selective inhibition with ureido-substituted benzenesulfonamides. Eur J Med Chem 2017; 132: 184–91. PMID: 28363153"
10.1021/acs.jmedchem.7b00766,10.1021/acs.jmedchem.7b00766,114.287735,"Falsini, M, Squarcialupi, L, Catarzi, D, et al. 3-Hydroxy-1H-quinazoline-24-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. J Med Chem 2017; 60: 6428–39. PMID: 28658574"
10.2174/187152011796817664,10.2174/187152011796817664,69.4298,"Liu, K, Zhu, HL. Nitroimidazoles as anti-tumor agents. Anticancer Agents Med Chem 2011; 11: 687–91. PMID: 21521156"
10.1038/bjc.1982.300,10.1038/bjc.1982.300,113.93377,"Overgaard, J, Overgaard, M, Nielsen, OS, et al. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo. Br J Cancer 1982; 46: 904–11. PMID: 7150484"
10.4155/fmc.11.69,10.4155/fmc.11.69,85.01558,"Supuran, CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011; 3: 1165–80. PMID: 21806379"
10.1080/14756366.2018.1482285,10.1080/14756366.2018.1482285,120.95218,"Aspatwar, A, Becker, HM, Parvathaneni, NK, et al. Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes. J Enzyme Inhib Med Chem 2018; 33: 1064–73. PMID: 29909747"
10.1007/978-3-319-33826-2_2,10.1007/978-3-319-33826-2_2,76.176926,"Gourmelon, A, Delrue, N. Validation in support of internationally harmonised OECD Test Guidelines for assessing the safety of chemicals. Adv Exp Med Biol 2016; 856: 9–32. PMID: 27671718"
10.1080/14756366.2017.1332056,10.1080/14756366.2017.1332056,127.8407,"Aspatwar, A, Hammaren, M, Koskinen, S, et al. beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. J Enzyme Inhib Med Chem 2017; 32: 832–40. PMID: 28629306"
10.1080/01480545.2016.1223095,10.1080/01480545.2016.1223095,137.37556,"Kazokaite, J, Aspatwar, A, Kairys, V, et al. Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide. Drug Chem Toxicol 2017; 40: 309–19. PMID: 27600313"
10.1016/j.radonc.2015.08.022,10.1016/j.radonc.2015.08.022,68.3261,"Dubois, LJ, Niemans, R, van Kuijk, SJ, et al. New ways to image and target tumour hypoxia and its molecular responses. Radiother Oncol 2015; 116: 352–7. PMID: 26324018"
10.1021/jm4009532,10.1021/jm4009532,114.40523,"Rami, M, Dubois, L, Parvathaneni, NK, et al. Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates. J Med Chem 2013; 56: 8512–20. PMID: 24128000"
10.1080/14756366.2017.1349764,10.1080/14756366.2017.1349764,115.88399,"De Simone, G, Langella, E, Esposito, D, et al. Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations. J Enzyme Inhib Med Chem 2017; 32: 1002–11. PMID: 28738704"
10.1371/journal.pone.0146021,10.1371/journal.pone.0146021,103.83957,"Ritz, C, Baty, F, Streibig, JC, Gerhard, D. Dose-response analysis using R. PLoS One 2015; 10: e0146021. PMID: 26717316"
10.3791/59315,10.3791/59315,114.105606,"Aspatwar, A, Hammaren, MM, Parikka, M, Parkkila, S. Rapid evaluation of toxicity of chemical compounds using zebrafish embryos. J Vis Exp 2019; 150: e59315."
10.1016/j.phrs.2013.01.011,10.1016/j.phrs.2013.01.011,123.87382,"Ernst, IM, Palani, K, Esatbeyoglu, T, et al. Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin iberin and cheirolin. Pharmacol Res 2013; 70: 155–62. PMID: 23403058"
10.1016/j.radonc.2013.06.018,10.1016/j.radonc.2013.06.018,107.76077,"Dubois, L, Peeters, SG, van Kuijk, SJ, et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol 2013; 108: 523–8. PMID: 23849171"
10.1016/j.bmc.2014.02.039,10.1016/j.bmc.2014.02.039,70.24541,"Bonnet, M, Hong, CR, Gu, Y, et al. Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers. Bioorg Med Chem 2014; 22: 2123–32. PMID: 24650701"
10.1007/s11095-008-9661-9,10.1007/s11095-008-9661-9,78.885956,"Anand, P, Kunnumakara, A, Sundaram, C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25: 2097–116. PMID: 18626751"
10.1002/cncr.20299,10.1002/cncr.20299,84.47065,"Siemann, DW, Chaplin, DJ, Horsman, MR. Vascular-targeting therapies for treatment of malignant disease. Cancer 2004; 100: 2491–9. PMID: 15197790"
10.1016/s0163-7258(98)00044-8,10.1016/s0163-7258(98)00044-8,89.328094,"Traxler, P, Furet, P. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors. Pharmacol Ther 1999; 82: 195–206. PMID: 10454197"
10.2174/138161209787582219,10.2174/138161209787582219,100.20282,"Sharma, PS, Sharma, R, Tyagi, T. Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. Curr Pharm Des 2009; 15: 758–76. PMID: 19275641"
10.2174/138945009788488378,10.2174/138945009788488378,106.27465,"Ocana, A, Serrano, R, Calero, R, Pandiella, A. Novel tyrosine kinase inhibitors in the treatment of cancer. Curr Drug Targets 2009; 10: 575–6. PMID: 19519359"
10.1021/jm401490p,10.1021/jm401490p,109.10644,"Clark, JD, Flanagan, ME, Telliez, JB. Discovery and development of Janus Kinase (JAK) inhibitors for inflammatory diseases: miniperspective. J Med Chem 2014; 57: 5023–38. PMID: 24417533"
10.1016/j.tips.2013.11.004,10.1016/j.tips.2013.11.004,96.458694,"Huang, M, Shen, A, Ding, J, Geng, M. Molecularly targeted cancer therapy: some lessons from the past decade. Trends Pharmacol Sci 2014; 35: 41–50. PMID: 24361003"
10.1158/1078-0432.ccr-14-2329,10.1158/1078-0432.ccr-14-2329,92.66793,"Touat, M, Ileana, E, Postel-Vinay, S, et al. Targeting FGFR signaling in cancer. Clin Cancer Res 2015; 21: 2684–94. PMID: 26078430"
10.1158/2159-8290.cd-12-0362,10.1158/2159-8290.cd-12-0362,127.42911,"Dieci, MV, Arnedos, M, Andre, F, Soria, JC. Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives. Cancer Discovery 2013; 3: 264–79. PMID: 23418312"
10.1016/j.tcb.2014.11.003,10.1016/j.tcb.2014.11.003,133.21156,"Carter, EP, Fearon, AE, Grose, RP. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol 2015; 25: 221–33. PMID: 25467007"
10.1126/science.1220834,10.1126/science.1220834,67.365906,"Singh, D, Chan, JM, Zoppoli, P, et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012; 337: 1231–5. PMID: 22837387"
10.1158/2159-8290.cd-13-0050,10.1158/2159-8290.cd-13-0050,60.095478,"Wu, YM, Su, F, Kalyana-Sundaram, S, et al. Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discovery 2013; 3: 636–47. PMID: 23558953"
10.1158/0008-5472.can-07-6307,10.1158/0008-5472.can-07-6307,107.29986,"Hilberg, F, Roth, GJ, Krssak, M, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 2008; 68: 4774–82. PMID: 18559524"
10.1158/1078-0432.ccr-14-3212,10.1158/1078-0432.ccr-14-3212,77.41079,"Helsten, T, Elkin, S, Arthur, E, et al. The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing. Clin Cancer Res 2016; 22: 259–67. PMID: 26373574"
10.1021/jm900431g,10.1021/jm900431g,131.9705,"Roth, GJ, Heckel, A, Colbatzky, F, et al. Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120). J Med Chem 2009; 52: 4466–80. PMID: 19522465"
10.1093/bioinformatics/bti537,10.1093/bioinformatics/bti537,162.16803,"Felder, CE, Rydberg, EH, Silman, I, Beckmann, JS, Prilusky, J, Sussman, JL, Man, O, Zeev-Ben-Mordehai, T. FoldIndex©: a simple tool to predict whether a given protein sequence is intrinsically unfolded, Bioinformatics, 2005, 21, 3435, 3438, PMID: 15955783"
10.1016/j.dib.2018.09.026,10.1016/j.dib.2018.09.026,106.05784,"Fernández, RD, Lucas, HR. Mass spectrometry data confirming tetrameric α-synuclein N-terminal acetylation, Data Brief, 2018a, 20, 1686, 1691, PMID: 30263921"
10.1016/j.pep.2018.07.008,10.1016/j.pep.2018.07.008,74.77515,"Fernández, RD, Lucas, HR. Isolation of recombinant tetrameric N-acetylated α-synuclein, Protein Expr Purif, 2018b, 152, 146, 154, PMID: 30041032"
10.1093/nar/gky1131,10.1093/nar/gky1131,205.60945,"Gable, AL, Szklarczyk, D, Lyon, D, Simonovic, M, Wyder, S, Mering Christian, v, Junge, A, Jensen, LJ, Doncheva, NT, Huerta-Cepas, J, Morris, JH, Bork, P. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res, 2018, 47, D607, D613"
10.1371/journal.pone.0090659,10.1371/journal.pone.0090659,163.6066,"Gath, J, Bousset, L, Habenstein, B, Melki, R, Böckmann, A, Meier, BH. Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity, PLoS One, 2014, 9, e90659, PMID: 24599158"
10.1002/mds.25776,10.1002/mds.25776,170.3561,"Gelpi, E, Navarro-Otano, J, Tolosa, E, Gaig, C, Compta, Y, Rey, MJ, Martí, MJ, Hernández, I, Valldeoriola, F, Reñé, R, Ribalta, T. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders, Mov Disord, 2014, 29, 1010, 1018, PMID: 24395122"
10.7554/elife.36402,10.7554/elife.36402,130.9745,"Guerrero-Ferreira, R, Taylor, NMI, Mona, D, Ringler, P, Lauer, ME, Riek, R, Britschgi, M, Stahlberg, H. Cryo-EM structure of alpha-synuclein fibrils, Elife, 2018, 7, e36402, PMID: 29969391"
10.1021/ja310518p,10.1021/ja310518p,101.16224,"Gurry, T, Ullman, O, Fisher, CK, Perovic, I, Pochapsky, T, Stultz, CM. The dynamic structure of α-synuclein multimers, J Am Chem Soc, 2013, 135, 3865, 3872, PMID: 23398399"
10.1038/s41598-018-35811-8,10.1038/s41598-018-35811-8,170.21397,"Hoffmann, AC, Minakaki, G, Menges, S, Salvi, R, Savitskiy, S, Kazman, A, Vicente Miranda, H, Mielenz, D, Klucken, J, Winkler, J, Xiang, W. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose, Sci Rep, 2019, 9, 544, PMID: 30679445"
10.1016/j.jsb.2018.04.003,10.1016/j.jsb.2018.04.003,111.43203,"Hwang, S, Fricke, P, Zinke, M, Giller, K, Wall, JS, Riedel, D, Becker, S, Lange, A. Comparison of the 3D structures of mouse and human α-synuclein fibrils by solid-state NMR and STEM, J Struct Biol, 2019, 206, 43, 48, PMID: 29678776"
10.1021/ja405993r,10.1021/ja405993r,107.68178,"Jiang, Z, de Messieres, M, Lee, JC. Membrane remodeling by α-synuclein and effects on amyloid formation, J Am Chem Soc, 2013, 135, 15970, 15973, PMID: 24099487"
10.1002/pro.2088,10.1002/pro.2088,139.53375,"Kang, L, Moriarty, G, Woods, L, Ashcroft, A, Radford, S, Baum, J. N-terminal acetylation of alpha-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer, Protein Sci, 2012, 21, 911, 917, PMID: 22573613"
10.1016/j.neulet.2013.04.058,10.1016/j.neulet.2013.04.058,114.46346,"Kara, E, Lewis, PA, Ling, H, Proukakis, C, Houlden, H, Hardy, J. α-Synuclein mutations cluster around a putative protein loop, Neurosci Lett, 2013, 546, 67, 70, PMID: 23669636"
10.1073/pnas.1700465115,10.1073/pnas.1700465115,168.832,"Kim, S, Yun, SP, Lee, S, Umanah, GE, Bandaru, VVR, Yin, X, Rhee, P, Karuppagounder, SS, Kwon, S-H, Lee, H, Mao, X, Kim, D, Pandey, A, Lee, G, Dawson, VL, Dawson, TM, Ko, HS. GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers, Proc Natl Acad Sci U S A, 2018, 115, 798, PMID: 29311330"
10.1021/bi026284c,10.1021/bi026284c,92.673294,"Kim, TD, Paik, SR, Yang, CH. Structural and functional implications of C-terminal regions of α-synuclein, Biochemistry, 2002, 41, 13782, 13790, PMID: 12427041"
10.1111/bpa.12374,10.1111/bpa.12374,103.46856,"Lassen, LB, Reimer, L, Ferreira, N, Betzer, C, Jensen, PH. Protein partners of α-synuclein in health and disease, Brain Pathol, 2016, 26, 389, 397, PMID: 26940507"
10.1371/journal.pone.0049750,10.1371/journal.pone.0049750,150.05972,"Lemkau, LR, Comellas, G, Lee, SW, Rikardsen, LK, Woods, WS, George, JM, Rienstra, CM. Site-specific perturbations of alpha-synuclein fibril structure by the parkinson’s disease associated mutations A53T and E46K, PLoS One, 2013, 8, e49750, PMID: 23505409"
10.1038/s41467-018-05971-2,10.1038/s41467-018-05971-2,133.11447,"Li, B, Ge, P, Murray, KA, Sheth, P, Zhang, M, Nair, G, Sawaya, MR, Shin, WS, Boyer, DR, Ye, S, Eisenberg, DS, Zhou, ZH, Jiang, L. Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel, Nat Commun, 2018a, 9, 3609, PMID: 30190461"
10.1038/s41422-018-0075-x,10.1038/s41422-018-0075-x,114.75883,"Li, Y, Zhao, C, Luo, F, Liu, Z, Gui, X, Luo, Z, Zhang, X, Li, D, Liu, C, Li, X. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy, Cell Res, 2018b, 28, 897, 903, PMID: 30065316"
10.1016/s0002-9440(10)65722-7,10.1016/s0002-9440(10)65722-7,158.19075,"Lippa, CF, Fujiwara, H, Mann, DM, Giasson, B, Baba, M, Schmidt, ML, Nee, LE, O’Connell, B, Pollen, DA, St George-Hyslop, P, Ghetti, B, Nochlin, D, Bird, TD, Cairns, NJ, Lee, VM, Iwatsubo, T, Trojanowski, JQ. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes, Am J Pathol, 1998, 153, 1365, 1370, PMID: 9811326"
10.3390/ijms20010141,10.3390/ijms20010141,110.98153,"Longhena, F, Faustini, G, Spillantini, MG, Bellucci, A. Living in promiscuity: the multiple partners of alpha-synuclein at the synapse in physiology and pathology, Int J Mol Sci, 2019, 20, E141, PMID: 30609739"
10.1039/c0mt00088d,10.1039/c0mt00088d,96.10022,"Lucas, HR, Lee, JC. Copper(II) enhances membrane-bound α-synuclein helix formation, Metallomics, 2011, 3, 280, 283, PMID: 21290070"
10.1021/bi501188a,10.1021/bi501188a,112.67617,"Luth, ES, Bartels, T, Dettmer, U, Kim, NC, Selkoe, DJ. Purification of α-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity, Biochemistry, 2015, 54, 279, 292, PMID: 25490121"
10.1002/pmic.201600399,10.1002/pmic.201600399,113.84994,"Minde, DP, Dunker, AK, Lilley, KS. Time, space, and disorder in the expanding proteome universe, Proteomics, 2017, 17, 1600399"
10.1016/j.nbd.2015.12.018,10.1016/j.nbd.2015.12.018,82.15628,"Mor, DE, Ugras, SE, Daniels, MJ, Ischiropoulos, H. Dynamic structural flexibility of α-synuclein, Neurobiol Dis, 2016, 88, 66, 74, PMID: 26747212"
10.1016/j.neuron.2018.09.014,10.1016/j.neuron.2018.09.014,183.31795,"Nuber, S, Rajsombath, M, Minakaki, G, Winkler, J, Müller, CP, Ericsson, M, Caldarone, B, Dettmer, U, Selkoe, DJ. Abrogating native α-synuclein tetramers in mice causes a L-Dopa-responsive motor syndrome closely resembling Parkinson’s disease, Neuron, 2018, 100, 75, 90.e5, PMID: 30308173"
10.1186/s40478-018-0587-0,10.1186/s40478-018-0587-0,176.37184,"Okuzumi, A, Kurosawa, M, Hatano, T, Takanashi, M, Nojiri, S, Fukuhara, T, Yamanaka, T, Miyazaki, H, Yoshinaga, S, Furukawa, Y, Shimogori, T, Hattori, N, Nukina, N. Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment, Acta Neuropathol Commun, 2018, 6, 96, PMID: 30231908"
10.1146/annurev-biochem-072711-164947,10.1146/annurev-biochem-072711-164947,119.26225,"Oldfield, CJ, Dunker, AK. Intrinsically disordered proteins and intrinsically disordered protein regions, Annu Rev Biochem, 2014, 83, 553, 584, PMID: 24606139"
10.1515/hsz-2016-0201,10.1515/hsz-2016-0201,109.40666,"Ottolini, D, Calí, T, Szabò, I, Brini, M. Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications, Biol Chem, 2017, 398, 77, 100, PMID: 27508962"
10.5607/en.2014.23.4.324,10.5607/en.2014.23.4.324,128.8327,"Oueslati, A, Ximerakis, M, Vekrellis, K. Protein transmission, seeding and degradation: key steps for α-synuclein prion-like propagation, Exp Neurobiol, 2014, 23, 324, 336, PMID: 25548532"
10.1038/nature14547,10.1038/nature14547,160.9443,"Peelaerts, W, Bousset, L, Van der Perren, A, Moskalyuk, A, Pulizzi, R, Giugliano, M, Van den Haute, C, Melki, R, Baekelandt, V. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration, Nature, 2015, 522, 340, PMID: 26061766"
10.1038/s41586-018-0104-4,10.1038/s41586-018-0104-4,154.80502,"Peng, C, Gathagan, RJ, Covell, DJ, Medellin, C, Stieber, A, Robinson, JL, Zhang, B, Pitkin, RM, Olufemi, MF, Luk, KC, Trojanowski, JQ, Lee, VM. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies, Nature, 2018, 557, 558, 563, PMID: 29743672"
10.1073/pnas.1512077112,10.1073/pnas.1512077112,115.405594,"Pochapsky, TC. From intrinsically disordered protein to context-dependent folding: The α-synuclein tetramer is teased out of hiding, Proc Natl Acad Sci U S A, 2015, 112, 9502, 9503, PMID: 26204916"
10.1038/nature15368,10.1038/nature15368,163.23137,"Rodriguez, JA, Ivanova, MI, Sawaya, MR, Cascio, D, Reyes, FE, Shi, D, Sangwan, S, Guenther, EL, Johnson, LM, Zhang, M, Jiang, L, Arbing, MA, Nannenga, BL, Hattne, J, Whitelegge, J, Brewster, AS, Messerschmidt, M, Boutet, S, Sauter, NK, Gonen, T. Structure of the toxic core of α-synuclein from invisible crystals, Nature, 2015, 525, 486, 490, PMID: 26352473"
10.1159/000355516,10.1159/000355516,104.644485,"Selkoe, D, Dettmer, U, Luth, E, Kim, N, Newman, A, Bartels, T. Defining the native state of α-synuclein, Neurodegener Dis, 2014, 13, 114, 117, PMID: 24192542"
10.1002/1873-3468.13047,10.1002/1873-3468.13047,143.08324,"Rovere, M, Sanderson, JB, Fonseca-Ornelas, L, Patel, DS, Bartels, T. Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces, FEBS Lett, 2018, 592, 1464, 1472, PMID: 29633780"
10.1110/ps.0235003,10.1110/ps.0235003,60.25429,"Sreerama, N, Woody, RW. Structural composition of βI-and βII-proteins, Protein Sci, 2003, 12, 384, 388, PMID: 12538903"
10.1007/s00441-018-2814-1,10.1007/s00441-018-2814-1,119.295654,"Steiner, JA, Quansah, E, Brundin, P. The concept of alpha-synuclein as a prion-like protein: ten years after, Cell Tissue Res, 2018, 373, 161, 173, PMID: 29480459"
10.1002/pro.3426,10.1002/pro.3426,103.07397,"Sung, YH, Eliezer, D. Structure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region, Protein Sci, 2018, 27, 1314, 1324, PMID: 29663556"
10.1021/bi900114z,10.1021/bi900114z,118.344894,"Trexler, AJ, Rhoades, E. α-Synuclein binds large unilamellar vesicles as an extended helix, Biochemistry, 2009, 48, 2304, 2306, PMID: 19220042"
10.1002/pro.2056,10.1002/pro.2056,97.57074,"Trexler, AJ, Rhoades, E. N-Terminal acetylation is critical for forming α-helical oligomer of α-synuclein, Protein Sci, 2012, 21, 601, 605, PMID: 22407793"
10.1111/j.1742-4658.2012.08489.x,10.1111/j.1742-4658.2012.08489.x,131.33391,"Tsigelny, IF, Sharikov, Y, Wrasidlo, W, Gonzalez, T, Desplats, PA, Crews, L, Spencer, B, Masliah, E. Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation, FEBS J, 2012, 279, 1000, 1013, PMID: 22251432"
10.1038/nsmb.3194,10.1038/nsmb.3194,155.31808,"Tuttle, MD, Comellas, G, Nieuwkoop, AJ, Covell, DJ, Berthold, DA, Kloepper, KD, Courtney, JM, Kim, JK, Barclay, AM, Kendall, A, Wan, W, Stubbs, G, Schwieters, CD, Lee, VMY, George, JM, Rienstra, CM. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein, Nat Struct Mol Biol, 2016, 23, 409, PMID: 27018801"
10.1021/ar300282r,10.1021/ar300282r,111.15397,"Tycko, R, Wickner, RB. Molecular structures of amyloid and prion fibrils: consensus versus controversy, Acc Chem Res, 2013, 46, 1487, 1496, PMID: 23294335"
10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7,10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7,116.46443,"Uversky, VN, Gillespie, JR, Fink, AL. Why are “natively unfolded” proteins unstructured under physiologic conditions, Proteins, 2000, 41, 415, 427, PMID: 11025552"
10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.3.co;2-z,10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7,116.46443,"Uversky, VN, Gillespie, JR, Fink, AL. Why are “natively unfolded” proteins unstructured under physiologic conditions, Proteins, 2000, 41, 415, 427, PMID: 11025552"
10.1002/ijch.201600116,10.1002/ijch.201600116,106.295105,"van Diggelen, F, Tepper, AWJW, Apetri, MM, Otzen, DE. α-Synuclein oligomers: a study in diversity, Isr J Chem, 2017, 57, 699, 723"
10.1007/s12035-012-8280-y,10.1007/s12035-012-8280-y,123.108376,"Wakabayashi, K, Tanji, K, Odagiri, S, Miki, Y, Mori, F, Takahashi, H. The Lewy body in parkinson’s disease and related neurodegenerative disorders, Mol Neurobiol, 2013, 47, 495, 508, PMID: 22622968"
10.1016/j.cub.2014.08.027,10.1016/j.cub.2014.08.027,109.873436,"Wang, L, Das, U, Scott David, A, Tang, Y, McLean Pamela, J, Roy, S. α-Synuclein multimers cluster synaptic vesicles and attenuate recycling, Curr Biol, 2014, 24, 2319, 2326, PMID: 25264250"
10.3389/fnmol.2016.00048,10.3389/fnmol.2016.00048,75.05835,"Wang, C, Zhao, C, Li, D, Tian, Z, Lai, Y, Diao, J, Liu, C. Versatile structures of α-synuclein, Front Mol Neurosci, 2016, 9, 48, PMID: 27378848"
10.1039/c8cc04054k,10.1039/c8cc04054k,93.94351,"Xu, L, Bhattacharya, S, Thompson, D. Re-designing the α-synuclein tetramer, Chem Commun (Camb), 2018, 54, 8080, 8083, PMID: 29971274"
10.1073/pnas.1113260108,10.1073/pnas.1113260108,175.87222,"Wang, W, Perovic, I, Chittuluru, J, Kaganovich, A, Nguyen, LT, Liao, J, Auclair, JR, Johnson, D, Landeru, A, Simorellis, AK, Ju, S, Cookson, MR, Asturias, FJ, Agar, JN, Webb, BN, Kang, C, Ringe, D, Petsko, GA, Pochapsky, TC, Hoang, QQ. A soluble α-synuclein construct forms a dynamic tetramer, Proc Natl Acad Sci U S A, 2011, 108, 17797, 17802, PMID: 22006323"
10.1111/j.1532-5415.2011.03777.x,10.1111/j.1532-5415.2011.03777.x,115.994934,"Andel, R, Crowe, M, Hahn, EA, Mortimer, JA, Pedersen, NL, Fratiglioni, L, Johansson, B, Gatz, M. Work-related stress may increase the risk of vascular dementia, J Am Geriatr Soc, 2012, 60, 60, 67, PMID: 22175444"
10.1007/s12017-010-8141-7,10.1007/s12017-010-8141-7,95.391426,"Balducci, C, Forloni, G. APP transgenic mice: their use and limitations, Neuromolecular Med, 2011, 13, 117, 137, PMID: 21152995"
10.1016/j.neurobiolaging.2014.04.019,10.1016/j.neurobiolaging.2014.04.019,132.33311,"Becerril-Ortega, J, Bordji, K, Fréret, T, Rush, T, Buisson, A. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer’s disease, Neurobiol Aging, 2014, 35, 2288, 2301, PMID: 24863668"
10.1161/hypertensionaha.114.04139,10.1161/hypertensionaha.114.04139,170.5087,"Broquères-You, D, Dere, E, Benessiano, J, Lévy, BI, Poittevin, M, Mariani, J, Cifuentes, D, Kubis, N, Merkulova-Rainon, T, Bonnin, P, Pocard, M. Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease, Hypertension, 2014, 65, 218, 224, PMID: 25331846"
10.1016/s1474-4422(18)30232-1,10.1016/s1474-4422(18)30232-1,120.58131,"Carmona, S, Zahs, K, Wu, E, Dakin, K, Bras, J, Guerreiro, R. The role of TREM2 in Alzheimer’s disease and other neurodegenerative disorders, Lancet Neurol, 2018, 17, 721, 730, PMID: 30033062"
10.1007/s40292-015-0108-1,10.1007/s40292-015-0108-1,111.223816,"Carnevale, D, Perrotta, M, Lembo, G, Trimarco, B. Pathophysiological links among hypertension and Alzheimer’s disease, High Blood Press Cardiovasc Prev, 2016, 23, 3, 7, PMID: 26054481"
10.1074/jbc.m100710200,10.1074/jbc.m100710200,178.78575,"Chishti, MA, Yang, DS, Janus, C, Phinney, AL, Horne, P, Pearson, J, Strome, R, Zuker, N, Loukides, J, French, J, Turner, S, Lozza, G, Grilli, M, Kunicki, S, Morissette, C, Paquette, J, Gervais, F, Bergeron, C, Fraser, PE, Carlson, GA. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695, J Biol Chem, 2001, 276, 21562, 21570, PMID: 11279122"
10.1074/jbc.m312946200,10.1074/jbc.m312946200,179.22809,"Davis, J, Xu, F, Deane, R, Romanov, G, Previti, ML, Zeigler, K, Zlokovic, BV, Van Nostrand, WE. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor, J Biol Chem, 2004, 279, 20296, 20306, PMID: 14985348"
10.1016/s1474-4422(04)00683-0,10.1016/s1474-4422(04)00683-0,88.05354,"de la Torre, JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics, Lancet Neurol, 2004, 3, 184, 190, PMID: 14980533"
10.1016/s0165-0173(00)00043-6,10.1016/s0165-0173(00)00043-6,88.661644,"de la Torre, JC, Stefano, GB. Evidence that Alzheimer’s disease is a microvascular disorder: The role of constitutive nitric oxide, Brain Res Rev, 2000, 34, 119, 136, PMID: 11113503"
10.1016/j.jacc.2017.07.724,10.1016/s0140-6736(17)31326-0,119.51181,"DeSimone, CV, Graff-Radford, J, El-Harasis, MA, Rabinstein, AA, Asirvatham, SJ, Holmes, DR. Cerebral amyloid angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation, J Am Coll Cardiol, 2017, 70, 1173, 1182, PMID: 28838368"
10.3109/09537104.2013.764979,10.3109/09537104.2013.764979,118.564644,"Ehrlich, D, Humpel, C. Effects of ethanol on aggregation, serotonin release, and amyloid precursor protein processing in rat and human platelets, Platelets, 2014, 25, 16, 22, PMID: 23402285"
10.1002/msj.20159,10.1002/msj.20159,84.7124,"Elder, GA, Gama Sosa, MA, De Gasperi, R. Transgenic mouse models of Alzheimer’s disease, Mt Sinai J Med, 2010, 77, 69, 81, PMID: 20101721"
10.1016/j.exger.2017.10.008,10.1016/j.exger.2017.10.008,99.21085,"Farina, N, Jernerén, F, Turner, C, Hart, K, Tabet, N. Homocysteine concentrations in the cognitive progression of Alzheimer’s disease, Exp Gerontol, 2017, 99, 146, 150, PMID: 29024723"
10.1016/j.nlm.2016.09.014,10.1016/j.nlm.2016.09.014,134.83264,"Foidl, BM, Do-Dinh, P, Hutter-Schmid, B, Bliem, HR, Humpel, C. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations, Neurobiol Learn Mem, 2016, 136, 86, 96, PMID: 27670619"
10.3389/fnagi.2018.00001,10.3389/fnagi.2018.00113,163.37936,"Foidl, BM, Humpel, C. Differential hyperphosphorylation of Tau-S199-T231 and -S396 in organotypic brain slices of Alzheimer Mice. A model to study early Tau hyperphosphorylation using okadaic acid, Front Aging Neurosci, 2018, 10, 1, 15, PMID: 29403371"
10.1016/j.bbi.2019.01.009,10.1016/j.bbi.2019.01.009,135.11406,"Foidl, BM, Humpel, C. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice, Brain Behav Immun, 2019, 78, 52, 64, PMID: 30664922"
10.3389/fphar.2014.00146,10.3389/fphar.2014.00146,101.68688,"Franco, R, Cedazo-Minguez, A. Successful therapies for Alzheimer’s disease: Why so many in animal models and none in humans, Front Pharmacol, 2014, 5, 146, PMID: 25009496"
10.1038/373523a0,10.1038/373523a0,152.45085,"Games, D, Adams, D, Alessandrini, R, Barbour, R, Borthelette, P, Blackwell, C, Carr, T, Clemens, J, Donaldson, T, Gillespie, F, Guido, T, Hagopian, S, Johnson-Wood, K, Khan, K, Lee, M, Leibowitz, P, Lieberburg, I, Little, S, Masliah, E, McConlogue, L. Alzheimer-type neuropathology in transgenic mice overexpressing V717F ß-amyloid precursor protein, Nature, 1995, 373, 523, 527, PMID: 7845465"
10.1016/j.brainresbull.2011.11.017,10.1016/j.brainresbull.2011.11.017,61.43929,"Hall, AM, Roberson, ED. Mouse models of Alzheimer’s disease, Brain Res Bull, 2012, 88, 3, 12, PMID: 22142973"
10.1038/nn1302,10.1038/nn1302,174.34894,"Herzig, MC, Winkler, DT, Burgermeister, P, Pfeifer, M, Kohler, E, Schmidt, SD, Danner, S, Abramowski, D, Stürchler-Pierrat, C, Bürki, K, Van Duinen, SG, Maat-Schieman, MLC, Staufenbiel, M, Mathews, PM, Jucker, M. Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis, Nat Neurosci, 2004, 7, 954, 960, PMID: 15311281"
10.1038/nm0198-097,10.1038/nm0198-097,185.6385,"Holcomb, L, Gordon, MN, Mcgowan, E, Yu, X, Benkovic, S, Jantzen, P, Wright, K, Saad, I, Mueller, R, Morgan, D, Sanders, S, Zehr, C, O’Campo, K, Hardy, J, Prada, CM, Eckman, C, Younkin, S, Hsiao, K, Duff, K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes, Nat Med, 1998, 4, 97, 100, PMID: 9427614"
10.1126/science.274.5284.99,10.1126/science.274.5284.99,140.24194,"Hsiao, K, Chapman, P, Nilsen, S, Eckman, C, Harigaya, Y, Younkin, S, Yang, F, Cole, G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 1996, 274, 99, 102, PMID: 8810256"
10.3892/etm.2016.3455,10.3892/etm.2016.3455,65.371864,"Huang, WJ, Zhang, X, Chen, WW. Association between alcohol and Alzheimer’s disease (Review), Exp Ther Med, 2016, 12, 1247, 1250, PMID: 27588045"
10.1016/j.exger.2010.11.032,10.1016/j.exger.2010.11.032,83.65302,"Humpel, C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer’s disease, Exp Gerontol, 2011, 46, 225, 232, PMID: 21112383"
10.2174/1567202614666170705150535,10.2174/1567202614666170705150535,83.66565,"Humpel, C. Platelets: their potential contribution to the generation of beta-amyloid plaques in Alzheimer’s disease, Curr Neurovasc Res, 2017, 14, 290, 298, PMID: 28677497"
10.1523/jneurosci.3333-14.2015,10.1523/jneurosci.3333-14.2015,172.18398,"Justice, NJ, Huang, L, Tian, JB, Cole, A, Pruski, M, Hunt, AJ, Flores, R, Zhu, MX, Arenkiel, BR, Zheng, H. Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses, J Neurosci, 2015, 35, 2612, 2623, PMID: 25673853"
10.1016/j.ynstr.2018.04.002,10.1016/j.ynstr.2018.04.002,61.47326,"Justice, NJ. The relationship between stress and Alzheimer’s disease, Neurobiol Stress, 2018, 8, 127, 133, PMID: 29888308"
10.3390/ijms17040503,10.3390/ijms17040503,89.17501,"Kimura, N. Diabetes mellitus induces Alzheimer’s disease pathology: Histopathological evidence from animal models, Int J Mol Sci, 2016, 17, 503, PMID: 27058526"
10.1038/d41586-018-05522-1,10.1038/d41586-018-05722-9,61.91127,"King, A. The search for better animal models of Alzheimer’s disease, Nature, 2018, 559, 13, 15, PMID: 29968833"
10.1016/j.trci.2018.06.014,10.1016/j.trci.2018.06.014,95.3316,"Kinney, JW, Bemiller, SM, Murtishaw, AS, Leisgang, AM, Salazar, AM, Lamb, BT. Inflammation as a central mechanism in Alzheimer’s disease, Alzheimer’s Dement Transl Res Clin Interv, 2018, 4, 575, 590"
10.1084/jem.20181035,10.1084/jem.20181035,128.16324,"Lazic, D, Sagare, AP, Nikolakopoulou, AM, Griffin, JH, Vassar, R, Zlokovic, BV. 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice, J Exp Med, 2019, 216, 279, 293, PMID: 30647119"
10.1126/science.1058189,10.1126/science.1058189,113.6884,"Lewis, J, Dickson, DW, Lin, WL, Chisholm, L, Corral, A, Jones, G, Yen, SH, Sahara, N, Skipper, L, Yager, D, Eckman, C, Hardy, J, Hutton, M, McGowan, E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science, 2001, 293, 1487, 1491, PMID: 11520987"
10.1038/sj.mp.4002072,10.1038/sj.mp.4002072,115.73166,"Marksteiner, J, Humpel, C. Beta-amyloid expression, release and extracellular deposition in aged rat brain slices, Mol Psychiatry, 2008, 13, 939, 952, PMID: 17712316"
10.1039/c3cc40779a,10.1039/c3cc40779a,101.96723,"Lv, X, Li, W, Luo, Y, Wang, D, Zhu, C, Huang, ZX, Tan, X. Exploring the differences between mouse mAβ 1-42 and human hAβ 1-42 for Alzheimer’s disease related properties and neuronal cytotoxicity, Chem Commun, 2013, 49, 5865, 5867"
10.1038/nrdp.2015.56,10.1038/nrdp.2015.56,78.067764,"Masters, CL, Bateman, R, Blennow, K, Rowe, CC, Sperling, RA, Cummings, JL. Alzheimer’s disease, Nat Rev Dis Prim, 2015, 1, 15056, PMID: 27188934"
10.1186/2051-5960-2-1,10.1186/s40478-014-0135-5,96.06578,"Morris, GP, Clark, IA, Vissel, B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease, Acta Neuropathol Commun, 2014, 2, 1, 21, PMID: 24383468"
10.1038/ncomms2494,10.1038/ncomms2494,102.603874,"Moreno-Gonzalez, I, Estrada, LD, Sanchez-Mejias, E, Soto, C. Smoking exacerbates amyloid pathology in a mouse model of Alzheimer’s disease, Nat Commun, 2013, 4, 1495, PMID: 23422663"
10.1007/s00702-017-1820-x,10.1007/s00702-017-1820-x,138.57527,"Mroczko, B, Groblewska, M, Litman-Zawadzka, A, Kornhuber, J, Lewczuk, P. Amyloid β oligomers (AβOs) in Alzheimer’s disease, J Neural Transm (Vienna), 2018, 125, 177, 191, PMID: 29196815"
10.1523/jneurosci.20-11-04050.2000,10.1523/jneurosci.20-11-04050.2000,176.08725,"Mucke, L, Masliah, E, Yu, GQ, Mallory, M, Rockenstein, EM, Tatsuno, G, Hu, K, Kholodenko, D, Johnson-Wood, K, McConlogue, L. High-level neuronal expression of Aß 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J Neurosci, 2000, 20, 4050, 4058, PMID: 10818140"
10.1523/jneurosci.1202-06.2006,10.1523/jneurosci.1202-06.2006,184.91875,"Oakley, H, Cole, SL, Logan, S, Maus, E, Shao, P, Craft, J, Guillozet-Bongaarts, A, Ohno, M, Disterhoft, J, Eldik, L Van, Berry, R, Vassar, R. Intraneuronal ß-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation, J Neurosci, 2006, 26, 10129, 10140, PMID: 17021169"
10.1016/s0896-6273(03)00434-3,10.1016/s0896-6273(03)00434-3,137.05046,"Oddo, S, Caccamo, A, Shepherd, JD, Murphy, MP, Golde, TE, Kayed, R, Metherate, R, Mattson, MP, Akbari, Y, LaFerla, FM. Triple-transgenic model of Alzheimer’s Disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction, Neuron, 2003, 39, 409, 421, PMID: 12895417"
10.1111/j.1460-9568.2010.07434.x,10.1111/j.1460-9568.2010.07434.x,119.473366,"Pirchl, M, Ullrich, C, Humpel, C. Differential effects of short-and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings, in vivo in rats, Eur J Neurosci, 2010, 32, 1516, 1527, PMID: 21044172"
10.5772/60535,10.5772/60535,106.72734,"Plagg, B, Humpel, C. Platelets in Alzheimer's Disease, The Non-Thrombotic Role of Platelets in Health and Disease. IntechOpen 2015, 2015, 191, 217"
10.1136/jnnp-2012-303898,10.1136/jnnp-2012-303898,102.325645,"Rannikmäe, K, Samarasekera, N, Martînez-Gonzâlez, NA, Salman, RAS, Sudlow, CLM. Genetics of cerebral amyloid angiopathy: Systematic review and meta-analysis, J Neurol Neurosurg Psychiatry, 2013, 84, 901, 908, PMID: 23457231"
10.1016/j.bcp.2013.12.024,10.1016/j.bcp.2013.12.024,94.765,"Reitz, C, Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers, Biochem Pharmacol, 2015, 88, 640, 651"
10.1097/wco.0b013e32835c4f04,10.1097/wco.0b013e32835c4f04,54.99832,"Rincon, F, Wright, CB. Vascular cognitive impairment, Curr Opin Neurol, 2013, 26, 29, 36, PMID: 23254555"
10.1089/dna.2016.3404,10.1089/dna.2016.3404,130.36171,"Olagnier, D, Muscolini, M, Coyne, CB, Diamond, MS, Hiscott, J. Mechanisms of Zika virus infection and Neuropathogenesis, DNA Cell Biol, 2016, 35, 8, 367, 372, DOI: 10.1089/dna.2016.3404, PMID: 27348136"
10.2471/blt.16.178608,10.2471/blt.16.178608,109.98759,"Jaenisch, T, Rosenberger, KD, Brito, C, Brady, O, Brasil, P, Marques, ET. Risk of microcephaly after Zika virus infection in Brazil, 2015 to 2016, Bull World Health Organ, 2017, 95, 3, 191, 198, DOI: 10.2471/BLT.16.178608, PMID: 28250532"
10.1371/journal.pmed.1002203,10.1371/journal.pmed.1002203,168.14737,"Krauer, F, Riesen, M, Reveiz, L, Oladapo, OT, Martinez-Vega, R, Porgo, TV, Haefliger, A, Broutet, NJ, Low, N, Group WHOZCW. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review, PLoS Med, 2017, 14, 1, e1002203, DOI: 10.1371/journal.pmed.1002203, PMID: 28045901"
10.1371/journal.pntd.0003580,10.1371/journal.pntd.0003580,131.65796,"Cleton, NB, Godeke, GJ, Reimerink, J, Beersma, MF, Doorn, HR, Franco, L, Goeijenbier, M, Jimenez-Clavero, MA, Johnson, BW, Niedrig, M. Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers, PLoS Negl Trop Dis, 2015, 9, 3, e0003580, DOI: 10.1371/journal.pntd.0003580, PMID: 25767876"
10.1001/jamapediatrics.2016.3982,10.1007/978-3-319-53643-9_4,48.526756,"Moore, CA, Staples, JE, Dobyns, WB, Pessoa, A, Ventura, CV, Fonseca, EB, Ribeiro, EM, Ventura, LO, Neto, NN, Arena, JF. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians, JAMA Pediatr, 2017, 171, 3, 288, 295, DOI: 10.1001/jamapediatrics.2016.3982, PMID: 27812690"
10.1016/j.ebiom.2017.01.008,10.1016/j.ebiom.2017.01.008,124.241005,"Wong, SJ, Furuya, A, Zou, J, Xie, X, Dupuis, AP, 2nd, Kramer, LD, Shi, PY. A multiplex microsphere immunoassay for Zika virus diagnosis, EBioMedicine, 2017, 16, 136, 140, DOI: 10.1016/j.ebiom.2017.01.008, PMID: 28094237"
10.1093/cid/ciw324,10.1093/cid/ciw324,123.742226,"Culjat, M, Darling, SE, Nerurkar, VR, Ching, N, Kumar, M, Min, SK, Wong, R, Grant, L, Melish, ME. Clinical and imaging findings in an infant with Zika Embryopathy, Clin Infect Dis, 2016, 63, 6, 805, 811, DOI: 10.1093/cid/ciw324, PMID: 27193747"
10.1007/s00381-016-3074-6,10.1007/s00381-016-3074-6,123.7619,"Cavalheiro, S, Lopez, A, Serra, S, Da Cunha, A, da Costa, MD, Moron, A, Lederman, HM. Microcephaly and Zika virus: neonatal neuroradiological aspects, Childs Nerv Syst, 2016, 32, 6, 1057, 1060, DOI: 10.1007/s00381-016-3074-6, PMID: 27080092"
10.15585/mmwr.mm6549e1,10.15585/mmwr.mm6549e1,144.63126,"Cuevas, EL, Tong, VT, Rozo, N, Valencia, D, Pacheco, O, Gilboa, SM, Mercado, M, Renquist, CM, Gonzalez, M, Ailes, EC. Preliminary report of microcephaly potentially associated with Zika virus infection during pregnancy -Colombia, January-November 2016, MMWR Morb Mortal Wkly Rep, 2016, 65, 49, 1409, 1413, DOI: 10.15585/mmwr.mm6549e1, PMID: 27977645"
10.1016/s0140-6736(16)00006-4,10.1016/s0140-6736(16)00006-4,137.28043,"Ventura, CV, Maia, M, Bravo-Filho, V, Gois, AL, Belfort, R, Jr. Zika virus in Brazil and macular atrophy in a child with microcephaly, Lancet, 2016, 387, 10015, 228, DOI: 10.1016/S0140-6736(16)00006-4, PMID: 26775125"
10.1007/s11604-017-0641-z,10.1007/s11604-017-0641-z,136.04474,"Mehrjardi MZ. · Carteaux, G, · Poretti, a,·, Taheri MS, · Bermudez, S, · Werner, H, · Hygino da Cruz Jr, L.C: Neuroimaging findings of postnatally acquired Zika virus infection: a pictorial essay. Jpn J Radiol. 2017;35:341–9."
10.1016/s0140-6736(16)30776-0,10.1016/s0140-6736(16)30776-0,136.09741,"Ventura, CV, Maia, M, Dias, N, Ventura, LO, Belfort, R, Jr. Zika: neurological and ocular findings in infant without microcephaly, Lancet, 2016, 387, 10037, 2502, DOI: 10.1016/S0140-6736(16)30776-0, PMID: 27287830"
10.15585/mmwr.mm6547e2,10.15585/mmwr.mm6547e2,151.60326,"van der Linden, V, Pessoa, A, Dobyns, W, Barkovich, AJ, Junior, HV, Filho, EL, Ribeiro, EM, Leal, MC, Coimbra, PP, Aragao, MF. Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth -Brazil, MMWR Morb Mortal Wkly Rep, 2016, 65, 47, 1343, 1348, DOI: 10.15585/mmwr.mm6547e2, PMID: 27906905"
10.1037/t11523-000,10.1037/t11523-000,75.66382,"Squires, J, Bricker, D. Ages & stages questionnaires, third edition (ASQ-3): a parent completed child monitoring system, 2009, Baltimore, Paul H. Brookes Publishing Co."
10.1056/nejmc1608612,10.1056/nejmc1608612,137.03021,"de Oliveira, WK, Carmo, EH, Henriques, CM, Coelho, G, Vazquez, E, Cortez-Escalante, J, Molina, J, Aldighieri, S, Espinal, MA, Dye, C. Zika virus infection and associated neurologic disorders in Brazil, N Engl J Med, 2017, 376, 16, 1591, 1593, DOI: 10.1056/NEJMc1608612, PMID: 28402236"
10.1037/t14978-000,10.1037/t14978-000,91.38271,"Bayley, N. Bayley scales of infant and toddler development 3rd edition (Bayley-III), 2006, San Antonio, The Psychological Corporation"
10.2105/ccdml.2868.145,10.2105/ccdml.2868.145,83.14278,Centers for Disease Control and Prevention Zika virus disease and Zika virus infection 2016 case definition. 2016. Available at: https://wwwn.cdc.gov/nndss/conditions/zika/case-definition/2016/06/.
10.1056/nejmoa0805715,10.1056/nejmoa0805715,130.7062,"Duffy, MR, Chen, TH, Hancock, WT, Powers, AM, Kool, JL, Lanciotti, RS, Pretrick, M, Marfel, M, Holzbauer, S, Dubray, C. Zika virus outbreak on Yap Island, Federated States of Micronesia, N Engl J Med, 2009, 360, 24, 2536, 2543, DOI: 10.1056/NEJMoa0805715, PMID: 19516034"
10.3201/eid1408.080287,10.3201/eid1408.080287,141.64058,"Lanciotti, RS, Kosoy, OL, Laven, JJ, Velez, JO, Lambert, AJ, Johnson, AJ, Stanfield, SM, Duffy, MR. Genetic and serologic properties of Zika virus associated with an epidemic, yap state, Micronesia, 2007, Emerg Infect Dis, 2008, 14, 8, 1232, 1239, DOI: 10.3201/eid1408.080287, PMID: 18680646"
10.3201/eid2006.140138,10.3201/eid2006.140138,121.13012,"Cao-Lormeau, VM, Roche, C, Teissier, A, Robin, E, Berry, AL, Mallet, HP, Sall, AA, Musso, D. Zika virus, French polynesia, south pacific, 2013, Emerg Infect Dis, 2014, 20, 6, 1085, 1086, PMID: 24856001"
10.1007/s00430-015-0445-7,10.1007/s00430-015-0445-7,180.00893,"Tappe, Dennis, Pérez-Girón, José Vicente, Zammarchi, Lorenzo, Rissland, Jürgen, Ferreira, Davis F, Jaenisch, Thomas, Gómez-Medina, Sergio, Günther, Stephan, Bartoloni, Alessandro, Muñoz-Fontela, César, Schmidt-Chanasit, Jonas. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase, Medical Microbiology and Immunology, 2015, 205, 3, 269, 273, DOI: 10.1007/s00430-015-0445-7, PMID: 26702627"
10.1186/s12916-016-0601-y,10.1186/s12916-016-0601-y,130.70622,"Anaya, J-M, Ramirez-Santana, C, Salgado-Castaneda, I, Chang, C, Ansari, A, Gershwin, ME. Zika virus and neurologic autoimmunity: the putative role of gangliosides, BMC Med, 2016, 14, 49, DOI: 10.1186/s12916-016-0601-y, PMID: 27001187"
10.2807/1560-7917.es2014.19.9.20720,10.2807/1560-7917.es2014.19.9.20720,180.20615,"Oehler, E, Watrin, L, Larre, P, Leparc-Goffart, I, Lastere, S, valour, F, Baudouin, L, Mallet, H, Musso, D, Ghawche, F. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013, Euro Surveill, 2014, 19, 9, DOI: 10.2807/1560-7917.ES2014.19.9.20720"
10.1016/s0140-6736(16)00644-9,10.1016/s0140-6736(16)00644-9,171.9304,"Mecharles, S, Herrmann, C, Poullain, P, Tran, TH, Deschamps, N, Mathon, G, Landais, A, Breurec, S, Lannuzel, A. Acute myelitis due to Zika virus infection, Lancet, 2016, 387, 10026, 1481, DOI: 10.1016/S0140-6736(16)00644-9, PMID: 26946926"
10.1056/nejmc1602964,10.1056/nejmc1602964,175.2679,"Carteaux, G, Maquart, M, Bedet, A, Contou, D, Brugieres, P, Fourati, S, Cleret de Langavant, L, de Broucker, T, Brun-Buisson, C, Leparc-Goffart, I. Zika virus associated with Meningoencephalitis, N Engl J Med, 2016, 374, 16, 1595, 1596, DOI: 10.1056/NEJMc1602964, PMID: 26958738"
10.1111/trf.13681,10.1111/trf.13681,130.61354,"Barjas-Castro, ML, Angerami, RN, Cunha, MS, Suzuki, A, Nogueira, JS, Rocco, IM, Maeda, AY, Vasami, FG, Katz, G, Boin, IF. Probable transfusion-transmitted Zika virus in Brazil, Transfusion, 2016, 56, 7, 1684, 1688, DOI: 10.1111/trf.13681, PMID: 27329551"
10.2807/1560-7917.es2014.19.14.20761,10.2807/1560-7917.es2014.19.14.20761,214.28145,"Musso, D, Nhan, T, Robin, E, Roche, C, Bierlaire, D, Zisou, K, Shan Yan, A, Cao-Lormeau, V, Broult, J. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014, Eurosurveillance, 2014, 19, 14, 20761, DOI: 10.2807/1560-7917.ES2014.19.14.20761, PMID: 24739982"
10.1111/trf.13677,10.1111/trf.13677,146.95184,"Lanteri, MC, Kleinman, SH, Glynn, SA, Musso, D, Keith Hoots, W, Custer, BS, Sabino, EC, Busch, MP. Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications, Transfusion, 2016, 56, 7, 1907, 1914, DOI: 10.1111/trf.13677, PMID: 27282638"
10.15585/mmwr.mm6508e2,10.15585/mmwr.mm6508e2,176.13474,"Hills, SL, Russell, K, Hennessey, M, Williams, C, Oster, AM, Fischer, M, Mead, P. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission -continental United States, 2016, MMWR Morb Mortal Wkly Rep, 2016, 65, 8, 215, 216, DOI: 10.15585/mmwr.mm6508e2, PMID: 26937739"
10.3201/eid1705.101939,10.3201/eid1705.101939,159.5908,"Foy, BD, Kobylinski, KC, Chilson Foy, JL, Blitvich, BJ, Travassos da Rosa, A, Haddow, AD, Lanciotti, RS, Tesh, RB. Probable non-vector-borne transmission of Zika virus, Colorado, USA, Emerg Infect Dis, 2011, 17, 5, 880, 882, DOI: 10.3201/eid1705.101939, PMID: 21529401"
10.1136/bmj.i720,10.1136/bmj.i720,143.35803,"McCarthy, M. Zika virus was transmitted by sexual contact in Texas, health officials report, BMJ, 2016, 352, i720, DOI: 10.1136/bmj.i720, PMID: 26848011"
10.2807/1560-7917.es.2016.21.8.30148,10.2807/1560-7917.es.2016.21.8.30148,147.81749,"Venturi G, Zammarchi L, Fortuna C, Remoli ME, Benedetti E, Fiorentini C, Trotta M, Rizzo C, Mantella A, Rezza G, et al. An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill. 2016;21(8):30148."
10.2807/1560-7917.es.2016.21.23.30254,10.2807/1560-7917.es.2016.21.23.30254,179.16795,"Freour T, Mirallie S, Hubert B, Splingart C, Barriere P, Maquart M, Leparc-Goffart I. Sexual transmission of Zika virus in an entirely asymptomatic couple returning from a Zika epidemic area, France, April 2016. Euro Surveill. 2016;21(23):30254."
10.2807/1560-7917.es.2016.21.23.30252,10.2807/1560-7917.es.2016.21.23.30252,152.37988,"Frank C, Cadar D, Schlaphof A, Neddersen N, Gunther S, Schmidt-Chanasit J, Tappe D. Sexual transmission of Zika virus in Germany, April 2016. Euro Surveill. 2016;21(23):30252."
10.1016/s0140-6736(16)30775-9,10.1016/s0140-6736(16)30775-9,151.21783,"Turmel, JM, Abgueguen, P, Hubert, B, Vandamme, YM, Maquart, M, Le Guillou-Guillemette, H, Leparc-Goffart, I. Late sexual transmission of Zika virus related to persistence in the semen, Lancet, 2016, 387, 10037, 2501, DOI: 10.1016/S0140-6736(16)30775-9, PMID: 27287833"
10.15585/mmwr.mm6528e2,10.15585/mmwr.mm6528e2,156.87106,"Davidson, A, Slavinski, S, Komoto, K, Rakeman, J, Weiss, D. Suspected female-to-male sexual transmission of Zika virus -New York City, 2016, MMWR Morb Mortal Wkly Rep, 2016, 65, 28, 716, 717, DOI: 10.15585/mmwr.mm6528e2, PMID: 27442327"
10.1056/nejmc1610613,10.1056/nejmc1610613,127.04878,"Swaminathan, S, Schlaberg, R, Lewis, J, Hanson, KE, Couturier, MR. Fatal Zika virus infection with secondary nonsexual transmission, N Engl J Med, 2016, 375, 19, 1907, 1909, DOI: 10.1056/NEJMc1610613, PMID: 27681699"
10.1093/cid/ciw509,10.1093/cid/ciw509,125.04312,"Matheron, S, d'Ortenzio, E, Leparc-Goffart, I, Hubert, B, de Lamballerie, X, Yazdanpanah, Y. Long-lasting persistence of Zika virus in semen, Clin Infect Dis, 2016, 63, 9, 1264, PMID: 27470244"
10.1097/aog.0000000000001625,10.1097/aog.0000000000001625,100.40969,"Meaney-Delman, D, Oduyebo, T, Polen, KN, White, JL, Bingham, AM, Slavinski, SA, Heberlein-Larson, L, St George, K, Rakeman, JL, Hills, S. Prolonged detection of Zika virus RNA in pregnant women, Obstet Gynecol, 2016, 128, 4, 724, 730, DOI: 10.1097/AOG.0000000000001625, PMID: 27479770"
10.1056/nejmoa1601824,10.1056/nejmoa1601824,128.5922,"Driggers, RW, Ho, CY, Korhonen, EM, Kuivanen, S, Jaaskelainen, AJ, Smura, T, Rosenberg, A, Hill, DA, DeBiasi, RL, Vezina, G. Zika virus infection with prolonged maternal Viremia and fetal brain abnormalities, N Engl J Med, 2016, 374, 22, 2142, 2151, DOI: 10.1056/NEJMoa1601824, PMID: 27028667"
10.2471/blt.16.171207,10.2471/blt.16.171207,134.62183,"Charrel, RN, Leparc-Goffart, I, Pas, S, de Lamballerie, X, Koopmans, M, Reusken, C. Background review for diagnostic test development for Zika virus infection, Bull World Health Organ, 2016, 94, 8, 574, 584D, DOI: 10.2471/BLT.16.171207, PMID: 27516635"
10.2807/1560-7917.es.2017.22.36.30609,10.2807/1560-7917.es.2017.22.36.30609,178.09476,"Mogling R, Zeller H, Revez J, Koopmans M, group Zrl, Reusken C: Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, May 2016. Euro Surveill. 2017;22(36):30609."
10.2471/blt.16.175950,10.2471/blt.16.175950,126.61799,"Corman, VM, Rasche, A, Baronti, C, Aldabbagh, S, Cadar, D, Reusken, CB, Pas, SD, Goorhuis, A, Schinkel, J, Molenkamp, R. Assay optimization for molecular detection of Zika virus, Bull World Health Organ, 2016, 94, 12, 880, 892, DOI: 10.2471/BLT.16.175950, PMID: 27994281"
10.1128/jcm.00987-17,10.1128/jcm.00987-17,171.1487,"Charrel, R, Mogling, R, Pas, S, Papa, A, Baronti, C, Koopmans, M, Zeller, H, Leparc-Goffart, I, Reusken, CB. Variable sensitivity in molecular detection of Zika virus in European expert laboratories: external quality assessment, November 2016, J Clin Microbiol, 2017, 55, 11, 3219, 3226, DOI: 10.1128/JCM.00987-17, PMID: 28835479"
10.3201/eid2405.171747,10.3201/eid2405.171747,192.12692,"Fischer, C, Pedroso, C, Mendrone, A, Bispo de Filipis, AM, Vallinoto, ACR, Ribeiro, B, Durignon, EL, Marques, ETA, Campos, GS, Viana, IFT, Levi, JE, Scarpelli, LE, Nogueira, M, de Souza Bastos, M, Souza, NCS, Khouri, R, Lira, SMC, Komninakis, SV, Baronti, C, Charrel, RN, Kümmerer, BM, Drosten, C, Brites, C, de Lamballerie, X, Niedrig, M, Netto, EM, Drexler, JF. External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil, Emerg Infect Dis, 2018, 24, 5, 888, 892, DOI: 10.3201/eid2405.171747"
10.1128/jcm.00442-17,10.1128/jcm.00442-17,168.3732,"L'Huillier, AG, Hamid-Allie, A, Kristjanson, E, Papageorgiou, L, Hung, S, Wong, CF, Stein, DR, Olsha, R, Goneau, LW, Dimitrova, K. Evaluation of Euroimmun anti-Zika virus IgM and IgG enzyme-linked Immunosorbent assays for Zika virus serologic testing, J Clin Microbiol, 2017, 55, 8, 2462, 2471, DOI: 10.1128/JCM.00442-17, PMID: 28566316"
10.1016/j.jbi.2008.08.010,10.1016/j.jbi.2008.08.010,128.08258,"Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 2009, 42, 2, 377, 381, DOI: 10.1016/j.jbi.2008.08.010, PMID: 18929686"
10.1001/jama.2016.19006,10.1001/jama.2016.19006,113.066345,"Honein, MA, Dawson, AL, Petersen, EE, Jones, AM, Lee, EH, Yazdy, MM, Ahmad, N, Macdonald, J, Evert, N, Bingham, A. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy, JAMA, 2017, 317, 1, 59, 68, DOI: 10.1001/jama.2016.19006, PMID: 27960197"
10.15585/mmwr.mm6613e1,10.15585/mmwr.mm6513e1er,126.95733,"Reynolds, MR, Jones, AM, Petersen, EE, Lee, EH, Rice, ME, Bingham, A, Ellington, SR, Evert, N, Reagan-Steiner, S, Oduyebo, T. Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure -U.S. Zika pregnancy registry, 2016, MMWR Morb Mortal Wkly Rep, 2017, 66, 13, 366, 373, DOI: 10.15585/mmwr.mm6613e1, PMID: 28384133"
10.15585/mmwr.mm6623e1,10.15585/mmwr.mm6615a7,93.25429,"Shapiro-Mendoza, CK, Rice, ME, Galang, RR, Fulton, AC, VanMaldeghem, K, Prado, MV, Ellis, E, Anesi, MS, Simeone, RM, Petersen, EE. Pregnancy outcomes after maternal Zika virus infection during pregnancy -U.S. territories, January 1, 2016-April 25, 2017, MMWR Morb Mortal Wkly Rep, 2017, 66, 23, 615, 621, DOI: 10.15585/mmwr.mm6623e1, PMID: 28617773"
10.1056/nejmoa1709481,10.1097/01.aoa.0000542352.41212.4b,111.06373,"Hoen, B, Schaub, B, Funk, AL, Ardillon, V, Boullard, M, Cabie, A, Callier, C, Carles, G, Cassadou, S, Cesaire, R. Pregnancy outcomes after ZIKV infection in French territories in the Americas, N Engl J Med, 2018, 378, 11, 985, 994, DOI: 10.1056/NEJMoa1709481, PMID: 29539287"
10.1371/journal.pntd.0002320,10.1371/journal.pntd.0002320,129.73048,"Jaenisch, Thomas, Sakuntabhai, Anavaj, Wilder-Smith, Annelies. Dengue Research Funded by the European Commission-Scientific Strategies of Three European Dengue Research Consortia, PLoS Neglected Tropical Diseases, 2013, 7, 12, e2320, DOI: 10.1371/journal.pntd.0002320, PMID: 24349584"
10.1016/s2214-109x(16)30255-8,10.1016/s2214-109x(16)30255-8,143.8356,"Van Kerkhove, MD, Reveiz, L, Souza, JP, Jaenisch, T, Carson, G, Broutet, N. Working group on ZHR: harmonisation of Zika virus research protocols to address key public health concerns, Lancet Glob Health, 2016, 4, 12, e911, e912, DOI: 10.1016/S2214-109X(16)30255-8, PMID: 27815145"
10.1186/s12916-018-1158-8,10.1186/s12916-018-1158-8,103.18431,"O'Reilly, KM, Lowe, R, Edmunds, WJ, Mayaud, P, Kucharski, A, Eggo, RM, Funk, S, Bhatia, D, Khan, K, Kraemer, MUG. Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis, BMC Med, 2018, 16, 1, 180, DOI: 10.1186/s12916-018-1158-8, PMID: 30285863"
10.1016/s0140-6736(16)32621-6,10.1016/s0140-6736(16)32621-6,129.67017,"Henao-Restrepo, AM, Camacho, A, Longini, IM, Watson, CH, Edmunds, WJ, Egger, M, Carroll, MW, Dean, NE, Diatta, I, Doumbia, M. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!), Lancet, 2017, 389, 10068, 505, 518, DOI: 10.1016/S0140-6736(16)32621-6, PMID: 28017403"
10.1016/s1473-3099(16)30463-7,10.1016/s1473-3099(16)30463-7,128.29486,"Ujiie, M, Sasaki, K, Yoshikawa, N, Enami, T, Shobayashi, T. Introduction of a hepatitis B vaccine into the national routine immunisation programme of Japan, Lancet Infect Dis, 2016, 16, 1325, DOI: 10.1016/S1473-3099(16)30463-7"
10.4254/wjh.v7.i3.488,10.4254/wjh.v7.i3.488,88.87047,"Lewis, JD, Enfield, KB, Sifri, CD. Hepatitis B in healthcare workers: transmission events and guidance for management, World J Hepatol, 2015, 7, 488, 497, DOI: 10.4254/wjh.v7.i3.488, PMID: 25848472"
10.1186/s12199-019-0769-9,10.1186/s12199-019-0769-9,131.75307,"Yasin J, Fisseha R, Mekonnen F, Yirdaw K. Occupational exposure to blood and body fluids and associated factors among health care workers at the University of Gondar Hospital, Northwest Ethiopia. Environ Health Prev Med. 2019;24:18."
10.2957/kanzo.52.87,10.2957/kanzo.52.87,136.7585,"Okuse, Chiaki, Yotsuyanagi, Hiroshi, Yamada, Norie, Yasuda, Kiyomi, Hara, Masatoshi, Matsuda, Takahide, Aono, Junko, Suzuki, Michihiro, Itoh, Fumio, Koike, Kazuhiko. Evaluation of usefulness of hepatitis B vaccination at St. Marianna University School of Medicine Hospital and related facilities, Kanzo, 2011, 52, 2, 87, 93, DOI: 10.2957/kanzo.52.87"
10.1016/j.jhep.2016.01.027,10.1016/j.jhep.2016.01.027,83.54069,"Tong, S, Revill, P. Overview of hepatitis B viral replication and genetic variability, J Hepatol, 2016, 64, S4, 16, DOI: 10.1016/j.jhep.2016.01.027, PMID: 27084035"
10.7883/yoken.65.476,10.7883/yoken.65.476,90.83917,"Shi, YH. Correlation between hepatitis B virus genotypes and clinical outcomes, Jpn J Infect Dis, 2012, 65, 476, 482, DOI: 10.7883/yoken.65.476, PMID: 23183198"
10.15585/mmwr.rr6701a1,10.15585/mmwr.rr6701a1,143.38716,"Schillie, S, Vellozzi, C, Reingold, A, Harris, A, Haber, P, Ward, JW. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep, 2018, 67, 1, 31, DOI: 10.15585/mmwr.rr6701a1"
10.4161/hv.4.1.4747,10.4161/hv.4.1.4747,53.79596,"Cook, IF. Evidence based route of administration of vaccines, Hum Vaccin, 2008, 4, 63, 73, DOI: 10.4161/hv.4.1.4747"
10.1016/j.vaccine.2008.04.054,10.1016/j.vaccine.2008.04.054,107.89866,"Cook, IF. Sexual dimorphism of humoral immunity with human vaccines, Vaccine, 2008, 26, 3551, 3555, DOI: 10.1016/j.vaccine.2008.04.054, PMID: 18524433"
10.1002/hep.29876,10.1002/hep.29876,126.09718,"Nishida, N, Sugiyama, M, Sawai, H, Nishina, S, Sakai, A, Ohashi, J. Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine, Hepatology, 2018, 68, 848, 858, DOI: 10.1002/hep.29876, PMID: 29534301"
10.1007/s00535-017-1316-3,10.1007/s00535-017-1316-3,119.9628,"Kato, M, Hamada-Tsutsumi, S, Okuse, C, Sakai, A, Matsumoto, N, Sato, M. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes, J Gastroenterol, 2017, 52, 1051, 1063, DOI: 10.1007/s00535-017-1316-3, PMID: 28197802"
10.1371/journal.pone.0118062,10.1371/journal.pone.0118062,132.77905,"Hamada-Tsutsumi, S, Iio, E, Watanabe, T, Murakami, S, Isogawa, M, Iijima, S. Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection, PLoS One, 2015, 10, e0118062, DOI: 10.1371/journal.pone.0118062, PMID: 25693196"
10.1111/jgh.13030,10.1111/jgh.13030,80.63427,"Ito, K, Yotsuyanagi, H, Sugiyama, M, Yatsuhashi, H, Karino, Y, Takikawa, Y. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan, J Gastroenterol Hepatol, 2016, 31, 180, 189, DOI: 10.1111/jgh.13030, PMID: 26110395"
10.1002/hep.21249,10.1002/hep.21249,103.61173,"Ozasa, A, Tanaka, Y, Orito, E, Sugiyama, M, Kang, JH, Hige, S. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection, Hepatology, 2006, 44, 326, 334, DOI: 10.1002/hep.21249, PMID: 16871568"
10.1002/jmv.20320,10.1002/jmv.20320,104.0377,"Suzuki, Y, Kobayashi, M, Ikeda, K, Suzuki, F, Arfase, Y, Akuta, N. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan, J Med Virol, 2005, 76, 33, 39, DOI: 10.1002/jmv.20320, PMID: 15779048"
10.1155/2017/1327492,10.1155/2017/1327492,126.41783,"Sahana, HV, Sarala, N, Prasad, SR. Decrease in anti-HBs antibodies over time in medical students and healthcare workers after hepatitis B vaccination, Biomed Res Int, 2017, 2017, 1327492, DOI: 10.1155/2017/1327492, PMID: 29082237"
10.1056/nejmcp041507,10.1056/nejmcp041507,79.81757,"Gregory, A, Poland, GA, Jacobson, RM. Prevention of hepatitis B with the hepatitis B vaccine, N Engl J Med, 2004, 351, 2832, 2838, DOI: 10.1056/NEJMcp041507, PMID: 15625334"
10.3748/wjg.v20.i30.10383,10.3748/wjg.v20.i30.10383,123.33656,"Filippelli, M, Lionetti, E, Gennaro, A, Lanzafame, A, Arrigo, T, Salpietro, C. Hepatitis B vaccine by intradermal route in non responder patients: an update, World J Gastroenterol, 2014, 20, 10383, 10394, DOI: 10.3748/wjg.v20.i30.10383, PMID: 25132754"
10.3109/00365548709117195,10.3109/00365548709117195,105.79578,"Wahl, M, Hermodsson, S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response, Scand J Infect Dis, 1987, 19, 617, 621, DOI: 10.3109/00365548709117195, PMID: 3441747"
10.1016/j.vetmic.2010.11.008,10.1016/j.vetmic.2010.11.008,74.224304,"Yu, H. Genetic diversity of H9N2 influenza viruses from pigs in China: a potential threat to human health, Vet Microbiol, 2011, 149, 254, 261, DOI: 10.1016/j.vetmic.2010.11.008, PMID: 21115230"
10.1016/j.meegid.2013.10.012,10.1016/j.meegid.2013.10.012,74.432625,"Sun, X. Evidence of avian-like H9N2 influenza A virus among dogs in Guangxi, China, Infect Genet Evol, 2013, 20, 471, 475, DOI: 10.1016/j.meegid.2013.10.012, PMID: 24161411"
10.1111/tbed.12805,10.1111/tbed.12805,93.762924,"Xue, R. H9N2 influenza virus isolated from minks has enhanced virulence in mice, Transbound Emerg Dis, 2018, 65, 904, 910, DOI: 10.1111/tbed.12805, PMID: 29333687"
10.1128/jvi.01059-18,10.1128/jvi.01059-18,47.61862,"Kandeil, A. et al. Isolation and Characterization of a Distinct Influenza A Virus from Egyptian Bats. J Virol 93, 10.1128/JVI.01059-18 (2019)."
10.3201/eid2407.172059,10.3201/eid2407.172059,75.92073,"Ma, MJ. Avian Influenza A Virus Infection among Workers at Live Poultry Markets, China, 2013-2016, Emerg Infect Dis, 2018, 24, 1246, 1256, DOI: 10.3201/eid2407.172059, PMID: 29912708"
10.1016/s0140-6736(99)03311-5,10.1016/s0140-6736(99)03311-5,73.07332,"Peiris, M. Human infection with influenza H9N2, Lancet, 1999, 354, 916, 917, DOI: 10.1016/S0140-6736(99)03311-5, PMID: 10489954"
10.2307/1588557,10.2307/1588557,121.079414,"Homme, PJ, Easterday, BC. Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus, Avian Dis, 1970, 14, 66, 74, DOI: 10.2307/1588557, PMID: 4314007"
10.3390/vetsci5040082,10.3390/vetsci5040082,95.98377,"Pusch, Elizabeth, Suarez, David. The Multifaceted Zoonotic Risk of H9N2 Avian Influenza, Veterinary Sciences, 2018, 5, 4, 82, DOI: 10.3390/vetsci5040082"
10.3201/eid2501.180618,10.3201/eid2501.180618,72.35164,"Ali, M. Avian Influenza A(H9N2) Virus in Poultry Worker, Pakistan, 2015, Emerg Infect Dis, 2019, 25, 136, 139, DOI: 10.3201/eid2501.180618, PMID: 30561309"
10.1371/journal.pone.0002923,10.1371/journal.pone.0002923,68.84357,"Wan, H. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential, PLoS One, 2008, 3, e2923, DOI: 10.1371/journal.pone.0002923, PMID: 18698430"
10.1007/s00705-013-1721-8,10.1007/s00705-013-1721-8,78.90444,"Zhang, K. Experimental infection of non-human primates with avian influenza virus (H9N2), Arch Virol, 2013, 158, 2127, 2134, DOI: 10.1007/s00705-013-1721-8, PMID: 23665767"
10.1016/j.virusres.2013.04.004,10.1016/j.virusres.2013.04.004,78.44001,"Zhang, K. Domestic cats and dogs are susceptible to H9N2 avian influenza virus, Virus Res, 2013, 175, 52, 57, DOI: 10.1016/j.virusres.2013.04.004, PMID: 23603563"
10.1073/pnas.160270697,10.1073/pnas.160270697,90.03156,"Lin, YP. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates, Proc Natl Acad Sci USA, 2000, 97, 9654, 9658, DOI: 10.1073/pnas.160270697, PMID: 10920197"
10.1073/pnas.96.16.9363,10.1073/pnas.96.16.9363,134.36354,"Guan, Y, Shortridge, KF, Krauss, S, Webster, RG. Molecular characterization of H9N2 influenza viruses: were they the donors of the “internal” genes of H5N1 viruses in Hong Kong, Proc Natl Acad Sci USA, 1999, 96, 9363, 9367, DOI: 10.1073/pnas.96.16.9363, PMID: 10430948"
10.1016/j.vetmic.2014.09.029,10.1016/j.vetmic.2014.09.029,120.229385,"Gu, M. Enzootic genotype S of H9N2 avian influenza viruses donates internal genes to emerging zoonotic influenza viruses in China, Vet Microbiol, 2014, 174, 309, 315, DOI: 10.1016/j.vetmic.2014.09.029, PMID: 25457363"
10.3201/eid2208.160146,10.3201/eid2208.160146,93.637856,"Shen, YY. Novel Reassortant Avian Influenza A(H5N6) Viruses in Humans, Guangdong, China, 2015, Emerg Infect Dis, 2016, 22, 1507, 1509, DOI: 10.3201/eid2208.160146, PMID: 27331418"
10.1016/j.chom.2013.09.001,10.1016/j.chom.2013.09.001,95.66815,"Wu, A. Sequential reassortments underlie diverse influenza H7N9 genotypes in China, Cell Host Microbe, 2013, 14, 446, 452, DOI: 10.1016/j.chom.2013.09.001, PMID: 24055604"
10.3390/v10090497,10.3390/v10090497,130.23042,"Mostafa, Ahmed, Abdelwhab, Elsayed, Mettenleiter, Thomas, Pleschka, Stephan. Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview, Viruses, 2018, 10, 9, 497, DOI: 10.3390/v10090497"
10.1128/jvi.02765-13,10.1128/jvi.02765-13,74.69251,"Sutton, TC. Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets, J Virol, 2014, 88, 6623, 6635, DOI: 10.1128/JVI.02765-13, PMID: 24696487"
10.1126/science.1229455,10.1126/science.1229455,96.25912,"Zhang, Y. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet, Science, 2013, 340, 1459, 1463, DOI: 10.1126/science.1229455, PMID: 23641061"
10.1371/journal.ppat.1000709,10.1371/journal.ppat.1000709,83.16357,"Gao, Y. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host, PLoS Pathog, 2009, 5, e1000709, DOI: 10.1371/journal.ppat.1000709, PMID: 20041223"
10.1126/science.1213362,10.1126/science.1213362,70.50971,"Herfst, S. Airborne transmission of influenza A/H5N1 virus between ferrets, Science, 2012, 336, 1534, 1541, DOI: 10.1126/science.1213362, PMID: 22723413"
10.1002/embj.201387442,10.1002/embj.201387442,98.771515,"de Graaf, M, Fouchier, RA. Role of receptor binding specificity in influenza A virus transmission and pathogenesis, EMBO J, 2014, 33, 823, 841, DOI: 10.1002/embj.201387442, PMID: 24668228"
10.1126/science.1136212,10.1126/science.1136212,82.315285,"Tumpey, TM. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission, Science, 2007, 315, 655, 659, DOI: 10.1126/science.1136212, PMID: 17272724"
10.4172/2161-0460.1000439,10.4172/2161-0460.1000439,135.29404,"Rohn, TT, Kim, N, Isho, NF, Mack, JM. The potential of CRISPR/Cas9 gene editing as a treatment strategy for Alzheimer’s disease, J Alzheimers Dis Parkinsonism, 2018, doi: 10.4172/2161-0460.1000439"
10.1111/cen3.12475,10.1111/cen3.12475,80.27433,"Saito, T, Saido, TC. Neuroinflammation in mouse models of Alzheimer’s disease, Clin Exp Neuroimmunol, 2018, 9, 211, 218, PMID: 30546389"
10.1038/nn.3697,10.1038/nn.3697,145.2956,"Saito, T, Matsuba, Y, Mihira, N, Takano, J, Nilsson, P, Itohara, S, Iwata, N, Saido, TC. Single App knock-in mouse models of Alzheimer’s disease, Nat Neurosci, 2014, 17, 661, 663, PMID: 24728269"
10.15252/embj.201797397,10.15252/embj.201797397,127.98414,"Sasaguri, H, Nilsson, P, Hashimoto, S, Nagata, K, Saito, T, De Strooper, B, Hardy, J, Vassar, R, Winblad, B, Saido, TC. APP mouse models for Alzheimer’s disease preclinical studies, EMBO J, 2017, 36, 2473, 2487, PMID: 28768718"
10.1038/nrneurol.2010.130,10.1038/nrneurol.2010.130,108.69953,"Sims-Robinson, C, Kim, B, Rosko, A, Feldman, EL. How does diabetes accelerate Alzheimer disease pathology, Nat Rev Neurol, 2010, 6, 551, 559, PMID: 20842183"
10.1073/pnas.1302212110,10.1073/pnas.1302212110,160.32956,"Singh, I, Sagare, AP, Coma, M, Perlmutter, D, Gelein, R, Bell, RD, Deane, RJ, Zhong, E, Parisi, M, Ciszewski, J, Kasper, RT, Deane, R. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance, Proc Natl Acad Sci U S A, 2013, 110, 14771, 14776, PMID: 23959870"
10.1084/jem.20171529,10.1084/jem.20171529,122.94423,"Song, WM, Joshita, S, Zhou, Y, Ulland, TK, Gilfillan, S, Colonna, M. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism, J Exp Med, 2018, 215, 745, 760, PMID: 29321225"
10.1073/pnas.94.24.13287,10.1073/pnas.94.24.13287,181.22925,"Sturchler-Pierrat, C, Abramowski, D, Duke, M, Wiederhold, K-H, Mistl, C, Rothacher, S, Ledermann, B, Burki, K, Frey, P, Paganetti, PA, Waridel, C, Calhoun, ME, Jucker, M, Probst, A, Staufenbiel, M, Sommer, B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc Natl Acad Sci U S A, 1997, 94, 13287, 13292, PMID: 9371838"
10.4061/2011/810981,10.4061/2011/810981,71.421814,"Tai, LM, Youmans, KL, Jungbauer, L, Yu, C, Ladu, MJ. Introducing human APOE into Aβ transgenic mouse models, Int J Alzheimers Dis, 2011, 2011, 810981, PMID: 22028984"
10.1016/j.neurobiolaging.2014.12.033,10.1016/j.neurobiolaging.2014.12.033,164.13162,"Turano, E, Busetto, G, Marconi, S, Guzzo, F, Farinazzo, A, Commisso, M, Bistaffa, E, Angiari, S, Musumeci, S, Sotgiu, S, Bonetti, B. Neurotoxicity and synaptic plasticity impairment of N-acetylglucosamine polymers: Implications for Alzheimer’s disease, Neurobiol Aging, 2015, 36, 1780, 1791, PMID: 25735590"
10.3233/jad-160527,10.3233/jad-160527,88.01343,"Vijayan, M, Reddy, PH. Stroke, vascular dementia, and Alzheimer’s disease: molecular links, J Alzheimers Dis, 2016, 54, 427, 443, PMID: 27567871"
10.4269/ajtmh.19-1943,10.4269/ajtmh.19-1943,76.992065,"Bogoch II, Chakrabarti S, Sharkawy A. In Memoriam: Jay Keystone (1943–2019). Am J Trop Med Hyg. 2019; 101: 953–4. DOI: 10.4269/ajtmh.19-1943"
10.1097/00000658-198404000-00007,10.1097/00000658-198404000-00007,86.84406,"Langer JC, Rose DB, Keystone JS, Taylor BR, Langer B. Diagnosis and management of hydatid disease of the liver. A 15-year North American experience. Ann Surg. 1984; 199: 412–7. DOI: 10.1097/00000658-198404000-00007 PMID: 6712316"
10.1086/514616,10.1086/514616,104.492004,"Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis. 1998; 27: 142–9. DOI: 10.1086/514616 PMID: 9675468"
10.1001/jama.291.23.2856,10.1001/jama.291.23.2856,139.95349,"Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004; 291: 2856–64. DOI: 10.1001/jama.291.23.2856 PMID: 15199037"
10.1056/nejmoa051331,10.1056/nejmoa051331,112.59598,"Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354: 119–30. DOI: 10.1056/NEJMoa051331 PMID: 16407507"
10.7326/0003-4819-158-6-201303190-00005,10.7326/0003-4819-158-6-201303190-00005,146.1118,"Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al; GeoSentinel Surveillance Network. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013; 158: 456–68. DOI: 10.7326/0003-4819-158-6-201303190-00005 PMID: 23552375"
10.1086/315533,10.1086/315533,71.5671,Galazka A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000; 181(Suppl 1): S2–9. DOI: 10.1086/315533 PMID: 10657184
10.3201/eid0404.980404,10.3201/eid0404.980404,105.78433,"Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998; 4: 539–50. DOI: 10.3201/eid0404.980404 PMID: 9866730"
10.1017/s0950268814001241,10.1017/s0950268814001241,100.80097,"Santos LS, Sant’anna LO, Ramos JN, Ladeira EM, Stavracakis-Peixoto R, Borges LL, et al. Diphtheria outbreak in Maranhão, Brazil: microbiological, clinical and epidemiological aspects. Epidemiol Infect. 2015; 143: 791–8. DOI: 10.1017/S0950268814001241 PMID: 25703400"
10.3201/eid2407.171712,10.3201/eid2407.171712,149.0266,"Lodeiro-Colatosti A, Reischl U, Holzmann T, Hernández-Pereira CE, Rísquez A, Paniz-Mondolfi AE. Diphtheria outbreak in Amerindian communities, Wonken, Venezuela, 2016–2017. Emerg Infect Dis. 2018; 24: 1340–4. DOI: 10.3201/eid2407.171712 PMID: 29912686"
10.1371/journal.pone.0121749,10.1371/journal.pone.0121749,131.2662,"Nanthavong N, Black AP, Nouanthong P, Souvannaso C, Vilivong K, Muller CP, et al. Diphtheria in Lao PDR: insufficient coverage or ineffective vaccine? PLoS One. 2015; 10: e0121749. DOI: 10.1371/journal.pone.0121749 PMID: 25909365"
10.3201/eid2308.162039,10.3201/eid2308.162039,94.25114,"du Plessis M, Wolter N, Allam M, de Gouveia L, Moosa F, Ntshoe G, et al. Molecular characterization of Corynebacterium diphtheriae outbreak isolates, South Africa, March–June 2015. Emerg Infect Dis. 2017; 23: 1308–15. DOI: 10.3201/eid2308.162039 PMID: 28726616"
10.1017/s0950268817000851,10.1017/s0950268817000851,110.06299,"Mahomed S, Archary M, Mutevedzi P, Mahabeer Y, Govender P, Ntshoe G, et al. An isolated outbreak of diphtheria in South Africa, 2015. Epidemiol Infect. 2017; 145: 2100–8. DOI: 10.1017/S0950268817000851 PMID: 28478776"
10.1016/j.cmi.2016.08.010,10.1016/j.cmi.2016.08.010,115.967316,"Meinel DM, Kuehl R, Zbinden R, Boskova V, Garzoni C, Fadini D, et al. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clin Microbiol Infect. 2016; 22: 1003.e1–8. DOI: 10.1016/j.cmi.2016.08.010 PMID: 27585943"
10.3201/eid2407.172026,10.3201/eid2407.172026,146.41162,"Dangel A, Berger A, Konrad R, Bischoff H, Sing A. Geographically diverse clusters of nontoxigenic Corynebacterium diphtheriae infection, Germany, 2016–2017. Emerg Infect Dis. 2018; 24: 1239–45. DOI: 10.3201/eid2407.172026 PMID: 29912709"
10.2807/1560-7917.es.2016.21.48.30414,10.2807/1560-7917.es.2016.21.48.30414,177.09016,"Kantsone I, Lucenko I, Perevoscikovs J. More than 20 years after re-emerging in the 1990s, diphtheria remains a public health problem in Latvia. Euro Surveill. 2016; 21: 30414. DOI: 10.2807/1560-7917.ES.2016.21.48.30414 PMID: 27934582"
10.1186/1471-2334-13-551,10.1186/1471-2334-13-551,152.26479,"Zasada AA, Rastawicki W, Rokosz N, Jagielski M. Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland. BMC Infect Dis. 2013; 13: 551. DOI: 10.1186/1471-2334-13-551 PMID: 24252165"
10.1371/journal.pone.0148605,10.1371/journal.pone.0148605,156.32573,"Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L. Long-term protection against diphtheria in the Netherlands after 50 Years of vaccination: results from a seroepidemiological study. PLoS One. 2016; 11: e0148605. DOI: 10.1371/journal.pone.0148605 PMID: 26863307"
10.1128/jcm.00362-11,10.1128/jcm.00362-11,96.87272,"Lowe CF, Bernard KA, Romney MG. Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol. 2011; 49: 2664–6. DOI: 10.1128/JCM.00362-11 PMID: 21525220"
10.1128/jcm.44.5.1625-1629.2006,10.1128/jcm.44.5.1625-1629.2006,138.07506,"Romney MG, Roscoe DL, Bernard K, Lai S, Efstratiou A, Clarke AM. Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada. J Clin Microbiol. 2006; 44: 1625–9. DOI: 10.1128/JCM.44.5.1625-1629.2006 PMID: 16672385"
10.3201/eid1911.130297,10.3201/eid1911.130297,109.58559,"Zasada AA. Nontoxigenic highly pathogenic clone of Corynebacterium diphtheriae, Poland, 2004-2012. Emerg Infect Dis. 2013; 19: 1870–2. DOI: 10.3201/eid1911.130297 PMID: 24209492"
10.1086/514997,10.1086/514997,147.7268,"Gubler J, Huber-Schneider C, Gruner E, Altwegg M. An outbreak of nontoxigenic Corynebacterium diphtheriae infection: single bacterial clone causing invasive infection among Swiss drug users. Clin Infect Dis. 1998; 27: 1295–8. DOI: 10.1086/514997 PMID: 9827285"
10.1128/jcm.05811-11,10.1128/jcm.05811-11,113.82827,"Farfour E, Badell E, Zasada A, Hotzel H, Tomaso H, Guillot S, et al. Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland. J Clin Microbiol. 2012; 50: 173–5. DOI: 10.1128/JCM.05811-11 PMID: 22090411"
10.1128/jcm.43.7.3447-3449.2005,10.1128/jcm.43.7.3447-3449.2005,154.2083,"Dewinter LM, Bernard KA, Romney MG. Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria. J Clin Microbiol. 2005; 43: 3447–9. DOI: 10.1128/JCM.43.7.3447-3449.2005 PMID: 16000474"
10.1017/s0950268811000963,10.1017/s0950268811000963,109.61584,"Viguetti SZ, Pacheco LG, Santos LS, Soares SC, Bolt F, Baldwin A, et al. Multilocus sequence types of invasive Corynebacterium diphtheriae isolated in the Rio de Janeiro urban area, Brazil. Epidemiol Infect. 2012; 140: 617–20. DOI: 10.1017/S0950268811000963 PMID: 21669023"
10.1186/1476-0711-4-8,10.1186/1476-0711-4-8,102.620895,"Zasada AA, Zaleska M, Podlasin RB, Seferynska I. The first case of septicemia due to nontoxigenic Corynebacterium diphtheriae in Poland: case report. Ann Clin Microbiol Antimicrob. 2005; 4: 8. DOI: 10.1186/1476-0711-4-8 PMID: 15876349"
10.1093/clind/16.2.271,10.1093/clind/16.2.271,136.20915,"Tiley SM, Kociuba KR, Heron LG, Munro R. Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae: report of seven cases and review. Clin Infect Dis. 1993; 16: 271–5. DOI: 10.1093/clind/16.2.271 PMID: 8443306"
10.15585/mmwr.mm6812a2,10.15585/mmwr.mm6812a2,157.69922,"Griffith J, Bozio CH, Poel AJ, Fitzpatrick K, DeBolt CA, Cassiday P, et al. Imported toxin-producing cutaneous diphtheria–Minnesota, Washington, and New Mexico, 2015–2018. MMWR Morb Mortal Wkly Rep. 2019; 68: 281–4. DOI: 10.15585/mmwr.mm6812a2 PMID: 30921303"
10.1093/jac/35.6.717,10.1093/jac/35.6.717,116.08133,Wilson AP. Treatment of infection caused by toxigenic and non-toxigenic strains of Corynebacterium diphtheriae. J Antimicrob Chemother. 1995; 35: 717–20. DOI: 10.1093/jac/35.6.717 PMID: 7559184
10.1093/jpids/pit022,10.1093/jpids/pit022,121.51552,"Fricchione MJ, Deyro HJ, Jensen CY, Hoffman JF, Singh K, Logan LK. Non-toxigenic penicillin and cephalosporin-resistant Corynebacterium diphtheriae endocarditis in a child: a case report and review of the literature. J Pediatric Infect Dis Soc. 2014; 3: 251–4. DOI: 10.1093/jpids/pit022 PMID: 26625388"
10.1128/jcm.05296-11,10.1128/jcm.05296-11,130.56079,"Mina NV, Burdz T, Wiebe D, Rai JS, Rahim T, Shing F, et al. Canada’s first case of a multidrug-resistant Corynebacterium diphtheriae strain, isolated from a skin abscess. J Clin Microbiol. 2011; 49: 4003–5. DOI: 10.1128/JCM.05296-11 PMID: 21880960"
10.1016/j.jiph.2014.05.006,10.1016/j.jiph.2014.05.006,94.78798,"FitzGerald RP, Rosser AJ, Perera DN. Non-toxigenic penicillin-resistant cutaneous C. diphtheriae infection: a case report and review of the literature. J Infect Public Health. 2015; 8: 98–100. DOI: 10.1016/j.jiph.2014.05.006 PMID: 25027172"
10.1016/j.clinmicnews.2015.11.003,10.1016/j.clinmicnews.2015.11.003,115.63535,"Bernard K, Pacheco AL. In vitro activity of 22 antimicrobial agents against Corynebacterium and Microbacterium species referred to the Canadian National Microbiology Laboratory. Clin Microbiol Newsl. 2015; 37: 187–98. DOI: 10.1016/j.clinmicnews.2015.11.003"
10.1128/jcm.06094-11,10.1128/jcm.06094-11,95.201,"Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012; 50: 1355–61. DOI: 10.1128/JCM.06094-11 PMID: 22238442"
10.1093/nar/gkw1004,10.1093/nar/gkw1004,92.71838,"Jia B, Raphenya AR, Alcock B, Waglechner N, Guo P, Tsang KK, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017; 45(D1): D566–73. DOI: 10.1093/nar/gkw1004 PMID: 27789705"
10.1016/j.cmi.2016.08.013,10.1016/j.cmi.2016.08.013,127.250206,"Benamrouche N, Hasnaoui S, Badell E, Guettou B, Lazri M, Guiso N, et al. Microbiological and molecular characterization of Corynebacterium diphtheriae isolated in Algeria between 1992 and 2015. Clin Microbiol Infect. 2016; 22: 1005.e1–7. DOI: 10.1016/j.cmi.2016.08.013 PMID: 27585941"
10.1016/s0147-619x(02)00115-4,10.1016/s0147-619x(02)00115-4,187.00961,"Tauch A, Bischoff N, Brune I, Kalinowski J. Insights into the genetic organization of the Corynebacterium diphtheriae erythromycin resistance plasmid pNG2 deduced from its complete nucleotide sequence. Plasmid. 2003; 49: 63–74. DOI: 10.1016/S0147-619X(02)00115-4 PMID: 12584002"
10.1128/aac.16.4.525,10.1128/aac.16.4.525,125.470764,"Coyle MB, Minshew BH, Bland JA, Hsu PC. Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions. Antimicrob Agents Chemother. 1979; 16: 525–7. DOI: 10.1128/AAC.16.4.525 PMID: 117748"
10.1186/1471-2164-13-141,10.1186/1471-2164-13-141,183.98415,"Schröder J, Maus I, Meyer K, Wördemann S, Blom J, Jaenicke S, et al. Complete genome sequence, lifestyle, and multi-drug resistance of the human pathogen Corynebacterium resistens DSM 45100 isolated from blood samples of a leukemia patient. BMC Genomics. 2012; 13: 141. DOI: 10.1186/1471-2164-13-141 PMID: 22524407"
10.1016/j.nmni.2016.09.006,10.1016/j.nmni.2016.09.006,201.50671,"Fernández-Natal I, Rodríguez-Lázaro D, Marrodán-Ciordia T, Sáez-Nieto JA, Valdezate S, Rodríguez-Pollán H, et al. Characterization and antimicrobial susceptibility of one antibiotic-sensitive and one multidrug-resistant Corynebacterium kroppenstedtii strain isolated from patients with granulomatous mastitis. New Microbes New Infect. 2016; 14: 93–7. DOI: 10.1016/j.nmni.2016.09.006 PMID: 27818775"
10.1128/jcm.01651-19,10.1128/jcm.01651-19,128.26862,"Chorlton SD, Ritchie G, Lawson T, Romney MG, Lowe CF. Whole-genome sequencing of Corynebacterium diphtheriae isolates recovered from an inner-city population demonstrates the predominance of a single molecular strain. J Clin Microbiol. 2019 Nov 20 [Epub ahead of print]."
10.1186/s12864-017-4276-3,10.1186/s12864-017-4276-3,168.40152,"Grosse-Kock S, Kolodkina V, Schwalbe EC, Blom J, Burkovski A, Hoskisson PA, et al. Genomic analysis of endemic clones of toxigenic and non-toxigenic Corynebacterium diphtheriae in Belarus during and after the major epidemic in 1990s. BMC Genomics. 2017; 18: 873. DOI: 10.1186/s12864-017-4276-3 PMID: 29132312"
10.1186/s12864-018-5147-2,10.1101/143800,136.48615,"Timms VJ, Nguyen T, Crighton T, Yuen M, Sintchenko V. Genome-wide comparison of Corynebacterium diphtheriae isolates from Australia identifies differences in the Pan-genomes between respiratory and cutaneous strains. BMC Genomics. 2018; 19: 869. DOI: 10.1186/s12864-018-5147-2 PMID: 30509172"
10.1111/1469-0691.12103,10.1111/1469-0691.12103,143.53027,"Farfour E, Badell E, Dinu S, Guillot S, Guiso N. Microbiological changes and diversity in autochthonous non-toxigenic Corynebacterium diphtheriae isolated in France. Clin Microbiol Infect. 2013; 19: 980–7. DOI: 10.1111/1469-0691.12103 PMID: 23320433"
10.1177/030098589002700212,10.1177/030098589002700212,147.35225,"Ossent P, Guscetti F, Metzler AE, Lang EM, Rübel A, Hauser B. Acute and fatal herpesvirus infection in a young Asian elephant (Elephas maximus). Vet Pathol. 1990; 27: 131–3. DOI: 10.1177/030098589002700212 PMID: 2161138"
10.1126/science.283.5405.1171,10.1126/science.283.5405.1171,126.10526,"Richman LK, Montali RJ, Garber RL, Kennedy MA, Lehnhardt J, Hildebrandt T, et al. Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science. 1999; 283: 1171–6. DOI: 10.1126/science.283.5405.1171 PMID: 10024244"
10.7589/0090-3558-36.1.1,10.7589/0090-3558-36.1.1,130.55261,"Richman LK, Montali RJ, Cambre RC, Schmitt D, Hardy D, Hildbrandt T, et al. Clinical and pathological findings of a newly recognized disease of elephants caused by endotheliotropic herpesviruses. J Wildl Dis. 2000; 36: 1–12. DOI: 10.7589/0090-3558-36.1.1 PMID: 10682740"
10.1136/vr.e1212,10.1136/vr.e1212,88.59676,Hayward GS. Conservation: clarifying the risk from herpesvirus to captive Asian elephants. Vet Rec. 2012; 170: 202–3. DOI: 10.1136/vr.e1212 PMID: 22368209
10.1093/ilar/ilv041,10.1093/ilar/ilv041,114.65814,"Long SY, Latimer EM, Hayward GS. Review of elephant endotheliotropic herpesviruses and acute hemorrhagic disease. ILAR J. 2016; 56: 283–96. DOI: 10.1093/ilar/ilv041 PMID: 26912715"
10.1128/jvi.01673-14,10.1128/jvi.01673-14,199.90607,"Richman LK, Zong J-C, Latimer EM, Lock J, Fleischer RC, Heaggans SY, et al. Elephant endotheliotropic herpesviruses EEHV1A, EEHV1B, and EEHV2 from cases of hemorrhagic disease are highly diverged from other mammalian herpesviruses and may form a new subfamily. J Virol. 2014; 88: 13523–46. DOI: 10.1128/JVI.01673-14 PMID: 25231303"
10.1128/jvi.00655-13,10.1128/jvi.00655-13,129.57004,"Wilkie GS, Davison AJ, Watson M, Kerr K, Sanderson S, Bouts T, et al. Complete genome sequences of elephant endotheliotropic herpesviruses 1A and 1B determined directly from fatal cases. J Virol. 2013; 87: 6700–12. DOI: 10.1128/JVI.00655-13 PMID: 23552421"
10.1128/genomea.00106-13,10.1128/genomea.00106-13,95.98233,"Ling PD, Reid JG, Qin X, Muzny DM, Gibbs R, Petrosino J, et al. Complete genome sequence of elephant endotheliotropic herpesvirus 1A. Genome Announc. 2013; 1: e0010613. DOI: 10.1128/genomeA.00106-13 PMID: 23580705"
10.1354/vp.46-1-97,10.1354/vp.46-1-97,165.59164,"Garner MM, Helmick K, Ochsenreiter J, Richman LK, Latimer E, Wise AG, et al. Clinico-pathologic features of fatal disease attributed to new variants of endotheliotropic herpesviruses in two Asian elephants (Elephas maximus). Vet Pathol. 2009; 46: 97–104. DOI: 10.1354/vp.46-1-97 PMID: 19112123"
10.1016/j.vetmic.2010.05.042,10.1016/j.vetmic.2010.05.042,196.92078,"Latimer E, Zong J-C, Heaggans SY, Richman LK, Hayward GS. Detection and evaluation of novel herpesviruses in routine and pathological samples from Asian and African elephants: identification of two new probosciviruses (EEHV5 and EEHV6) and two new gammaherpesviruses (EGHV3B and EGHV5). Vet Microbiol. 2011; 147: 28–41. DOI: 10.1016/j.vetmic.2010.05.042 PMID: 20579821"
10.1136/vr.e6833,10.1136/vr.e6833,121.72053,"Denk D, Stidworthy MF, Redrobe S, Latimer E, Hayward GS, Cracknell J, et al. Fatal elephant endotheliotropic herpesvirus type 5 infection in a captive Asian elephant. Vet Rec. 2012; 171: 380–1. DOI: 10.1136/vr.e6833 PMID: 23065589"
10.1128/jvi.01675-14,10.1128/jvi.01675-14,171.13817,"Zong J-C, Latimer EM, Long SY, Richman LK, Heaggans SY, Hayward GS. Comparative genome analysis of four elephant endotheliotropic herpesviruses, EEHV3, EEHV4, EEHV5, and EEHV6, from cases of hemorrhagic disease or viremia. J Virol. 2014; 88: 13547–69. DOI: 10.1128/JVI.01675-14 PMID: 25231309"
10.1128/jvi.02936-15,10.1128/jvi.02936-15,210.49187,"Zong J-C, Heaggans SY, Long SY, Latimer EM, Nofs SA, Bronson E, et al. Detection of quiescent infections with multiple elephant endotheliotropic herpesviruses (EEHVs), including EEHV2, EEHV3, EEHV6 and EEHV7, within lymphoid lung nodules or lung and spleen tissue samples from five asymptomatic adult african elephants. J Virol. 2015; 90: 3028–43. DOI: 10.1128/JVI.02936-15 PMID: 26719245"
10.1038/srep06299,10.1038/srep06299,139.40927,"Wilkie GS, Davison AJ, Kerr K, Stidworthy MF, Redrobe S, Steinbach F, et al. First fatality associated with elephant endotheliotropic herpesvirus 5 in an Asian elephant: pathological findings and complete viral genome sequence. Sci Rep. 2014; 4: 6299. DOI: 10.1038/srep06299 PMID: 25199796"
10.1128/msphere.00081-15,10.1128/msphere.00081-15,140.88148,"Ling PD, Long SY, Fuery A, Peng RS, Heaggans SY, Qin X, et al. A complete genome sequence of elephant endotheliotropic herpesvirus 4 (EEHV4): the first example of a GC-rich branch proboscivirus. MSphere. 2016; 1: e00081–15. DOI: 10.1128/mSphere.00081-15 PMID: 27340695"
10.1128/msphere.00091-16,10.1128/msphere.00091-16,133.00336,"Ling PD, Long SY, Zong JC, Heaggans SY, Qin X, Hayward GS. Comparison of the gene coding contents and other unusual features of the GC-rich and AT-rich branch probosciviruses. MSphere. 2016; 1: e00091–16. DOI: 10.1128/mSphere.00091-16 PMID: 27340696"
10.2460/ajvr.71.8.925,10.2460/ajvr.71.8.925,185.2762,"Stanton JJ, Zong J-C, Latimer E, Tan J, Herron A, Hayward GS, et al. Detection of pathogenic elephant endotheliotropic herpesvirus in routine trunk washes from healthy adult Asian elephants (Elephas maximus) by use of a real-time quantitative polymerase chain reaction assay. Am J Vet Res. 2010; 71: 925–33. DOI: 10.2460/ajvr.71.8.925 PMID: 20673092"
10.1638/1042-7260-44.1.42,10.1638/1042-7260-44.1.42,135.60432,"Stanton JJ, Zong J-C, Eng C, Howard L, Flanagan J, Stevens M, et al. Kinetics of viral loads and genotypic analysis of elephant endotheliotropic herpesvirus-1 infection in captive Asian elephants (Elephas maximus). J Zoo Wildl Med. 2013; 44: 42–54. DOI: 10.1638/1042-7260-44.1.42 PMID: 23505702"
10.1638/1042-7260-44.1.136,10.1638/1042-7260-44.1.136,142.63545,"Atkins L, Zong J-C, Tan J, Mejia A, Heaggans SY, Nofs SA, et al. EEHV-5, a newly recognized elephant herpesvirus associated with clinical and subclinical infections in captive asian elephants (Elephas maximus). J Zoo Wildl Med. 2013; 44: 136–43. DOI: 10.1638/1042-7260-44.1.136 PMID: 23505714"
10.1638/2015-0072.1,10.1638/2015-0072.1,119.3177,"Fuery A, Browning GR, Tan J, Long S, Hayward GS, Cox SK, et al. Clinical infection of captive Asian elephants (Elephas maximus) with elephant endotheliotropic herpesvirus 4. J Zoo Wildl Med. 2016; 47: 311–8. DOI: 10.1638/2015-0072.1 PMID: 27010293"
10.1080/01652176.2006.9695209,10.1080/01652176.2006.9695209,124.18816,"Reid CE, Hildebrandt TB, Marx N, Hunt M, Thy N, Reynes JM, et al. Endotheliotropic elephant herpes virus (EEHV) infection. The first PCR-confirmed fatal case in Asia. Vet Q. 2006; 28: 61–4. DOI: 10.1080/01652176.2006.9695209 PMID: 16841568"
10.7589/2012-07-193,10.7589/2012-07-193,106.92468,"Zachariah A, Zong J-C, Long SY, Latimer EM, Heaggans SY, Richman LK, et al. Fatal herpesvirus hemorrhagic disease in wild and orphan asian elephants in southern India. J Wildl Dis. 2013; 49: 381–93. DOI: 10.7589/2012-07-193 PMID: 23568914"
10.1638/1042-7260-44.1.100,10.1638/1042-7260-44.1.100,163.00494,"Sripiboon S, Tankaew P, Lungka G, Thitaram C. The occurrence of elephant endotheliotropic herpesvirus in captive Asian elephants (Elephas maximus): first case of EEHV4 in Asia. J Zoo Wildl Med. 2013; 44: 100–4. DOI: 10.1638/1042-7260-44.1.100 PMID: 23505709"
10.1638/2013-0264r1.1,10.1638/2013-0264r1.1,123.50616,"Bouchard B, Xaymountry B, Thongtip N, Lertwatcharasarakul P, Wajjwalku W. First reported case of elephant endotheliotropic herpes virus infection in Laos. J Zoo Wildl Med. 2014; 45: 704–7. DOI: 10.1638/2013-0264R1.1 PMID: 25314848"
10.1007/s00705-019-04469-6,10.1111/vop.12296,82.44905,"Lertwatcharasarakul P, Sanyathitiseree P, Thongtip N, Charoenphan P, Boonyasart B, Maneewan N, et al. Genetic variant of elephant endotheliotropic herpesvirus detected from captive Asian elephants (Elephas maximus) in Thailand from 2007 to 2013. Wetchasan Sattawaphaet. 2015; 45: 73."
10.1016/j.meegid.2016.08.004,10.1016/j.meegid.2016.08.004,139.48004,"Sripiboon S, Jackson B, Ditcham W, Holyoake C, Robertson I, Thitaram C, et al. Molecular characterisation and genetic variation of Elephant Endotheliotropic Herpesvirus infection in captive young Asian elephants in Thailand. Infect Genet Evol. 2016; 44: 487–94. DOI: 10.1016/j.meegid.2016.08.004 PMID: 27503594"
10.1371/journal.pone.0202438,10.1371/journal.pone.0202438,145.88052,"Zachariah A, Sajesh PK, Santhosh S, Bathrachalam C, Megha M, Pandiyan J, et al. Extended genotypic evaluation and comparison of twenty-two cases of lethal EEHV1 hemorrhagic disease in wild and captive Asian elephants in India. PLoS One. 2018; 13: e0202438. DOI: 10.1371/journal.pone.0202438 PMID: 30133540"
10.1007/s00436-016-5253-5,10.1007/s00436-016-5253-5,101.17816,"Song LG, Wu XY, Sacko M, Wu ZD. History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination. Parasitol Res. 2016; 115: 4071–81. DOI: 10.1007/s00436-016-5253-5 PMID: 27679451"
10.1038/s41572-018-0013-8,10.1038/s41572-018-0013-8,94.43525,"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018; 4: 13. DOI: 10.1038/s41572-018-0013-8 PMID: 30093684"
10.1186/s40249-018-0505-5,10.1186/s40249-018-0505-5,97.71424,"Habib MR, Lv S, Guo YH, Gu WB, Standley CJ, Caldeira RL, et al. Morphological and molecular characterization of invasive Biomphalaria straminea in southern China. Infect Dis Poverty. 2018; 7: 120. DOI: 10.1186/s40249-018-0505-5 PMID: 30526682"
10.1111/jtm.12032,10.1111/jtm.12032,100.03498,"Wang ZQ, Wang Y, Jia LJ, Cui J. Schistosoma haematobium infection in workers returning from Africa to China. J Travel Med. 2013; 20: 256–8. DOI: 10.1111/jtm.12032 PMID: 23809077"
10.4172/1747-0862.1000035,10.4172/1747-0862.1000035,72.12501,"Peyre M, Samaha H, Makonnen YJ, Saad A, Abd-Elnabi A, Galal S, et al. Avian influenza vaccination in Egypt: Limitations of the current strategy. J Mol Genet Med. 2009; 3: 198–204. PMID: 20076791"
10.1007/s00705-012-1269-z,10.1007/s00705-012-1269-z,143.66302,"El-Zoghby EF, Arafa AS, Hassan MK, Aly MM, Selim A, Kilany WH, et al. Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in Egypt. Arch Virol. 2012; 157: 1167–72. DOI: 10.1007/s00705-012-1269-z PMID: 22426861"
10.3201/eid2405.171935,10.3201/eid2405.171935,123.15595,"Salaheldin AH, El-Hamid HS, Elbestawy AR, Veits J, Hafez HM, Mettenleiter TC, et al. Multiple introductions of influenza A(H5N8) virus into poultry, Egypt, 2017. Emerg Infect Dis. 2018; 24: 943–6. DOI: 10.3201/eid2405.171935 PMID: 29470165"
10.1128/jvi.01300-17,10.1128/jvi.01300-17,164.35089,"Naguib MM, Ulrich R, Kasbohm E, Eng CLP, Hoffmann D, Grund C, et al. Natural reassortants of potentially zoonotic avian influenza viruses H5N1 and H9N2 from Egypt display distinct pathogenic phenotypes in experimentally infected chickens and ferrets. J Virol. 2017; 91: e01300–17. DOI: 10.1128/JVI.01300-17 PMID: 28931674"
10.1099/jgv.0.000657,10.1099/jgv.0.000657,163.15175,"Kandeil A, El-Shesheny R, Maatouq A, Moatasim Y, Cai Z, McKenzie P, et al. Novel reassortant H9N2 viruses in pigeons and evidence for antigenic diversity of H9N2 viruses isolated from quails in Egypt. J Gen Virol. 2017; 98: 548–62. DOI: 10.1099/jgv.0.000657 PMID: 27902350"
10.1038/srep27211,10.1038/srep27211,150.27768,"Hoffmann B, Hoffmann D, Henritzi D, Beer M, Harder TC. Riems influenza a typing array (RITA): An RT-qPCR-based low density array for subtyping avian and mammalian influenza a viruses. Sci Rep. 2016; 6: 27211. DOI: 10.1038/srep27211 PMID: 27256976"
10.1099/vir.0.021238-0,10.1099/vir.0.021238-0,112.28292,"Kim HR, Park CK, Oem JK, Bae YC, Choi JG, Lee OS, et al. Characterization of H5N2 influenza viruses isolated in South Korea and their influence on the emergence of a novel H9N2 influenza virus. J Gen Virol. 2010; 91: 1978–83. DOI: 10.1099/vir.0.021238-0 PMID: 20392898"
10.1038/s41598-017-16936-8,10.1038/s41598-017-16936-8,159.05666,"Pohlmann A, Starick E, Grund C, Höper D, Strebelow G, Globig A, et al. Swarm incursions of reassortants of highly pathogenic avian influenza virus strains H5N8 and H5N5, clade 2.3.4.4b, Germany, winter 2016/17. Sci Rep. 2018; 8: 15. DOI: 10.1038/s41598-017-16936-8 PMID: 29311555"
10.1016/j.vetmic.2018.10.028,10.1016/j.vetmic.2018.10.028,167.45695,"Abolnik C, Stutchbury S, Hartman MJ. Experimental infection of racing pigeons (Columba livia domestica) with highly pathogenic Clade 2.3.4.4 sub-group B H5N8 avian influenza virus. Vet Microbiol. 2018; 227: 127–32. DOI: 10.1016/j.vetmic.2018.10.028 PMID: 30473343"
10.1073/pnas.0509182102,10.1073/pnas.0509182102,90.142525,"Sato, E. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proceedings of the National Academy of Sciences of the United States of America, 2005, 102, 18538, 18543, DOI: 10.1073/pnas.0509182102, PMID: 16344461"
10.1126/science.1129139,10.1126/science.1129139,117.37786,"Galon, J. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science (New York, N.Y.), 2006, 313, 1960, 1964, DOI: 10.1126/science.1129139"
10.1016/j.immuni.2013.07.012,10.1016/j.immuni.2013.07.012,90.37768,"Chen, DS, Mellman, I. Oncology meets immunology: the cancer-immunity cycle, Immunity, 2013, 39, 1, 10, DOI: 10.1016/j.immuni.2013.07.012, PMID: 23890059"
10.1038/bjc.2011.189,10.1038/bjc.2011.189,113.32636,"Gooden, MJ, de Bock, GH, Leffers, N, Daemen, T, Nijman, HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis, British journal of cancer, 2011, 105, 93, 103, DOI: 10.1038/bjc.2011.189, PMID: 21629244"
10.1007/s10549-016-3743-x,10.1007/s10549-016-3743-x,119.04072,"Matsumoto, H. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer, Breast cancer research and treatment, 2016, 156, 237, 247, DOI: 10.1007/s10549-016-3743-x, PMID: 26960711"
10.1016/j.imbio.2005.11.003,10.1016/j.imbio.2005.11.003,69.084496,"Lopez, M. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines, Immunobiology, 2006, 211, 127, 136, DOI: 10.1016/j.imbio.2005.11.003, PMID: 16446177"
10.1097/sla.0000000000002616,10.1097/sla.0000000000002616,95.84835,"Yagi, T. PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer, Annals of surgery, 2019, 269, 471, 478, DOI: 10.1097/SLA.0000000000002616, PMID: 29206673"
10.1038/srep44823,10.1038/srep44823,67.14686,"Jiang, D. Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma, Scientific reports, 2017, 7, 44823, DOI: 10.1038/srep44823, PMID: 28322245"
10.18632/oncotarget.18606,10.18632/oncotarget.18606,120.26226,"Jesinghaus, M. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping, Oncotarget, 2017, 8, 46756, 46768, DOI: 10.18632/oncotarget.18606, PMID: 28657901"
10.1159/000487164,10.1159/000487164,85.30437,"Zheng, X. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis, Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, 45, 720, 732, DOI: 10.1159/000487164"
10.1038/nri727,10.1038/nri727,81.98704,"Sharpe, AH, Freeman, GJ. The B7-CD28 superfamily, Nature reviews. Immunology, 2002, 2, 116, 126, DOI: 10.1038/nri727, PMID: 11910893"
10.4049/jimmunol.167.1.132,10.4049/jimmunol.167.1.132,127.24134,"Wallin, JJ, Liang, L, Bakardjiev, A, Sha, WC. Enhancement of CD8+ T cell responses by ICOS/B7h costimulation, Journal of immunology (Baltimore, Md: 1950), 2001, 167, 132, 139, DOI: 10.4049/jimmunol.167.1.132"
10.1016/j.cllc.2017.12.001,10.1016/j.cllc.2017.12.001,94.13073,"Hald, SM. LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival, Clinical lung cancer, 2018, 19, 249, 259 e242, DOI: 10.1016/j.cllc.2017.12.001, PMID: 29396238"
10.1016/j.jtho.2017.01.019,10.1016/j.jtho.2017.01.019,118.307915,"He, Y. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 2017, 12, 814, 823, DOI: 10.1016/j.jtho.2017.01.019"
10.7150/jca.26949,10.7150/jca.26949,72.766525,"Zhang, Y. Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma, Journal of Cancer, 2018, 9, 4287, 4293, DOI: 10.7150/jca.26949, PMID: 30519331"
10.1371/journal.pone.0081799,10.1371/journal.pone.0081799,80.013466,"Jiang, J. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer, PloS one, 2013, 8, e81799, DOI: 10.1371/journal.pone.0081799, PMID: 24339967"
10.1309/ajcp9q6ovlvshtmy,10.1309/ajcp9q6ovlvshtmy,84.82406,"Zhuang, X. Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC, American journal of clinical pathology, 2012, 137, 978, 985, DOI: 10.1309/AJCP9Q6OVLVSHTMY, PMID: 22586058"
10.2147/ott.s170385,10.2147/ott.s170385,80.74452,"He, Y. TIM-3, a promising target for cancer immunotherapy, OncoTargets and therapy, 2018, 11, 7005, 7009, DOI: 10.2147/OTT.S170385, PMID: 30410357"
10.1111/cas.13237,10.1111/cas.13237,108.38268,"Tsutsumi, S. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma, Cancer science, 2017, 108, 1119, 1127, DOI: 10.1111/cas.13237, PMID: 28294486"
10.1056/nejmoa1112088,10.1056/nejmoa1112088,50.009518,"van Hagen, P. Preoperative chemoradiotherapy for esophageal or junctional cancer, The New England journal of medicine, 2012, 366, 2074, 2084, DOI: 10.1056/NEJMoa1112088, PMID: 22646630"
10.1038/srep36956,10.1038/srep36956,66.90729,"Kim, HR. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients, Scientific reports, 2016, 6, 36956, DOI: 10.1038/srep36956, PMID: 27841362"
10.1186/1556-276x-9-526,10.1186/1556-276x-9-526,113.58261,"Meena, JS, Sze, SM, Chand, U, Tseng, T-Y. Overview of emerging nonvolatile memory technologies, Nanoscale Res. Lett, 2014, 9, 526, DOI: 10.1186/1556-276X-9-526, PMID: 25278820"
10.1109/isscc.2014.6757458,10.1109/isscc.2014.6757458,73.858406,"Park, KT. Three-dimensional 128Gb MLC vertical NAND Flash-memory with 24-WL stacked layers and 50MB/s high-speed programming, In Digest of Technical Papers -IEEE International Solid-State Circuits Conference, 2014, 57, 334, 335"
10.1109/iedm.2015.7409666,10.1109/iedm.2015.7409666,87.73013,"Cappelletti, P. Non volatile memory evolution and revolution. In Technical Digest -International Electron Devices Meeting, IEDM 2016-Febru, 10.1.1-10.1.4 (2015)."
10.1109/jproc.2010.2070050,10.1109/jproc.2010.2070050,55.54335,"Wong, H-SP. Phase Change Memory, Proc. IEEE, 2010, 98, 2201, 2227, DOI: 10.1109/JPROC.2010.2070050"
10.1002/adfm.201500826,10.1002/adfm.201500826,114.47744,"Deringer, VL, Dronskowski, R, Wuttig, M. Microscopic Complexity in Phase-Change Materials and its Role for Applications, Adv. Funct. Mater, 2015, 25, 6343, 6359, DOI: 10.1002/adfm.201500826"
10.1080/02670836.2017.1341723,10.1080/02670836.2017.1341723,90.054344,"Sarwat, SG. Materials science and engineering of phase change random access memory, Materials Science and Technology (United Kingdom), 2017, 33, 1890, 1906, DOI: 10.1080/02670836.2017.1341723"
10.1109/led.2019.2935890,10.1109/led.2019.2935890,124.92966,"He, M. Ultra-Low Program Current and Multilevel Phase Change Memory for High-Density Storage Achieved by a Low-Current SET Pre-Operation, IEEE Electron Device Lett, 2019, 40, 1595, 1598, DOI: 10.1109/LED.2019.2935890"
10.1002/aelm.201800127,10.1002/aelm.201870043,95.76685,"Wu, Q. Increasing the Atomic Packing Efficiency of Phase-Change Memory Glass to Reduce the Density Change upon Crystallization, Adv. Electron. Mater, 2018, 4, 1800127, DOI: 10.1002/aelm.201800127"
10.1109/jeds.2016.2594190,10.1109/jeds.2016.2594190,89.03398,"Aluguri, R, Tseng, T-Y. Overview of Selector Devices for 3-D Stackable Cross Point RRAM Arrays, J. Electron Device Soc, 2016, 4, 294, 306, DOI: 10.1109/JEDS.2016.2594190"
10.1109/vlsit.2016.7573389,10.1109/vlsit.2016.7573389,121.88323,"Koo, Y, Baek, K. & Hwang, H. Te-based amorphous binary OTS device with excellent selector characteristics for x-point memory applications. In Digest of Technical Papers –IEEE Symposium on VLSI Technology 2016-Septe, 1–2 (2016)."
10.1088/0268-1242/29/10/104005,10.1088/0268-1242/29/10/104005,109.94694,"Shenoy, RS. MIEC (mixed-ionic-electronic-conduction)-based access devices for non-volatile crossbar memory arrays, Semicond. Sci. Technol, 2014, 29, 104005, DOI: 10.1088/0268-1242/29/10/104005"
10.1109/vlsit.2010.5556229,10.1109/vlsit.2010.5556229,95.12571,"Gopalakrishnan, K. et al. Highly-scalable novel access device based on Mixed Ionic Electronic conduction (MIEC) materials for high density phase change memory (PCM) arrays. In 2010 IEEE Symposium on VLSI Technology, 205–206 (2010)."
10.1109/iedm.2017.8268323,10.1109/iedm.2017.8268323,78.18101,"Clima, S. et al. Atomistic investigation of the electronic structure, thermal properties and conduction defects in Ge-rich Ge xSe 1−x materials for selector applications. In Technical Digest –IEEE International Electron Devices Meeting, 4.1.1–4.1.4 (2018)."
10.1016/j.surfcoat.2017.11.013,10.1016/j.surfcoat.2017.11.013,91.81987,"Schmitz, J. Low temperature thin films for next-generation microelectronics (invited), Surf. Coatings Technol, 2018, 343, 83, 88, DOI: 10.1016/j.surfcoat.2017.11.013"
10.1109/led.2012.2209394,10.1109/led.2012.2209394,99.67209,"Srinivasan, VSS. Punchthrough-diode-based bipolar RRAM selector by Si epitaxy, IEEE Electron Device Lett, 2012, 33, 1396, 1398, DOI: 10.1109/LED.2012.2209394"
10.1063/1.4766508,10.1063/1.4766508,135.74724,"Huet, K, Boniface, C, Negru, R, Venturini, J. Ultra low thermal budget anneals for 3D memories: Access device formation, In AIP Conference Proceedings, 2012, 1496, 135, 138, DOI: 10.1063/1.4766508"
10.1063/1.3457866,10.1063/1.3457866,122.993286,"Huang, JJ, Kuo, CW, Chang, WC, Hou, TH. Transition of stable rectification to resistive-switching in Ti/TiO2/Pt oxide diode, Appl. Phys. Lett, 2010, 96, 262901, DOI: 10.1063/1.3457866"
10.1038/srep45143,10.1038/srep45143,91.12499,"Zhang, L. Resistive switching mechanism in the one diode-one resistor memory based on p+ -Si/n-ZnO heterostructure revealed by, in-situ TEM, Sci. Rep, 2017, 7, 45143, DOI: 10.1038/srep45143, PMID: 28322336"
10.1038/nmat3456,10.1038/nmat3456,66.80132,"Zhang, W. Role of vacancies in metal-insulator transitions of crystalline phase-change materials, Nat. Mater, 2012, 11, 952, 956, DOI: 10.1038/nmat3456, PMID: 23064498"
10.1021/acsami.7b16755,10.1021/acsami.7b16755,98.75976,"Hatayama, S. Inverse Resistance Change Cr, 2Ge, 2Te, 6-Based PCRAM Enabling Ultralow-Energy Amorphization, ACS Appl. Mater. Interfaces, 2018, 10, 2725, 2734, DOI: 10.1021/acsami.7b16755, PMID: 29280374"
10.1039/c9tc02963j,10.1039/c9tc02963j,69.38086,"Xu, M. Understanding CrGeTe, 3: an abnormal phase change material with inverse resistance and density contrast, J. Mater. Chem. C, 2019, 7, 9025, 9030, DOI: 10.1039/C9TC02963J"
10.1021/acs.jpcc.9b02415,10.1021/acs.jpcc.9b02415,92.50402,"Yu, Z. Pressure-Induced Structural Phase Transition and a Special Amorphization Phase of Two-Dimensional Ferromagnetic Semiconductor Cr, 2Ge, 2Te, 6, J. Phys. Chem. C, 2019, 123, 13885, 13891, DOI: 10.1021/acs.jpcc.9b02415"
10.1063/1.5029327,10.1063/1.5029327,105.12248,"Shuang, Y. Contact resistance change memory using N-doped Cr, 2Ge, 2Te, 6 phase-change material showing non-bulk resistance change, Appl. Phys. Lett, 2018, 112, 183504, DOI: 10.1063/1.5029327"
10.1007/978-1-4757-1123-3_5,10.1007/978-1-4757-1123-3_5,91.6284,"Tauc, J. Optical Properties and Electronic Structure of Amorphous Semiconductors. In Optical Properties of Solids 123–136 (Springer US, 2012)."
10.1038/srep13362,10.1038/srep13362,81.034035,"Bae, Y. C. et al. All oxide semiconductor-based bidirectional vertical p-n-p selectors for 3D stackable crossbar-array electronics. Sci. Rep. 5 (2015)."
10.1016/j.actamat.2012.11.050,10.1016/j.actamat.2012.11.050,87.66932,"Ho, HW. Optical response characteristics arising from delocalized electrons in phase change materials, Acta Mater, 2013, 61, 1757, 1763, DOI: 10.1016/j.actamat.2012.11.050"
10.1109/jrproc.1957.278528,10.1109/jrproc.1957.278528,113.333305,"Sah, C, Noyce, R, Shockley, W. Carrier Generation and Recombination in P-N Junctions and P-N Junction Characteristics, Proc. IRE, 1957, 45, 1228, 1243, DOI: 10.1109/JRPROC.1957.278528"
10.1021/acsami.7b02838,10.1021/acsami.7b02838,107.78782,"Lee, HS. Coupling Two-Dimensional MoTe, 2 and InGaZnO Thin-Film Materials for Hybrid PN Junction and CMOS Inverters, ACS Appl. Mater. Interfaces, 2017, 9, 15592, 15598, DOI: 10.1021/acsami.7b02838, PMID: 28436650"
10.1109/wcpec.2006.279597,10.1109/wcpec.2006.279597,103.12796,"Breitenstein, O. et al. Interpretation of the Commonly Observed I-V Characteristics of C-SI Cells Having Ideality Factor Larger Than Two. In 2006 IEEE 4th World Conference on Photovoltaic Energy Conference 879–884 (2006)."
10.4028/3-908451-37-x.1,10.4028/www.scientific.net/ddf.261-262.1,106.56328,"Simoen, E, Claeys, C, Vanhellemont, J. Defect Analysis in Semiconductor Materials Based on p-n Junction Diode Characteristics, Defect Diffus. Forum, 2007, 261–262, 1, 24"
10.1109/iedm.2003.1269381,10.1109/iedm.2003.1269381,160.01663,"Bolognesi, C. R, Watkins, S. P. & Moll, N. Breakdown voltage limitations, impact ionization, and interband tunneling in InP/GaAsSb/InP type-II NpN DHBTs. In IEEE International Electron Devices Meeting, 30.3.1–30.3.4 (2003)."
10.1149/2.004202jes,10.1149/2.004202jes,107.87135,"Podpirka, A, Ramanathan, S. Heteroepitaxial La, 2−xSr, xNiO, 4 -Nb-Doped SrTiO, 3 Junctions: Synthesis and Rectification Characteristics, J. Electrochem. Soc, 2011, 159, H72, H78, DOI: 10.1149/2.004202jes"
10.1088/0268-1242/30/1/015003,10.1088/0268-1242/30/1/015003,119.02006,"Zhang, WP, Chen, S, Qian, SB, Ding, SJ. Effects of thermal annealing on the electrical characteristics of In-Ga-Zn-O thin-film transistors with Al, 2O, 3 gate dielectric, Semicond. Sci. Technol, 2015, 30, 015003, DOI: 10.1088/0268-1242/30/1/015003"
10.1109/iedm.2011.6131479,10.1109/iedm.2011.6131479,73.340645,"Wu, J. Y. et al. A low power phase change memory using thermally confined TaN/TiN bottom electrode. In IEEE International Electron Devices Meeting 3.2.1–3.2.4 (2011)."
10.3390/mi10050281,10.3390/mi10050281,90.64619,"Oh, SI. Effect of Electrode Material on the Crystallization of GeTe Grown by Atomic Layer Deposition for Phase Change Random Access Memory, Micromachines, 2019, 10, 281, DOI: 10.3390/mi10050281"
10.1039/c6tc01881e,10.1039/c6tc01881e,105.96807,"Dixon, SC, Scanlon, DO, Carmalt, CJ, Parkin, IP. n-Type doped transparent conducting binary oxides: an overview, J. Mater. Chem. C, 2016, 4, 6946, 6961, DOI: 10.1039/C6TC01881E"
10.1002/pssa.200983774,10.1002/pssa.200983774,101.201805,"Hitosugi, T, Yamada, N, Nakao, S, Hirose, Y, Hasegawa, T. Properties of TiO, 2-based transparent conducting oxides, Phys. status solidi, 2010, 207, 1529, 1537, DOI: 10.1002/pssa.200983774"
10.1016/j.abb.2014.07.034,10.1016/j.abb.2014.07.034,88.8424,"Paiva, KBS, Granjeiro, JM. Bone tissue remodeling and development: focus on matrix metalloproteinase functions, Arch. Biochem. Biophys, 2014, 561, 74, 87, DOI: 10.1016/j.abb.2014.07.034, PMID: 25157440"
10.1126/science.289.5484.1504,10.1126/science.289.5484.1504,112.22267,"Teitelbaum, SL. Bone resorption by osteoclasts, Science, 2000, 289, 1504, 1508, DOI: 10.1126/science.289.5484.1504, PMID: 10968780"
10.1038/nrc3055,10.1038/nrc3055,85.1103,"Weilbaecher, KN, Guise, TA, McCauley, LK. Cancer to bone: a fatal attraction, Nat. Rev. Cancer, 2011, 11, 411, 25, DOI: 10.1038/nrc3055, PMID: 21593787"
10.1006/bbrc.1999.0252,10.1006/bbrc.1999.0252,128.403,"Takahashi, N, Udagawa, N, Suda, T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function, Biochem. Biophys. Res. Commun, 1999, 256, 449, 455, DOI: 10.1006/bbrc.1999.0252, PMID: 10080918"
10.1016/s8756-3282(99)00214-8,10.1016/s8756-3282(99)00214-8,88.9493,"Kartsogiannis, V. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues, Bone, 1999, 25, 525, 34, DOI: 10.1016/S8756-3282(99)00214-8, PMID: 10574572"
10.1016/j.bone.2005.05.003,10.1016/j.bone.2005.05.003,78.40875,"Nancollas, GH. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite, Bone, 2006, 38, 617, 27, DOI: 10.1016/j.bone.2005.05.003, PMID: 16046206"
10.1210/er.2007-0014,10.1210/er.2007-0014,113.35407,"Kearns, AE, Khosla, S, Kostenuik, PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease, Endocr. Rev, 2008, 29, 155, 192, DOI: 10.1210/er.2007-0014, PMID: 18057140"
10.1359/jbmr.2000.15.8.1467,10.1359/jbmr.2000.15.8.1467,110.55567,"Coxon, FP. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298, J. Bone Miner. Res, 2000, 15, 1467, 1476, DOI: 10.1359/jbmr.2000.15.8.1467, PMID: 10934645"
10.1200/jco.2010.31.3304,10.1016/s0084-3873(11)00219-7,95.45437,"Henry, DH. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, J. Clin. Oncol, 2011, 29, 1125, 1132, DOI: 10.1200/JCO.2010.31.3304, PMID: 21343556"
10.1097/mou.0b013e3283449e19,10.1097/mou.0b013e3283449e19,76.30788,"Sonpavde, G, Sternberg, CN. Contemporary management of metastatic castration-resistant prostate cancer, Curr. Opin. Urol, 2011, 21, 241, 247, DOI: 10.1097/MOU.0b013e3283449e19, PMID: 21455038"
10.4158/ep14106.or,10.4158/ep14106.or,105.09239,"Sheedy, K, Camara, M, Camacho, P. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis, Endocr. Pract, 2015, 21, 275, 279, DOI: 10.4158/EP14106.OR, PMID: 25370317"
10.1159/000323368,10.1159/000323368,132.31853,"Vuorimies, I, Toiviainen-Salo, S, Hero, M, Mäkitie, O. Zoledronic acid treatment in children with osteogenesis imperfecta, Horm. Res. Paediatr, 2011, 75, 346, 353, DOI: 10.1159/000323368, PMID: 21293106"
10.1200/jco.2012.46.4255,10.1200/jco.2012.46.4255,87.15322,"Karras, NA. Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl, J. Clin. Oncol, 2013, 31, e200, e202, DOI: 10.1200/JCO.2012.46.4255, PMID: 23509309"
10.1016/j.bone.2013.10.004,10.1016/j.bone.2013.10.004,98.139534,"Cornelis, F. Bisphosphonate therapy for unresectable symptomatic benign bone tumors: a long-term prospective study of tolerance and efficacy, Bone, 2014, 58, 11, 16, DOI: 10.1016/j.bone.2013.10.004, PMID: 24120668"
10.1210/jc.2008-1531,10.1210/jc.2008-1531,70.98523,"Bachrach, LK, Ward, LM. Clinical review: Bisphosphonate use in childhood osteoporosis, J. Clin. Endocrinol. Metab, 2009, 94, 400, 409, DOI: 10.1210/jc.2008-1531, PMID: 19033370"
10.1159/000354303,10.1159/000354303,143.56282,"Ooi, HL, Briody, J, Biggin, A, Cowell, CT, Munns, CF. Intravenous zoledronic acid given every 6 months in childhood osteoporosis, Horm. Res. Paediatr, 2013, 80, 179, 184, DOI: 10.1159/000354303, PMID: 24052046"
10.1002/pbc.22681,10.1002/pbc.22681,65.03315,"August, KJ. The use of zoledronic acid in pediatric cancer patients, Pediatr. Blood Cancer, 2011, 56, 610, 614, DOI: 10.1002/pbc.22681, PMID: 21298747"
10.1038/nrendo.2009.58,10.1038/nrendo.2009.58,93.75385,"Marini, JC. Use of bisphosphonates in children—proceed with caution, Nat. Rev. Endocrinol, 2009, 5, 241, 243, DOI: 10.1038/nrendo.2009.58, PMID: 19444252"
10.1007/s00774-015-0677-z,10.1007/s00774-015-0677-z,75.8184,"Setsu, N. Severe hypercalcemia following denosumab treatment in a juvenile patient, J. Bone Miner. Metab, 2016, 34, 118, 122, DOI: 10.1007/s00774-015-0677-z, PMID: 26056018"
10.1038/nrg1380,10.1038/nrg1380,97.53103,"Tucker, A, Sharpe, P. The cutting-edge of mammalian development; how the embryo makes teeth, Nat. Rev. Genet, 2004, 5, 499, 508, DOI: 10.1038/nrg1380, PMID: 15211352"
10.1111/ecc.12740,10.1111/ecc.12740,85.41329,"Katsimbri, P. The biology of normal bone remodelling, Eur. J. Cancer Care (Engl), 2017, 26, e12740, DOI: 10.1111/ecc.12740"
10.1038/16852,10.1038/16852,71.189644,"Kong, YY. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 1999, 397, 315, 323, DOI: 10.1038/16852, PMID: 9950424"
10.1016/j.bone.2014.08.018,10.1016/j.bone.2014.08.018,101.80513,"Lézot, F. Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies, Bone, 2014, 68, 146, 152, DOI: 10.1016/j.bone.2014.08.018, PMID: 25193159"
10.1016/j.bone.2014.12.011,10.1016/j.bone.2014.12.011,125.99957,"Lézot, F. Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acid, Bone, 2015, 73, 51, 59, DOI: 10.1016/j.bone.2014.12.011, PMID: 25532478"
10.1074/jbc.m111.246280,10.1074/jbc.m111.246280,139.68994,"Furuya, Y. Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts, J. Biol. Chem, 2011, 286, 37023, 37031, DOI: 10.1074/jbc.M111.246280, PMID: 21862583"
10.1053/j.ajkd.2006.11.045,10.1053/j.ajkd.2006.11.045,120.576675,"Yajima, A, Inaba, M, Tominaga, Y, Ito, A. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism, Am. J. Kidney Dis, 2007, 49, 440, 451, DOI: 10.1053/j.ajkd.2006.11.045, PMID: 17336706"
10.3109/10520298909106985,10.3109/10520298909106985,128.7337,"Villanueva, AR, Lundin, KD. A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams, Stain Technol, 1989, 64, 129, 138, DOI: 10.3109/10520298909106985, PMID: 2480003"
10.1007/s40272-013-0051-3,10.1007/s40272-013-0051-3,70.68038,"Federman, N. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets, Pediatr. Drugs, 2014, 16, 21, 28, DOI: 10.1007/s40272-013-0051-3"
10.1016/s1470-2045(16)30096-1,10.3410/f.726438889.793525325,93.92924,"Piperno-Neumann, S. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial, Lancet Oncol, 2016, 17, 1070, 1080, DOI: 10.1016/S1470-2045(16)30096-1, PMID: 27324280"
10.1210/jc.2010-1502,10.1016/j.yend.2011.04.005,109.9998,"Bone, HG. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass, J. Clin. Endocrinol. Metab, 2011, 96, 972, 980, DOI: 10.1210/jc.2010-1502, PMID: 21289258"
10.1007/s00774-016-0806-3,10.1007/s00774-016-0806-3,120.4891,"Shiraki, M, Tanaka, S, Suzuki, H, Ueda, S, Nakamura, T. Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis, J. Bone Miner. Metab, 2017, 35, 675, 684, DOI: 10.1007/s00774-016-0806-3, PMID: 28000034"
10.1016/j.bone.2003.08.013,10.1016/j.bone.2003.08.013,95.21205,"Pan, B. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells, in vitro, Bone, 2004, 34, 112, 123, DOI: 10.1016/j.bone.2003.08.013, PMID: 14751568"
10.1002/jbmr.453,10.1002/jbmr.453,122.29683,"Battaglia, S. Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient, J. Bone Miner. Res, 2011, 26, 2439, 2451, DOI: 10.1002/jbmr.453, PMID: 21713986"
10.1021/tx700151t,10.1021/tx700151t,113.282555,"Dieterle, F. Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates, Chem. Res. Toxicol, 2007, 20, 1291, 1299, DOI: 10.1021/tx700151t, PMID: 17676813"
10.4049/jimmunol.179.11.7497,10.4049/jimmunol.179.11.7497,141.24248,"Stolina, M. Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responses, J. Immunol, 2007, 179, 7497, 7505, DOI: 10.4049/jimmunol.179.11.7497, PMID: 18025194"
10.1016/j.bone.2010.11.008,10.1016/j.bone.2010.11.008,95.915634,"Rogers, MJ, Crockett, JC, Coxon, FP, Mönkkönen, J. Biochemical and molecular mechanisms of action of bisphosphonates, Bone, 2011, 49, 34, 41, DOI: 10.1016/j.bone.2010.11.008, PMID: 21111853"
10.1111/odi.12587,10.1111/odi.12587,73.11911,"Vermeer, J. Bone-site-specific responses to zoledronic acid, Oral Dis, 2017, 23, 126, 133, DOI: 10.1111/odi.12587, PMID: 27706930"
10.1359/jbmr.050604,10.1359/jbmr.050604,102.84683,"Smith, EJ. Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits, J. Bone Miner. Res, 2005, 20, 1731, 1741, DOI: 10.1359/JBMR.050604, PMID: 16160731"
10.1016/0003-9969(84)90105-5,10.1016/0003-9969(84)90105-5,103.75157,"Marks, SC, Cahill, DR. Experimental study in the dog of the non-active role of the tooth in the eruptive process, Arch. Oral Biol, 1984, 29, 311, 322, DOI: 10.1016/0003-9969(84)90105-5, PMID: 6586126"
10.1111/j.1600-0714.1985.tb00461.x,10.1111/j.1600-0714.1985.tb00461.x,109.232124,"Wise, GE, Marks, SC, Cahill, DR. Ultrastructural features of the dental follicle associated with formation of the tooth eruption pathway in the dog, J. Oral Pathol, 1985, 14, 15, 26, DOI: 10.1111/j.1600-0714.1985.tb00461.x, PMID: 3918150"
10.1007/s00774-003-0481-z,10.1007/s00774-003-0481-z,100.91295,"Suzuki, T, Suda, N, Ohyama, K. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NF kappa-B ligand (RANKL), J. Bone Miner. Metab, 2004, 22, 185, 191, DOI: 10.1007/s00774-003-0481-z, PMID: 15108059"
10.1111/j.1600-0722.2006.00406.x,10.1111/j.1600-0722.2006.00406.x,130.42223,"Wise, GE, Yao, S. Regional differences of expression of bone morphogenetic protein-2 and RANKL in the rat dental follicle, Eur. J. Oral Sci, 2006, 114, 512, 516, DOI: 10.1111/j.1600-0722.2006.00406.x, PMID: 17184234"
10.1177/154405910808700509,10.1177/154405910808700509,92.48155,"Wise, GE, King, GJ. Mechanisms of tooth eruption and orthodontic tooth movement, J. Dent. Res, 2008, 87, 414, 434, DOI: 10.1177/154405910808700509, PMID: 18434571"
10.1177/00220345000790120301,10.1177/00220345000790120301,100.80682,"Wise, GE, Lumpkin, SJ, Huang, H, Zhang, Q. Osteoprotegerin and osteoclast differentiation factor in tooth eruption, J. Dent. Res, 2000, 79, 1937, 1942, DOI: 10.1177/00220345000790120301, PMID: 11201042"
10.1111/j.1600-0722.2008.00529.x,10.1111/j.1600-0722.2008.00529.x,149.88603,"Kamoun-Goldrat, A, Ginisty, D, Le Merrer, M. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta, Eur. J. Oral Sci, 2008, 116, 195, 198, DOI: 10.1111/j.1600-0722.2008.00529.x, PMID: 18471236"
10.1111/jop.12516,10.1111/jop.12516,110.40725,"Hernandez, M, Phulpin, B, Mansuy, L, Droz, D. Use of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review, J. Oral Pathol. Med, 2017, 46, 321, 326, DOI: 10.1111/jop.12516, PMID: 27778394"
10.1177/00220345420210040901,10.1177/00220345420210040901,104.509636,"Sicher, H. Tooth eruption: axial movement of teeth with limited growth, J. Dent. Res, 1942, 21, 395, 402, DOI: 10.1177/00220345420210040901"
10.1111/j.1601-6343.2009.01439.x,10.1111/j.1601-6343.2009.01439.x,88.754974,"Wise, G. Cellular and molecular basis of tooth eruption, Orthod. Craniofac. Res, 2009, 12, 67, 73, DOI: 10.1111/j.1601-6343.2009.01439.x, PMID: 19419449"
10.1073/pnas.1810200115,10.1073/pnas.1810200115,95.49751,"Takahashi, A. Autocrine regulation of mesenchymal progenitor cell fates orchestrates tooth eruption, Proc. Natl. Acad. Sci. USA, 2019, 116, 575, 580, DOI: 10.1073/pnas.1810200115, PMID: 30509999"
10.1111/j.1469-7580.2011.01367.x,10.1111/j.1469-7580.2011.01367.x,93.15189,"Lungová, V. Tooth-bone morphogenesis during postnatal stages of mouse first molar development, J. Anat, 2011, 218, 699, 716, DOI: 10.1111/j.1469-7580.2011.01367.x, PMID: 21418206"
10.1043/0003-3219(2005)75[927:mgiswi]2.0.co;2,10.2319/070506-275,39.231003,"Leonardi, M, Armi, P, Baccetti, T, Franchi, L, Caltabiano, M. Mandibular growth in subjects with infraoccluded deciduous molars: A superimposition study, Angle Orthod, 2005, 75, 927, 934, PMID: 16448233"
10.1172/jci42528,10.1172/jci42528,104.43957,"Nishikawa, K. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation, J. Clin. Invest, 2010, 120, 3455, 3465, DOI: 10.1172/JCI42528, PMID: 20877012"
10.1128/iai.67.8.4231-4236.1999,10.1128/iai.67.8.4231-4236.1999,119.55019,"Chiang, CY, Kyritsis, G, Graves, DT, Amar, S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide, Infect. Immun, 1999, 67, 4231, 4236, PMID: 10417196"
10.1101/gad.1119303,10.1101/gad.1119303,111.9352,"Kim, S. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation, Genes Dev, 2003, 17, 1979, 1991, DOI: 10.1101/gad.1119303, PMID: 12923053"
10.1038/ki.2008.242,10.1038/ki.2008.242,128.48213,"Yajima, A, Inaba, M, Tominaga, Y, Ito, A. Bone formation by minimodeling is more active than remodeling after parathyroidectomy, Kidney Int, 2008, 74, 775, 781, DOI: 10.1038/ki.2008.242, PMID: 18528319"
10.1097/j.pain.0000000000000160,10.1097/j.pain.0000000000001363,79.565315,"Treede, R-D, Rief, W, Barke, A, Aziz, Q, Bennett, MI, Benoliel, R. A classification of chronic pain for ICD-11, Pain, 2015, 156, 6, 1003, PMID: 25844555"
10.1097/00002508-199506000-00024,10.1097/00002508-199506000-00024,76.99154,"Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994."
10.1136/bmjopen-2017-017876,10.1136/bmjopen-2017-017876,138.43097,"Rushton, AB, Evans, DW, Middlebrook, N, Heneghan, NR, Small, C, Lord, J. Development of a screening tool to predict the risk of chronic pain and disability following musculoskeletal trauma: protocol for a prospective observational study in the United Kingdom, BMJ Open, 2018, 8, 4, e017876, DOI: 10.1136/bmjopen-2017-017876, PMID: 29705750"
10.1136/postgradmedj-2013-132215,10.1136/postgradmedj-2013-132215,96.63403,"Reddi, D, Curran, N. Chronic pain after surgery: pathophysiology, risk factors and prevention, Postgrad Med J, 2014, 90, 1062, 222, 227, DOI: 10.1136/postgradmedj-2013-132215, PMID: 24572639"
10.1371/journal.pone.0074195,10.1371/journal.pone.0074195,121.93954,"Bouhassira, D, Letanoux, M, Hartemann, A. Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study, PLoS One, 2013, 8, 9, e74195, DOI: 10.1371/journal.pone.0074195, PMID: 24058527"
10.1186/1741-7015-8-37,10.1186/1741-7015-8-37,145.66446,"Johnson, RW, Bouhassira, D, Kassianos, G, Leplège, A, Schmader, KE, Weinke, T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life, BMC Med, 2010, 8, 1, 37, DOI: 10.1186/1741-7015-8-37, PMID: 20565946"
10.1136/bmjopen-2017-017392,10.1136/bmjopen-2017-017392,119.57445,"Qin, Z, Xie, S, Mao, Z, Liu, Y, Wu, J, Furukawa, TA. Comparative efficacy and acceptability of antiepileptic drugs for classical trigeminal neuralgia: a Bayesian network meta-analysis protocol, BMJ Open, 2018, 8, 1, e017392, DOI: 10.1136/bmjopen-2017-017392, PMID: 29358420"
10.1097/ajp.0000000000000354,10.1097/ajp.0000000000000354,110.6665,"Arnold, LM, Choy, E, Clauw, DJ, Goldenberg, DL, Harris, RE, Helfenstein, M, Jr. Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field, Clin J Pain, 2016, 32, 9, 737, DOI: 10.1097/AJP.0000000000000354, PMID: 27022674"
10.1016/j.ddmec.2006.09.008,10.1016/j.ddmec.2006.09.008,96.38536,"Ossipov, MH, Porreca, F. Chronic pain: multiple manifestations, multiple mechanisms, Drug Discov Today, 2006, 3, 3, 301, 303, DOI: 10.1016/j.ddmec.2006.09.008"
10.1038/nrn3516,10.1038/nrn3516,108.32116,"Bushnell, MC, Ceko, M, Low, LA. Cognitive and emotional control of pain and its disruption in chronic pain, Nat Rev Neurosci, 2013, 14, 7, 502, 511, DOI: 10.1038/nrn3516, PMID: 23719569"
10.1016/j.neubiorev.2013.12.006,10.1016/j.neubiorev.2013.12.006,78.10758,"Simons, LE, Elman, I, Borsook, D. Psychological processing in chronic pain: a neural systems approach, Neurosci Biobehav Rev, 2014, 39, 61, 78, DOI: 10.1016/j.neubiorev.2013.12.006, PMID: 24374383"
10.1002/ejp.1003,10.1002/ejp.1003,128.77765,"Malfliet, A, Coppieters, I, Van Wilgen, P, Kregel, J, De Pauw, R, Dolphens, M. Brain changes associated with cognitive and emotional factors in chronic pain: a systematic review, Eur J Pain, 2017, 21, 5, 769, 786, DOI: 10.1002/ejp.1003, PMID: 28146315"
10.1136/archdischild-2013-304207,10.1136/archdischild-2013-304207,69.75561,"Rajapakse, D, Liossi, C, Howard, RF. Presentation and management of chronic pain, Arch Dis Child, 2014, 99, 5, 474, 480, DOI: 10.1136/archdischild-2013-304207, PMID: 24554056"
10.1016/j.ejpain.2005.06.009,10.1016/j.ejpain.2005.06.009,120.67984,"Breivik, H, Collett, B, Ventafridda, V, Cohen, R, Gallacher, D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment, Eur J Pain, 2006, 10, 4, 287, 333, DOI: 10.1016/j.ejpain.2005.06.009, PMID: 16095934"
10.1016/j.jpain.2010.07.002,10.1016/j.jpain.2010.07.002,102.44983,"Johannes, CB, Le, TK, Zhou, X, Johnston, JA, Dworkin, RH. The prevalence of chronic pain in United States adults: results of an Internet-based survey, J Pain, 2010, 11, 11, 1230, 1239, DOI: 10.1016/j.jpain.2010.07.002, PMID: 20797916"
10.1016/s0140-6736(12)61729-2,10.3410/f.719894686.793525441,84.5564,"Vos, T, Flaxman, AD, Naghavi, M, Lozano, R, Michaud, C, Ezzati, M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 2012, 380, 9859, 2163, 2196, DOI: 10.1016/S0140-6736(12)61729-2, PMID: 23245607"
10.2147/jpr.s105892,10.2147/jpr.s105892,115.28517,"Dueñas, M, Ojeda, B, Salazar, A, Mico, JA, Failde, I. A review of chronic pain impact on patients, their social environment and the health care system, J Pain Res, 2016, 9, 457, DOI: 10.2147/JPR.S105892, PMID: 27418853"
10.1371/journal.pone.0099048,10.1371/journal.pone.0099048,97.54087,"Smith, D, Wilkie, R, Uthman, O, Jordan, JL, McBeth, J. Chronic pain and mortality: a systematic review, PLoS One, 2014, 9, 6, e99048, DOI: 10.1371/journal.pone.0099048, PMID: 24901358"
10.1136/bmj.323.7314.662,10.1136/bmj.323.7314.662,178.14589,"Macfarlane, GJ, Crombie, I, McBeth, J, Silman, AJ. Widespread body pain and mortality: prospective population based study commentary: an interesting finding, but what does it mean, BMJ, 2001, 323, 7314, 662, DOI: 10.1136/bmj.323.7314.662, PMID: 11566829"
10.1093/rheumatology/ken424,10.1093/rheumatology/ken424,118.495415,"McBeth, J, Symmons, D, Silman, A, Allison, T, Webb, R, Brammah, T. Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality, Rheumatology, 2008, 48, 1, 74, 77, DOI: 10.1093/rheumatology/ken424"
10.3109/09638280902874154,10.3109/09638280902874154,107.19977,"Andersson, HI. Increased mortality among individuals with chronic widespread pain relates to lifestyle factors: a prospective population-based study, Disabil Rehabil, 2009, 31, 24, 1980, 1987, DOI: 10.3109/09638280902874154, PMID: 19874076"
10.1503/cmaj.051351,10.1503/cmaj.051351,64.59354,"Warburton, DE, Nicol, CW, Bredin, SS. Health benefits of physical activity: the evidence, Can Med Assoc J, 2006, 174, 6, 801, 809, DOI: 10.1503/cmaj.051351, PMID: 16534088"
10.1056/nejm199910283411806,10.1056/nejm199910283411806,104.69732,"Alter, DA, Naylor, CD, Austin, P, Tu, JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction, N Engl J Med, 1999, 341, 18, 1359, 1367, DOI: 10.1056/NEJM199910283411806, PMID: 10536129"
10.1155/2011/727094,10.1155/2011/727094,108.631744,"VanDenKerkhof, EG, Macdonald, HM, Jones, GT, Power, C, Macfarlane, GJ. Diet, lifestyle and chronic widespread pain: results from the 1958 British Birth Cohort Study, Pain Res Manag, 2011, 16, 2, 87, 92, DOI: 10.1155/2011/727094, PMID: 21499583"
10.3389/fnana.2017.00051,10.3389/fnana.2017.00051,78.704414,"Martins, I, Tavares, I. Reticular formation and pain: the past and the future, Front Neuroanat, 2017, 11, 51, DOI: 10.3389/fnana.2017.00051, PMID: 28725185"
10.1038/nn.3969,10.1038/nn.3969,134.33679,"Segerdahl, AR, Mezue, M, Okell, TW, Farrar, JT, Tracey, I. The dorsal posterior insula subserves a fundamental role in human pain, Nat Neurosci, 2015, 18, 4, 499, DOI: 10.1038/nn.3969, PMID: 25751532"
10.1038/nn.4664,10.1038/nn.4664,83.249466,"Nevian, T. The cingulate cortex: divided in pain, Nat Neurosci, 2017, 20, 11, 1515, DOI: 10.1038/nn.4664, PMID: 29073647"
10.1007/s12035-018-1130-9,10.1007/s12035-018-1130-9,86.22247,"Ong, Wei-Yi, Stohler, Christian S, Herr, Deron R. Role of the Prefrontal Cortex in Pain Processing, Molecular Neurobiology, 2018, 56, 2, 1137, 1166, DOI: 10.1007/s12035-018-1130-9, PMID: 29876878"
10.1155/2009/462879,10.1155/2009/462879,97.69175,"Loyd, Dayna R, Murphy, Anne Z. The Role of the Periaqueductal Gray in the Modulation of Pain in Males and Females: Are the Anatomy and Physiology Really that Different, Neural Plasticity, 2009, 2009, 1, 12, DOI: 10.1155/2009/462879"
10.1002/cne.20751,10.1002/cne.20751,75.429405,"Mason, P. Ventromedial medulla: pain modulation and beyond, J Comp Neurol, 2005, 493, 1, 2, 8, DOI: 10.1002/cne.20751, PMID: 16255004"
10.1097/wco.0b013e32836336ad,10.1097/wco.0b013e32836336ad,65.92173,"Apkarian, AV, Baliki, MN, Farmer, MA. Predicting transition to chronic pain, Curr Opin Neurol, 2013, 26, 4, 360, DOI: 10.1097/WCO.0b013e32836336ad, PMID: 23823463"
10.1212/wnl.59.5_suppl_2.s2,10.1212/wnl.59.5_suppl_2.s2,103.50483,"Bolay, H, Moskowitz, MA. Mechanisms of pain modulation in chronic syndromes, Neurology, 2002, 59, 5 suppl 2, S2, S7, DOI: 10.1212/WNL.59.5_suppl_2.S2, PMID: 12221149"
10.1093/bja/aen088,10.1093/bja/aen088,52.082996,"D'mello, R, Dickenson, A. Spinal cord mechanisms of pain, Br J Anaesth, 2008, 101, 1, 8, 16, DOI: 10.1093/bja/aen088, PMID: 18417503"
10.1016/j.jpain.2007.09.006,10.1016/j.jpain.2007.09.006,97.42928,"Chapman, CR, Tuckett, RP, Song, CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions, J Pain, 2008, 9, 2, 122, 145, DOI: 10.1016/j.jpain.2007.09.006, PMID: 18088561"
10.1007/978-94-017-7537-3_8,10.1007/978-94-017-7537-3_8,81.67064,"Heinricher, Mary M. Pain Modulation and the Transition from Acute to Chronic Pain, Advances in Experimental Medicine and Biology, 2016, Dordrecht, Springer Netherlands, 105, 115"
10.2217/fnl.14.57,10.2217/fnl.14.57,114.885025,"Martucci, KT, Ng, P, Mackey, S. Neuroimaging chronic pain: what have we learned and where are we going, Future Neurol, 2014, 9, 6, 615, 626, DOI: 10.2217/fnl.14.57, PMID: 28163658"
10.1002/ejp.1205,10.1002/ejp.1205,107.3153,"Ikeda, E, Li, T, Kobinata, H, Zhang, S, Kurata, J. Anterior insular volume decrease is associated with dysfunction of the reward system in patients with chronic pain, European Journal of Pain, 2018, 22, 6, 1170, 1179, DOI: 10.1002/ejp.1205, PMID: 29436061"
10.1523/jneurosci.2541-04.2004,10.1523/jneurosci.2541-04.2004,111.61939,"Apkarian, AV, Sosa, Y, Sonty, S, Levy, RM, Harden, RN, Parrish, TB. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density, J Neurosci, 2004, 24, 46, 10410, 10415, DOI: 10.1523/JNEUROSCI.2541-04.2004, PMID: 15548656"
10.1016/j.brainres.2014.05.025,10.1016/j.brainres.2014.05.025,106.35854,"Ezzati, A, Zimmerman, ME, Katz, MJ, Sundermann, EE, Smith, JL, Lipton, ML. Hippocampal subfields differentially correlate with chronic pain in older adults, Brain Res, 2014, 1573, 54, 62, DOI: 10.1016/j.brainres.2014.05.025, PMID: 24878607"
10.1097/psy.0b013e31827e60f3,10.1097/psy.0b013e31827e60f3,129.74283,"Noll-Hussong, M, Otti, A, Wohlschlaeger, AM, Zimmer, C, Henningsen, P, Lahmann, C. Neural correlates of deficits in pain-related affective meaning construction in patients with chronic pain disorder, Psychosom Med, 2013, 75, 2, 124, 136, DOI: 10.1097/PSY.0b013e31827e60f3, PMID: 23362496"
10.1002/art.38191,10.1002/art.38191,125.02594,"Loggia, ML, Berna, C, Kim, J, Cahalan, CM, Gollub, RL, Wasan, AD. Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia, Arthritis Rheum, 2014, 66, 1, 203, 212, DOI: 10.1002/art.38191"
10.1515/revneuro-2015-0010,10.1515/revneuro-2015-0010,69.81886,"Buonocore, MH, Maddock, RJ. Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods, Rev Neurosci, 2015, 26, 6, 609, 632, DOI: 10.1515/revneuro-2015-0010, PMID: 26200810"
10.1016/j.nic.2010.04.003,10.1016/j.nic.2010.04.003,93.252846,"Horská, A, Barker, PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging, Neuroimaging Clin, 2010, 20, 3, 293, 310, DOI: 10.1016/j.nic.2010.04.003"
10.1016/0730-725x(90)90060-f,10.1016/0730-725x(90)90060-f,135.70944,"Leroy-Willig, A, Duboc, D, Bittoun, J, Jolivet, O, Doumith, R, Paturneau-Jouas, M. Spectroscopic MRI: a tool for the evaluation of systemic lipid storage disease, Magn Reson Imaging, 1990, 8, 4, 511, 515, DOI: 10.1016/0730-725X(90)90060-F, PMID: 2392038"
10.1602/neurorx.2.2.197,10.1602/neurorx.2.2.197,127.98729,"Lin, A, Ross, BD, Harris, K, Wong, W. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making, NeuroRx, 2005, 2, 2, 197, 214, DOI: 10.1602/neurorx.2.2.197, PMID: 15897945"
10.1007/s00249-009-0517-y,10.1007/s00249-009-0517-y,87.79653,"van der Graaf, M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications, Eur Biophys J, 2010, 39, 527, 540, DOI: 10.1007/s00249-009-0517-y, PMID: 19680645"
10.1016/j.crad.2008.07.002,10.1016/j.crad.2008.07.002,75.63093,"Soares, D, Law, M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications, Clin Radiol, 2009, 64, 1, 12, 21, DOI: 10.1016/j.crad.2008.07.002, PMID: 19070693"
10.1007/s11682-013-9251-2,10.1007/s11682-013-9251-2,106.54952,"Zhou, B, Yuan, F, He, Z, Tan, C. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson’s disease, Brain Imaging Behav, 2014, 8, 1, 97, 101, DOI: 10.1007/s11682-013-9251-2, PMID: 23955491"
10.1177/1051228405284200,10.1177/1051228405284200,91.08812,"Narayana, PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis, J Neuroimaging, 2005, 15, 4 Suppl, 46s, 57s, DOI: 10.1177/1051228405284200, PMID: 16385018"
10.1038/s41598-017-16046-5,10.1038/s41598-017-16046-5,133.47392,"Voets NL, Hodgetts CJ, Sen A, Adcock JE, Emir U. Hippocampal MRS and subfield volumetry at 7T detects dysfunction not specific to seizure focus. Scientific Reports. 7(1). 10.1038/s41598-017-16046-5."
10.1186/s13643-018-0830-6,10.1186/s13643-018-0830-6,133.02843,"Drago, T, O’Regan, PW, Welaratne, I, Rooney, S, O’Callaghan, A, Malkit, M. A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder, Syst Rev, 2018, 7, 1, 158, DOI: 10.1186/s13643-018-0830-6, PMID: 30309391"
10.1016/j.nicl.2014.10.005,10.1016/j.nicl.2014.10.005,99.048584,"Marsman, A, Mandl, RC, Klomp, DW, Bohlken, MM, Boer, VO, Andreychenko, A. GABA and glutamate in schizophrenia: a 7 T (1)H-MRS study, Neuroimage Clin, 2014, 6, 398, 407, DOI: 10.1016/j.nicl.2014.10.005, PMID: 25379453"
10.1038/s41537-017-0013-9,10.1038/s41537-017-0013-9,141.74927,"Birur, B, Kraguljac, NV, Shelton, RC, Lahti, AC. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature, NPJ Schizophr, 2017, 3, 1, 15, DOI: 10.1038/s41537-017-0013-9, PMID: 28560261"
10.1016/j.jad.2018.04.010,10.1016/j.jad.2018.04.010,133.78525,"Atagun, MI, Sikoglu, EM, Can, SS, Ugurlu, GK, Kaymak, SU, Caykoylu, A. Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: a proton magnetic resonance spectroscopy study, J Affect Disord, 2018, 235, 15, 19, DOI: 10.1016/j.jad.2018.04.010, PMID: 29631202"
10.1111/j.1399-5618.2012.01033.x,10.1111/j.1399-5618.2012.01033.x,130.07538,"Gigante, AD, Bond, DJ, Lafer, B, Lam, RW, Young, LT, Yatham, LN. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis, Bipolar Disord, 2012, 14, 5, 478, 487, DOI: 10.1111/j.1399-5618.2012.01033.x, PMID: 22834460"
10.1016/j.neubiorev.2015.02.009,10.1016/j.neubiorev.2015.02.009,118.788216,"Naaijen, J, Lythgoe, DJ, Amiri, H, Buitelaar, JK, Glennon, JC. Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies, Neurosci Biobehav Rev, 2015, 52, 74, 88, DOI: 10.1016/j.neubiorev.2015.02.009, PMID: 25712432"
10.1017/s2045796017000361,10.1017/s2045796017000361,107.84298,"Delvecchio, G, Stanley, JA, Altamura, AC, Brambilla, P. Metabolic alterations in generalised anxiety disorder: a review of proton magnetic resonance spectroscopic studies, Epidemiol Psychiatr Sci, 2017, 26, 6, 587, 595, DOI: 10.1017/S2045796017000361, PMID: 28789715"
10.1002/mrm.20679,10.1002/mrm.20679,102.6541,"Maril, N, Collins, CM, Greenman, RL, Lenkinski, RE. Strategies for shimming the breast, Magn Reson Med, 2005, 54, 5, 1139, 1145, DOI: 10.1002/mrm.20679, PMID: 16217775"
10.1002/mrm.1213,10.1002/mrm.1213,107.336655,"Tkac, I, Andersen, P, Adriany, G, Merkle, H, Ugurbil, K, Gruetter, R. In vivo 1H NMR spectroscopy of the human brain at 7 T, Magn Reson Med, 2001, 46, 3, 451, 456, DOI: 10.1002/mrm.1213, PMID: 11550235"
10.1002/mrm.21043,10.1002/mrm.21043,149.99976,"Mlynarik, V, Gambarota, G, Frenkel, H, Gruetter, R. Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition, Magn Reson Med, 2006, 56, 5, 965, 970, DOI: 10.1002/mrm.21043, PMID: 16991116"
10.1002/mrm.21302,10.1002/mrm.21302,132.97568,"Scheenen, TW, Klomp, DW, Wijnen, JP, Heerschap, A. Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses, Magn Reson Med, 2008, 59, 1, 1, 6, DOI: 10.1002/mrm.21302, PMID: 17969076"
10.1002/nbm.3804,10.1002/nbm.3804,139.42986,"Bhogal, AA, Schür, RR, Houtepen, LC, van de Bank, B, Boer, VO, Marsman, A. 1H–MRS processing parameters affect metabolite quantification: the urgent need for uniform and transparent standardization, NMR Biomed, 2017, 30, 11, e3804, DOI: 10.1002/nbm.3804"
10.1007/s00702-002-0781-9,10.1007/s00702-002-0781-9,131.02893,"Grachev, I, Ramachandran, T, Thomas, P, Szeverenyi, N, Fredrickson, B. Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study, J Neural Transm, 2003, 110, 3, 287, 312, DOI: 10.1007/s00702-002-0781-9, PMID: 12658377"
10.1016/s0304-3959(00)00340-7,10.1016/s0304-3959(00)00340-7,122.400475,"Grachev, ID, Fredrickson, BE, Apkarian, AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study, Pain, 2000, 89, 1, 7, 18, DOI: 10.1016/S0304-3959(00)00340-7, PMID: 11113288"
10.1016/j.neuroimage.2010.09.039,10.1016/j.neuroimage.2010.11.069,160.46156,"Gussew, A, Rzanny, R, Güllmar, D, Scholle, H-C, Reichenbach, JR. 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain, Neuroimage, 2011, 54, 2, 1315, 1323, DOI: 10.1016/j.neuroimage.2010.09.039, PMID: 20869447"
10.1002/art.27430,10.1002/art.27430,113.74102,"Valdés, M, Collado, A, Bargalló, N, Vázquez, M, Rami, L, Gómez, E. Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study, Arthritis Rheum, 2010, 62, 6, 1829, 1836, DOI: 10.1002/art.27430, PMID: 20191578"
10.1186/ar3072,10.1186/ar3072,169.2205,"Fayed, N, Garcia-Campayo, J, Magallón, R, Andrés-Bergareche, H, Luciano, JV, Andres, E. Localized 1 H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate, Arthritis Res Therapy, 2010, 12, 4, R134, DOI: 10.1186/ar3072"
10.3174/ajnr.a2550,10.3174/ajnr.a2550,169.2104,"Feraco, P, Bacci, A, Pedrabissi, Fab, Passamonti, L, Zampogna, G, Pedrabissi, Fed, Malavolta, N, Leonardi, M. Metabolic Abnormalities in Pain-Processing Regions of Patients with Fibromyalgia: A 3T MR Spectroscopy Study, American Journal of Neuroradiology, 2011, 32, 9, 1585, 1590, DOI: 10.3174/ajnr.A2550, PMID: 21799042"
10.1016/j.pain.2012.07.022,10.1016/j.pain.2012.07.022,155.85042,"Widerström-Noga, E, Pattany, PM, Cruz-Almeida, Y, Felix, ER, Perez, S, Cardenas, DD. Metabolite concentrations in the anterior cingulate cortex predict high neuropathic pain impact after spinal cord injury, Pain, 2013, 154, 2, 204, 212, DOI: 10.1016/j.pain.2012.07.022, PMID: 23141478"
10.1016/j.mri.2005.10.021,10.1016/j.mri.2005.10.021,142.79686,"Fukui, S, Matsuno, M, Inubushi, T, Nosaka, S. N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with 1H-MRS, Magn Reson Imaging, 2006, 24, 1, 75, 79, DOI: 10.1016/j.mri.2005.10.021, PMID: 16410181"
10.2337/dc07-2088,10.2337/dc07-2088,133.80948,"Sorensen, L, Siddall, PJ, Trenell, MI, Yue, DK. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy, Diabetes Care, 2008, 31, 5, 980, 981, DOI: 10.2337/dc07-2088, PMID: 18299445"
10.1007/s11481-013-9460-x,10.1007/s11481-013-9460-x,120.50856,"Chang, L, Munsaka, SM, Kraft-Terry, S, Ernst, T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain, J NeuroImmune Pharmacol, 2013, 8, 3, 576, 593, DOI: 10.1007/s11481-013-9460-x, PMID: 23666436"
10.1136/bmj.b2535,10.1136/bmj.b2535,166.69827,"Moher, D, Liberati, A, Tetzlaff, J, Altman, D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 2009, 339, b2535, DOI: 10.1136/bmj.b2535, PMID: 19622551"
10.1016/0197-2456(86)90046-2,10.1016/0197-2456(86)90046-2,96.405426,"DerSimonian, R, Laird, N. Meta-analysis in clinical trials, Control Clin Trials, 1986, 7, 3, 177, 188, DOI: 10.1016/0197-2456(86)90046-2, PMID: 3802833"
10.1136/bmj.d549,10.1136/bmj.d549,115.32549,"Riley, RD, Higgins, JP, Deeks, JJ. Interpretation of random effects meta-analyses, BMJ, 2011, 342, d549, DOI: 10.1136/bmj.d549, PMID: 21310794"
10.3389/fpsyg.2013.00863,10.3389/fpsyg.2013.00863,119.946434,"Lakens, D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs, Front Psychol, 2013, 4, 863, DOI: 10.3389/fpsyg.2013.00863, PMID: 24324449"
10.1136/bmj.g6284,10.1136/bmj.g6284,167.51094,"Sedgwick, P. Multiple hypothesis testing and Bonferroni's correction, BMJ, 2014, 349, oct20 3, g6284, g6284, DOI: 10.1136/bmj.g6284, PMID: 25331533"
10.1111/j.1467-9868.2010.00746.x,10.1111/j.1467-9868.2010.00746.x,114.69512,"Benjamini, Yoav. Discovering the false discovery rate, Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2010, 72, 4, 405, 416, DOI: 10.1111/j.1467-9868.2010.00746.x"
10.1136/bmj.327.7414.557,10.1136/bmj.327.7414.557,119.78748,"Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses, BMJ, 2003, 327, 7414, 557, 560, DOI: 10.1136/bmj.327.7414.557, PMID: 12958120"
10.1016/1359-0189(90)90036-w,10.1016/1359-0189(90)90036-w,75.364685,"Galbraith, RF. The radial plot: graphical assessment of spread in ages, Int J Radiat Appl Instrum D Nucl Tracks Radiat Meas, 1990, 17, 3, 207, 214, DOI: 10.1016/1359-0189(90)90036-W"
10.1136/bmj.39489.470347.ad,10.1136/bmj.39489.470347.ad,138.94696,"Guyatt, GH, Oxman, AD, Vist, GE, Kunz, R, Falck-Ytter, Y, Alonso-Coello, P. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 2008, 336, 7650, 924, 926, DOI: 10.1136/bmj.39489.470347.AD, PMID: 18436948"
10.1016/0140-6736(91)90201-y,10.1016/0140-6736(91)90201-y,117.370255,"Easterbrook, PJ, Gopalan, R, Berlin, JA, Matthews, DR. Publication bias in clinical research, Lancet, 1991, 337, 8746, 867, 872, DOI: 10.1016/0140-6736(91)90201-Y, PMID: 1672966"
10.1371/journal.pone.0025491,10.1371/journal.pone.0025491,130.93684,"Thorlund, K, Imberger, G, Walsh, M, Chu, R, Gluud, C, Wetterslev, J. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis-a simulation study, PLoS One, 2011, 6, 10, e25491, DOI: 10.1371/journal.pone.0025491, PMID: 22028777"
10.1136/bmj.315.7109.629,10.1136/bmj.315.7109.629,135.98299,"Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test, BMJ, 1997, 315, 7109, 629, 634, DOI: 10.1136/bmj.315.7109.629, PMID: 9310563"
10.1016/j.amjsurg.2007.08.040,10.1016/j.amjsurg.2007.08.040,140.13359,"Ghaemmaghami, V, Sperry, J, Gunst, M, Friese, R, Starr, A, Frankel, H, Gentilello, LM, Shafi, S. Effects of early use of external pelvic compression on transfusion requirements and mortality in pelvic fractures, Am J Surg, 2007, 194, 6, 720, 723, DOI: 10.1016/j.amjsurg.2007.08.040, PMID: 18005760"
10.1097/00005373-199007000-00015,10.1097/00005373-199007000-00015,127.81802,"Burgess, AR, Eastridge, BJ, Young, JW, Ellison, TS, Ellison, PS, Jr, Poka, A, Bathon, GH, Brumback, RJ. Pelvic ring disruptions: effective classification system and treatment protocols, J Trauma, 1990, 30, 7, 848, 856, DOI: 10.1097/00005373-199007000-00015, PMID: 2381002"
10.1186/1749-7922-9-18,10.1186/1749-7922-9-18,242.9957,"Magnone, S, Coccolini, F, Manfredi, R, Piazzalunga, D, Agazzi, R, Arici, C, Barozzi, M, Bellanova, G, Belluati, A, Berlot, G. Management of hemodynamically unstable pelvic trauma: results of the first Italian consensus conference (cooperative guidelines of the Italian Society of Surgery, the Italian Association of Hospital Surgeons, the Multi-specialist Italian Society of Young Surgeons, the Italian Society of Emergency Surgery and Trauma, the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care, the Italian Society of Orthopaedics and Traumatology, the Italian Society of Emergency Medicine, the Italian Society of Medical Radiology -Section of Vascular and Interventional Radiology-and the World Society of Emergency Surgery), World J Emerg Surg, 2014, 9, 1, 18, DOI: 10.1186/1749-7922-9-18, PMID: 24606950"
10.1097/bot.0000000000000056,10.1097/bot.0000000000000056,106.23144,"Toth, L, King, KL, McGrath, B, Balogh, ZJ. Factors associated with pelvic fracture-related arterial bleeding during trauma resuscitation: a prospective clinical study, J Orthop Trauma, 2014, 28, 9, 489, 495, DOI: 10.1097/BOT.0000000000000056, PMID: 24375268"
10.1097/01.ta.0000158251.40760.b2,10.1097/01.ta.0000158251.40760.b2,134.89671,"Balogh, Z, Caldwell, E, Heetveld, M, D'Amours, S, Schlaphoff, G, Harris, I, Sugrue, M. Institutional practice guidelines on management of pelvic fracture-related hemodynamic instability: do they make a difference, J Trauma, 2005, 58, 4, 778, 782, DOI: 10.1097/01.TA.0000158251.40760.B2, PMID: 15824655"
10.1007/s00264-008-0537-8,10.1007/s00264-008-0537-8,81.582565,"Tsai, CH, Fong, YC, Chen, YH, Hsu, CJ, Chang, CH, Hsu, HC. The epidemiology of traumatic humeral shaft fractures in Taiwan, Int Orthop, 2009, 33, 2, 463, 467, DOI: 10.1007/s00264-008-0537-8, PMID: 18414861"
10.18632/oncotarget.24468,10.18632/oncotarget.24468,147.11311,"Kuo, PJ, Wu, SC, Chien, PC, Chang, SS, Rau, CS, Tai, HL, Peng, SH, Lin, YC, Chen, YC, Hsieh, HY. Artificial neural network approach to predict surgical site infection after free-flap reconstruction in patients receiving surgery for head and neck cancer, Oncotarget, 2018, 9, 17, 13768, 13782, DOI: 10.18632/oncotarget.24468, PMID: 29568393"
10.1016/j.injury.2009.10.037,10.1016/j.injury.2009.10.037,158.27138,"Papakostidis, C, Giannoudis, PV. Pelvic ring injuries with haemodynamic instability: efficacy of pelvic packing, a systematic review, Injury, 2009, 40, S53, S61, DOI: 10.1016/j.injury.2009.10.037, PMID: 19895954"
10.1097/ta.0000000000001034,10.1097/ta.0000000000001034,119.07418,"Costantini, TW, Coimbra, R, Holcomb, JB, Podbielski, JM, Catalano, R, Blackburn, A, Scalea, TM, Stein, DM, Williams, L, Conflitti, J. Current management of hemorrhage from severe pelvic fractures: results of an American Association for the Surgery of Trauma multi-institutional trial, J Trauma Acute Care Surg, 2016, 80, 5, 717, 723, DOI: 10.1097/TA.0000000000001034, PMID: 26958799"
10.4103/0974-2700.86632,10.1007/s00068-009-8245-7,66.09776,"Lustenberger, T, Meier, C, Benninger, E, Lenzlinger, PM, Keel, MJ. C-clamp and pelvic packing for control of hemorrhage in patients with pelvic ring disruption, J Emerg Trauma Shock, 2011, 4, 4, 477, 482, PMID: 22090741"
10.1097/00000658-199106000-00002,10.1097/00000658-199106000-00002,99.68925,"Poole, GV, Ward, EF, Muakkassa, FF, Hsu, HS, Griswold, JA, Rhodes, RS. Pelvic fracture from major blunt trauma. Outcome is determined by associated injuries, Ann Surg, 1991, 213, 6, 532, 538, DOI: 10.1097/00000658-199106000-00002, PMID: 2039283"
10.1016/s0020-1383(00)00074-7,10.1016/s0020-1383(00)00074-7,164.31445,"Gustavo Parreira, J, Coimbra, R, Rasslan, S, Oliveira, A, Fregoneze, M, Mercadante, M. The role of associated injuries on outcome of blunt trauma patients sustaining pelvic fractures, Injury, 2000, 31, 9, 677, 682, DOI: 10.1016/S0020-1383(00)00074-7, PMID: 11084153"
10.1155/2014/878601,10.1155/2014/878601,120.98604,"Yang, NP, Chan, CL, Chu, D, Lin, YZ, Lin, KB, Yu, CS, Yu, IL, Chang, NT. Epidemiology of hospitalized traumatic pelvic fractures and their combined injuries in Taiwan: 2000-2011 National Health Insurance data surveillance, Biomed Res Int, 2014, 2014, 878601, PMID: 24804258"
10.1016/j.ijge.2012.01.016,10.1016/j.ijge.2012.01.016,87.436966,"Chiang, W-K, Huang, S-T, Chang, W-H, Huang, M-Y, Chien, D-K, Tsai, C-H. Mortality factors regarding the injury severity score in elderly trauma patients, Int J Gerontol, 2012, 6, 3, 192, 195, DOI: 10.1016/j.ijge.2012.01.016"
10.1177/2151458515616250,10.1177/2151458515616250,98.653465,"Buller, LT, Best, MJ, Quinnan, SM. A nationwide analysis of pelvic ring fractures: incidence and trends in treatment, length of stay, and mortality, Geriatr Orthop Surg Rehabil, 2016, 7, 1, 9, 17, DOI: 10.1177/2151458515616250, PMID: 26929851"
10.1097/ta.0000000000002062,10.1097/ta.0000000000002062,152.7902,"Oliphant, BW, Tignanelli, CJ, Napolitano, LM, Goulet, JA, Hemmila, MR. American College of Surgeons Committee on Trauma verification level affects trauma center management of pelvic ring injuries and patient mortality, J Trauma Acute Care Surg, 2019, 86, 1, 1, 10, DOI: 10.1097/TA.0000000000002062, PMID: 30188423"
10.1016/j.injury.2008.12.006,10.1016/j.injury.2008.12.006,99.086876,"Suzuki, T, Smith, WR, Moore, EE. Pelvic packing or angiography: competitive or complementary, Injury, 2009, 40, 4, 343, 353, DOI: 10.1016/j.injury.2008.12.006, PMID: 19278678"
10.1016/j.ijsu.2016.05.072,10.1016/j.ijsu.2016.05.072,89.15977,"Filiberto, DM, Fox, AD. Preperitoneal pelvic packing: technique and outcomes, Int J Surg, 2016, 33, Pt B, 222, 224, DOI: 10.1016/j.ijsu.2016.05.072, PMID: 27373522"
10.1016/j.jamcollsurg.2010.12.020,10.1016/j.jamcollsurg.2010.12.020,152.51788,"Burlew, CC, Moore, EE, Smith, WR, Johnson, JL, Biffl, WL, Barnett, CC, Stahel, PF. Preperitoneal pelvic packing/external fixation with secondary angioembolization: optimal care for life-threatening hemorrhage from unstable pelvic fractures, J Am Coll Surg, 2011, 212, 4, 628, 635, DOI: 10.1016/j.jamcollsurg.2010.12.020, PMID: 21463801"
10.1016/j.ijsu.2016.02.057,10.1016/j.ijsu.2016.02.057,92.42331,"Salcedo, ES, Brown, IE, Corwin, MT, Galante, JM. Pelvic angioembolization in trauma -Indications and outcomes, Int J Surg, 2016, 33, Pt B, 231, 236, DOI: 10.1016/j.ijsu.2016.02.057, PMID: 26912018"
10.1186/s13017-016-0077-2,10.1186/s13017-016-0077-2,155.77312,"Chiara, O, di Fratta, E, Mariani, A, Michaela, B, Prestini, L, Sammartano, F, Cimbanassi, S. Efficacy of extra-peritoneal pelvic packing in hemodynamically unstable pelvic fractures, a Propensity Score Analysis, World J Emerg Surg, 2016, 11, 22, DOI: 10.1186/s13017-016-0077-2, PMID: 27252773"
10.1097/ta.0000000000000609,10.1097/ta.0000000000000609,91.020515,"Biffl, WL, Fox, CJ, Moore, EE. The role of REBOA in the control of exsanguinating torso hemorrhage, J Trauma Acute Care Surg, 2015, 78, 5, 1054, 1058, DOI: 10.1097/TA.0000000000000609, PMID: 25909430"
10.1186/s13037-019-0183-7,10.1186/s13037-019-0183-7,158.56393,"Blondeau, B, Orlando, A, Jarvis, S, Banton, K, Berg, GM, Patel, N, Meinig, R, Tanner, A, 2nd, Carrick, M, Bar-Or, D. Variability in pelvic packing practices for hemodynamically unstable pelvic fractures at US level 1 trauma centers, Patient Saf Surg, 2019, 13, 3, DOI: 10.1186/s13037-019-0183-7, PMID: 30675184"
10.1186/s13037-019-0201-9,10.1186/s13037-019-0201-9,172.12778,"Jarvis, S, Orlando, A, Blondeau, B, Banton, K, Reynolds, C, Berg, GM, Patel, N, Kelly, M, Carrick, M, Bar-Or, D. Variability in the timeliness of interventional radiology availability for angioembolization of hemodynamically unstable pelvic fractures: a prospective survey among U.S. level I trauma centers, Patient Saf Surg, 2019, 13, 23, DOI: 10.1186/s13037-019-0201-9, PMID: 31249625"
10.1007/s00264-013-1828-2,10.1007/s00264-013-1828-2,113.6538,"Jain, S, Bleibleh, S, Marciniak, J, Pace, A. A national survey of United Kingdom trauma units on the use of pelvic binders, Int Orthop, 2013, 37, 7, 1335, 1339, DOI: 10.1007/s00264-013-1828-2, PMID: 23420325"
10.1007/s12245-010-0224-6,10.1007/s12245-010-0224-6,80.299515,"Ooi, CK, Goh, HK, Tay, SY, Phua, DH. Patients with pelvic fracture: what factors are associated with mortality, Int J Emerg Med, 2010, 3, 4, 299, 304, DOI: 10.1007/s12245-010-0224-6, PMID: 21373296"
10.1097/bot.0b013e31817440cf,10.1097/bot.0b013e31817440cf,138.41045,"Koo, H, Leveridge, M, Thompson, C, Zdero, R, Bhandari, M, Kreder, HJ, Stephen, D, McKee, MD, Schemitsch, EH. Interobserver reliability of the young-burgess and tile classification systems for fractures of the pelvic ring, J Orthop Trauma, 2008, 22, 6, 379, 384, DOI: 10.1097/BOT.0b013e31817440cf, PMID: 18594301"
10.1097/ta.0b013e31828b82f5,10.1097/01586154-201305000-00026,161.32605,"ATLS Subcommittee, American College of Surgeons’ Committee on Trauma, International ATLS working group, Advanced trauma life support (ATLS®): the ninth edition, J Trauma Acute Care Surg, 2013, 74, 5, 1363, 1366, PMID: 23609291"
10.1097/bot.0b013e3181d3cb6b,10.1097/bot.0b013e3181d3cb6b,139.75627,"Manson, T, O'Toole, RV, Whitney, A, Duggan, B, Sciadini, M, Nascone, J. Young-Burgess classification of pelvic ring fractures: does it predict mortality, transfusion requirements, and non-orthopaedic injuries, J Orthop Trauma, 2010, 24, 10, 603, 609, DOI: 10.1097/BOT.0b013e3181d3cb6b, PMID: 20871246"
10.1097/ta.0b013e31823dca9a,10.1097/ta.0b013e31823dca9a,137.44821,"Cullinane, DC, Schiller, HJ, Zielinski, MD, Bilaniuk, JW, Collier, BR, Como, J, Holevar, M, Sabater, EA, Sems, SA, Vassy, WM. Eastern Association for the Surgery of Trauma practice management guidelines for hemorrhage in pelvic fracture-update and systematic review, J Trauma, 2011, 71, 6, 1850, 1868, PMID: 22182895"
10.1097/ta.0000000000001230,10.1097/ta.0000000000001230,159.60143,"Tran, TL, Brasel, KJ, Karmy-Jones, R, Rowell, S, Schreiber, MA, Shatz, DV, Albrecht, RM, Cohen, MJ, DeMoya, MA, Biffl, WL. Western Trauma Association Critical Decisions in Trauma: management of pelvic fracture with hemodynamic instability-2016 updates, J Trauma Acute Care Surg, 2016, 81, 6, 1171, 1174, DOI: 10.1097/TA.0000000000001230, PMID: 27537512"
10.1097/ta.0b013e31820cede0,10.1097/ta.0b013e31820cede0,124.82712,"Tai, DK, Li, WH, Lee, KY, Cheng, M, Lee, KB, Tang, LF, Lai, AK, Ho, HF, Cheung, MT. Retroperitoneal pelvic packing in the management of hemodynamically unstable pelvic fractures: a level I trauma center experience, J Trauma, 2011, 71, 4, E79, E86, DOI: 10.1097/TA.0b013e31820cede0, PMID: 21610537"
10.1097/01.bot.0000389016.21888.f4,10.1097/01.bot.0000389016.21888.f4,144.81026,"Burgess, A. Invited commentary: Young-Burgess classification of pelvic ring fractures: does it predict mortality, transfusion requirements, and non-orthopaedic injuries, J Orthop Trauma, 2010, 24, 10, 609, DOI: 10.1097/01.bot.0000389016.21888.f4, PMID: 20871247"
10.1097/ta.0b013e3182a9005f,10.1097/ta.0b013e3182a9005f,133.2516,"Stahel, PF, Mauffrey, C, Smith, WR, McKean, J, Hao, J, Burlew, CC, Moore, EE. External fixation for acute pelvic ring injuries: decision making and technical options, J Trauma Acute Care Surg, 2013, 75, 5, 882, 887, DOI: 10.1097/TA.0b013e3182a9005f, PMID: 24158211"
10.1007/s00068-012-0242-6,10.1007/s00068-012-0242-6,125.63703,"Lindahl, J, Handolin, L, Soderlund, T, Porras, M, Hirvensalo, E. Angiographic embolization in the treatment of arterial pelvic hemorrhage: evaluation of prognostic mortality-related factors, Eur J Trauma Emerg Surg, 2013, 39, 1, 57, 63, DOI: 10.1007/s00068-012-0242-6, PMID: 23420138"
10.1111/ans.13651,10.1111/ans.13651,133.39694,"Lumsdaine, W, Weber, DG, Balogh, ZJ. Pelvic fracture-specific scales versus general patient reported scales for pelvic fracture outcomes: a systematic review, ANZ J Surg, 2016, 86, 9, 687, 690, DOI: 10.1111/ans.13651, PMID: 27283794"
10.7759/cureus.2194,10.7759/cureus.2194,152.6094,"Azeemuddin, M, Sayani, R, Turab, NAQ, Mustahsan, SM, Hasan, M, Khan, DB, Mubarak, F. Institutional review of hemorrhagic pelvic emergencies effectively managed with percutaneous arterial embolization, Cureus, 2018, 10, 2, e2194, PMID: 29662732"
10.1016/j.injury.2018.06.044,10.1016/j.injury.2018.06.044,152.41382,"Mann, SM, Banaszek, D, Lajkosz, K, Brogly, SB, Stanojev, SM, Evans, C, Bardana, DD, Yach, J, Hall, S. High-energy trauma patients with pelvic fractures: Management trends in Ontario, Canada. Injury, 2018, 49, 10, 1830, 1840, DOI: 10.1016/j.injury.2018.06.044, PMID: 29997027"
10.1016/j.amjsurg.2017.11.024,10.1016/j.amjsurg.2017.11.024,124.03275,"Moskowitz, EE, Burlew, CC, Moore, EE, Pieracci, FM, Fox, CJ, Campion, EM, Lawless, RA, Cohen, MJ. Preperitoneal pelvic packing is effective for hemorrhage control in open pelvic fractures, Am Surg, 2018, 215, 4, 675, 677, DOI: 10.1016/j.amjsurg.2017.11.024"
10.5435/jaaos-d-16-00600,10.5435/jaaos-d-16-00600,76.97218,"Vaidya, R, Waldron, J, Scott, A, Nasr, K. Angiography and embolization in the management of bleeding pelvic fractures, J Am Acad Orthop Surg, 2018, 26, 4, e68, e76, DOI: 10.5435/JAAOS-D-16-00600, PMID: 29351135"
10.1186/s13017-019-0248-z,10.1186/s13017-019-0248-z,104.51778,"Chou, CH, Wu, YT, Fu, CY, Liao, CH, Wang, SY, Bajani, F, Hsieh, CH. Hemostasis as soon as possible? The role of the time to angioembolization in the management of pelvic fracture, World J Emerg Surg, 2019, 14, 28, DOI: 10.1186/s13017-019-0248-z, PMID: 31210779"
10.1097/01.ta.0000221673.98117.c9,10.1097/01.ta.0000221673.98117.c9,102.5228,"Totterman, A, Madsen, JE, Skaga, NO, Roise, O. Extraperitoneal pelvic packing: a salvage procedure to control massive traumatic pelvic hemorrhage, J Trauma, 2007, 62, 4, 843, 852, DOI: 10.1097/01.ta.0000221673.98117.c9, PMID: 17426538"
10.1007/s00402-005-0827-1,10.1007/s00402-005-0827-1,158.63359,"Suzuki, T, Shindo, M, Kataoka, Y, Kobayashi, I, Nishimaki, H, Yamamoto, S, Uchino, M, Takahira, N, Yokoyama, K, Soma, K. Clinical characteristics of pelvic fracture patients with gluteal necrosis resulting from transcatheter arterial embolization, Arch Orthop Trauma Surg, 2005, 125, 7, 448, 452, DOI: 10.1007/s00402-005-0827-1, PMID: 15986182"
10.1007/s11999-013-3119-z,10.1007/s11999-013-3119-z,142.53725,"Matityahu, A, Marmor, M, Elson, JK, Lieber, C, Rogalski, G, Lin, C, Belaye, T, Miclau, T, 3rd, Kandemir, U. Acute complications of patients with pelvic fractures after pelvic angiographic embolization, Clin Orthop Relat Res, 2013, 471, 9, 2906, 2911, DOI: 10.1007/s11999-013-3119-z, PMID: 23846601"
10.1016/j.injury.2008.08.038,10.1016/j.injury.2008.08.038,158.24554,"Osborn, PM, Smith, WR, Moore, EE, Cothren, CC, Morgan, SJ, Williams, AE, Stahel, PF. Direct retroperitoneal pelvic packing versus pelvic angiography: a comparison of two management protocols for haemodynamically unstable pelvic fractures, Injury, 2009, 40, 1, 54, 60, DOI: 10.1016/j.injury.2008.08.038, PMID: 19041967"
10.1097/ta.0000000000002266,10.1097/ta.0000000000002266,155.77617,"Do, WS, Forte, DM, Sheldon, RR, Weiss, JB, Barron, MR, Sokol, KK, Black, GE, Hegge, SR, Eckert, MJ, Martin, MJ. Preperitoneal balloon tamponade and resuscitative endovascular balloon occlusion of the aorta: alternatives to open packing for pelvic fracture-associated hemorrhage, J Trauma Acute Care Surg, 2019, 87, 1, 18, 26, DOI: 10.1097/TA.0000000000002266, PMID: 31260423"
10.1016/j.jamcollsurg.2006.03.017,10.1016/j.jamcollsurg.2006.03.017,145.61746,"Papadopoulos, IN, Kanakaris, N, Bonovas, S, Triantafillidis, A, Garnavos, C, Voros, D, Leukidis, C. Auditing 655 fatalities with pelvic fractures by autopsy as a basis to evaluate trauma care, J Am Coll Surgeons, 2006, 203, 1, 30, 43, DOI: 10.1016/j.jamcollsurg.2006.03.017"
10.18356/55eb9109-en,10.18356/55eb9109-en,94.30421,United Nations. The Sustainable Development Goals Report. https://www.un.org/development/desa/publications/sustainable-development-goals-report-2016.html. Updated 2016. Accessed 13 May 2019.
10.1136/bmj.331.7525.1107,10.1136/bmj.331.7525.1107,95.43047,"Adam T, Lim SS, Mehta S, et al. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ. 2005; 331: 1107 DOI: DOI: 10.1136/bmj.331.7525.1107 PMID: 16282407"
10.17367/jacsd.2018.3.6,10.17367/jacsd.2018.3.6,80.62527,World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. https://www.who.int/reproductivehalth/publications/maternal_perinatal_health/anc-positive-pregnancy-experience. Updated 2016. Accessed 13 May 2019.
10.1016/s0140-6736(00)04722-x,10.1016/s0140-6736(00)04722-x,81.01826,"Villar J, Baaqeal H, Piaggio G, et al. WHO antenatal care randomized trial for the evaluation of a new model of routine antenatal care. Lancet. 2001; 357: 1551–64. DOI: DOI: 10.1016/S0140-6736(00)04722-X PMID: 11377642"
10.1016/s0140-6736(00)04723-1,10.1016/s0140-6736(00)04723-1,85.14711,"Carroli G, Villar J, Piaggio G, et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet. 2001; 357: 1565–70. PMID: 11377643"
10.1186/s12913-018-3370-9,10.1186/s12913-018-3370-9,131.20668,"Fekadu GA, Kassa GM, Berhe AK, Muche AA and Katiso NA. The effect of antenatal care on use of institutional delivery service and postnatal care in Ethiopia: A systematic review and meta-analysis. BMC Health Serv Res. 208; 18: 577 DOI: DOI: 10.1186/s12913-018-3370-9 PMID: 30041655"
10.1093/ije/dyx125,10.1093/inthealth/ihz030,73.56863,Doku DT and Neupane S. Survival analysis of the association between antenatal care attendance and neonatal mortality in 57 low-and middle-income countries. Int J Epidemiol. 2017; 46: 1668–77. PMID: 29040531
10.1016/j.respe.2009.02.148,10.1016/j.respe.2010.04.008,164.6729,"Normes de la zone de sante relatives aux interventions integrees de sante de la mere, Du nouveau-ne et de l’enfant en republique democratique du congo Republique democratique du congo ministere de la sante publique 2012."
10.1111/tmi.12171,10.1111/tmi.12171,105.12903,"Lydia F, Bruno LD, Bavon M, et al. Antenatal and delivery services in Kinshasa, Democratic Republic of Congo: Care-seeking and experiences reported by women in a household-based survey. Trop Med Int Health. 2013; 18: 1211–21. DOI: DOI: 10.1111/tmi.12171 PMID: 23964667"
10.1016/0277-9536(94)90226-7,10.1016/0277-9536(94)90226-7,101.37504,Thaddeus S and Maine D. Too far to walk: Maternal mortality in context. Soc Sci Med. 1994; 38: 1091–110. DOI: DOI: 10.1016/0277-9536(94)90226-7 PMID: 8042057
10.1186/1471-2393-9-34,10.1186/1471-2393-9-34,107.369644,Gabrysch S and Campbell OMR. Still too far to walk: Literature review of the determinants of delivery service use. BMC Pregnancy Childb. 2009; 9: 34 DOI: DOI: 10.1186/1471-2393-9-34
10.1186/1471-2393-14-94,10.1186/1471-2393-14-94,119.06929,"Joshi C, Torvaldsen S, Hodgson R and Hayen A. Factors associated with the use and quality of antenatal care in Nepal: A population-based study using the demographic and health survey data. BMC Pregnancy Childb. 2014; 14: 94 DOI: DOI: 10.1186/1471-2393-14-94"
10.1016/s0277-9536(01)00313-6,10.1016/s0277-9536(01)00313-6,94.62018,Navaneetham K and Dharmalingam A. Utilization of maternal health care services in Southern India. Soc Sci Med. 2001; 55: 1849–69. DOI: DOI: 10.1016/S0277-9536(01)00313-6
10.1186/1471-2393-12-66,10.1186/1471-2393-12-66,126.59375,"Ntambue A, Malonga F, Dramaix-Wilmet M and Donnen P. Determinants of maternal health services utilization in urban settings of the Democratic Republic of Congo—A case study of Lubumbashi City. BMC Pregnancy Childb. 2012; 12: 66 DOI: DOI: 10.1186/1471-2393-12-66"
10.1186/s13104-015-1312-8,10.1186/s13104-015-1312-8,100.616905,"Acharya D, Khanal V, Singh JK, Adhikari M and Gautam S. Impact of mass media on the utilization of antenatal care services among women of rural community in Nepal. BMC Res Notes. 2015; 8: 345 DOI: DOI: 10.1186/s13104-015-1312-8 PMID: 26264412"
10.1111/tmi.12910,10.1111/tmi.12910,112.093094,"Virgo S, Gon G, Cavallaro FL, Graham W and Woodd S. Who delivers where? The effect of obstetric risk on facility delivery in East Africa. Trop Med Int Health. 2017; 22: 1081–98. DOI: DOI: 10.1111/tmi.12910 PMID: 28627069"
10.4269/ajtmh.15-0356,10.4269/ajtmh.15-0356,110.447205,"Matanock A, Anderson T, Ayers T, et al. Integrating water treatment into antenatal care: Impact on use of maternal health services and household water treatment by mothers—Rural Uganda, 2013. Am J Trop Med Hyg. 2016; 94: 1150–6. DOI: DOI: 10.4269/ajtmh.15-0356 PMID: 27001758"
10.1111/j.1525-1446.2007.00638.x,10.1111/j.1525-1446.2007.00638.x,118.10625,"Trinh LTT, Dibley MJ and Byles J. Determinants of antenatal care utilization in three rural areas of Vietnam. Public Health Nurs. 2007; 24: 300–10. DOI: DOI: 10.1111/j.1525-1446.2007.00638.x PMID: 17553019"
10.1080/0032472031000149896,10.1080/0032472031000149896,95.432556,Guilkey DK and Jayne S. Fertility transition in Zimbabwe: Determinants of contraceptive use and method choice. Population Studies. 1997; 51: 173–89. DOI: DOI: 10.1080/0032472031000149896
10.15707/disem.2013.23.1.011,10.15707/disem.2013.23.1.011,94.54723,"Jeong LU, Jin KS and Uk SH. A study on the analysis of employment decision factor of the visually impaired using data mining technique. Korea Employment Agency for the Disabled. 2013; 23: 273–302. DOI: DOI: 10.15707/disem.2013.23.1.011"
10.3109/14767058.2010.545908,10.3109/14767058.2010.545908,103.41053,"Ali AA and Adam I. Lack of antenatal care, education, and high maternal mortality in Kassala hospital, eastern Sudan during 2005–2009. J Matern Fetal Neonatal Med. 2011; 24: 1077–8. DOI: DOI: 10.3109/14767058.2010.545908 PMID: 21231847"
10.1111/jmwh.12627,10.1111/jmwh.12627,135.58257,"Origlia P, Jevitt C, Sayn-Wittgenstein FZ and Cignacco E. Experiences of antenatal care among women who are socioeconomically deprived in high-income industrialized countries: An integrative review. J Midwifery Womens Health. 2017; 62 DOI: DOI: 10.1111/jmwh.12627"
10.4314/eamj.v81i2.9128,10.4314/eamj.v81i2.9128,146.62474,"Mosoko JJ, Delvaux T, Glynn JR, Zekeng L, Macauley I and Buve A. Induced abortion among women attending antenatal clinics in Yaounde, Cameroon. East Afr Med J. 2004; 81: 71–7. DOI: DOI: 10.4314/eamj.v81i2.9128 PMID: 15125089"
10.1080/07399332.2014.908194,10.1080/07399332.2014.908194,93.87433,Ettarh RR and Kimani J. Influence of distance to health facilities on the use of skilled attendants at birth in Kenya. Health Care Women Int. 2016; 37: 237–49. DOI: DOI: 10.1080/07399332.2014.908194 PMID: 24730670
10.1016/s2214-109x(18)30065-2,10.1016/s2214-109x(18)30065-2,75.142715,"Mitchell S, Gelman A, Ross R, et al. The Millennium Villages Project: A retrospective, observational, endline evaluation. Lancet Glob Health. 2018; 6: e500–13. DOI: DOI: 10.1016/S2214-109X(18)30065-2 PMID: 29653625"
10.1016/j.cell.2010.03.015,10.1016/j.cell.2010.03.015,118.76433,"Kessenbrock, K, Plaks, V, Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, 2010, 141, 52, 67, DOI: 10.1016/j.cell.2010.03.015, PMID: 20371345"
10.1016/j.semcancer.2010.05.002,10.1016/j.semcancer.2010.05.002,169.42952,"Bourboulia, D, Stetler-Stevenson, WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion, Seminars in cancer biology, 2010, 20, 161, 168, DOI: 10.1016/j.semcancer.2010.05.002, PMID: 20470890"
10.1126/scisignal.127re6,10.1126/scisignal.127re6,123.87339,"Stetler-Stevenson, WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities, Science signaling, 2008, 1, re6, DOI: 10.1126/scisignal.127re6, PMID: 18612141"
10.1186/gb-2011-12-11-233,10.1186/gb-2011-12-11-233,86.86785,"Murphy, G. Tissue inhibitors of metalloproteinases, Genome biology, 2011, 12, 233, DOI: 10.1186/gb-2011-12-11-233, PMID: 22078297"
10.1016/s0092-8674(03)00551-8,10.1016/s0092-8674(03)00551-8,67.00135,"Seo, DW. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism, Cell, 2003, 114, 171, 180, DOI: 10.1016/S0092-8674(03)00551-8, PMID: 12887919"
10.1074/jbc.273.2.871,10.1074/jbc.273.2.871,107.55631,"Butler, GS. The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study, The Journal of biological chemistry, 1998, 273, 871, 880, DOI: 10.1074/jbc.273.2.871, PMID: 9422744"
10.1074/jbc.m110.166439,10.1074/jbc.m110.166439,88.493286,"Fernandez, CA. The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor, The Journal of biological chemistry, 2010, 285, 41886, 41895, DOI: 10.1074/jbc.M110.166439, PMID: 20940305"
10.1074/jbc.m406792200,10.1074/jbc.m406792200,114.85982,"Emonard, H. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism, The Journal of biological chemistry, 2004, 279, 54944, 54951, DOI: 10.1074/jbc.M406792200, PMID: 15489233"
10.1038/s41598-017-04648-y,10.1038/s41598-017-04648-y,77.58783,"Johanns, M. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2, Sci Rep, 2017, 7, 4328, DOI: 10.1038/s41598-017-04648-y, PMID: 28659595"
10.1007/s10555-007-9105-8,10.1007/s10555-007-9105-8,107.257645,"Stetler-Stevenson, WG. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2, Cancer Metastasis Rev, 2008, 27, 57, 66, DOI: 10.1007/s10555-007-9105-8, PMID: 18058195"
10.1016/j.tcb.2018.08.006,10.1016/j.tcb.2018.08.006,97.19244,"Grunwald, B, Schoeps, B, Kruger, A. Recognizing the Molecular Multifunctionality and Interactome of TIMP-1, Trends in cell biology, 2019, 29, 6, 19, DOI: 10.1016/j.tcb.2018.08.006, PMID: 30243515"
10.1097/cji.0b013e3182619c8e,10.1097/cji.0b013e3182619c8e,90.36559,"Guedez, L. TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis, Journal of immunotherapy (Hagerstown, Md: 1997), 2012, 35, 502, 512, DOI: 10.1097/CJI.0b013e3182619c8e"
10.1016/j.ajpath.2011.07.035,10.1016/j.ajpath.2011.07.035,103.68485,"Bourboulia, D. Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment, The American journal of pathology, 2011, 179, 2589, 2600, DOI: 10.1016/j.ajpath.2011.07.035, PMID: 21933655"
10.1093/nar/gkx907,10.1093/nar/gkx907,135.12013,"Dingerdissen, HM. BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery, Nucleic acids research, 2018, 46, D1128, d1136, DOI: 10.1093/nar/gkx907, PMID: 30053270"
10.1038/nrc.2016.115,10.1038/nrc.2016.115,110.26435,"Jackson, HW, Defamie, V, Waterhouse, P, Khokha, R. TIMPs: versatile extracellular regulators in cancer, Nature reviews. Cancer, 2017, 17, 38, 53, DOI: 10.1038/nrc.2016.115, PMID: 27932800"
10.1158/1055-9965.epi-15-0578,10.1158/1055-9965.epi-15-0578,114.635254,"Torre, LA, Siegel, RL, Ward, EM, Jemal, A. Global Cancer Incidence and Mortality Rates and Trends–An Update, Cancer Epidemiol Biomarkers Prev, 2016, 25, 16, 27, DOI: 10.1158/1055-9965.Epi-15-0578, PMID: 26667886"
10.1371/journal.pone.0124230,10.1371/journal.pone.0124230,97.98278,"Zhu, L. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis, PloS one, 2015, 10, e0124230, DOI: 10.1371/journal.pone.0124230, PMID: 25905787"
10.1002/(sici)1097-0215(20000320)89:2<118::aid-ijc3>3.0.co;2-8,10.1002/(sici)1097-0215(20000320)89:2<118::aid-ijc3>3.0.co;2-8,82.59723,"Remacle, A. High levels of TIMP-2 correlate with adverse prognosis in breast cancer, Int J Cancer, 2000, 89, 118, 121, DOI: 10.1002/(sici)1097-0215, PMID: 10756061"
10.1186/bcr1503,10.1186/bcr1503,83.29449,"Tetu, B. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis, Breast Cancer Res, 2006, 8, R28, DOI: 10.1186/bcr1503, PMID: 16776850"
10.18632/oncotarget.801,10.18632/oncotarget.801,110.74677,"Bourboulia, D. TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells, Oncotarget, 2013, 4, 166, 176, DOI: 10.18632/oncotarget.801, PMID: 23371049"
10.1093/carcin/bgz172,10.1093/carcin/bgz172,69.63377,"Peeney, D. et al. TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer. Carcinogenesis, 10.1093/carcin/bgz172 (2019)."
10.1016/j.jtho.2017.03.010,10.1016/j.jtho.2017.03.010,94.91689,"Faruki, H. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape, J Thorac Oncol, 2017, 12, 943, 953, DOI: 10.1016/j.jtho.2017.03.010, PMID: 28341226"
10.1038/s41598-018-25357-0,10.1038/s41598-018-25357-0,70.91914,"Du, T. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism, Scientific Reports, 2018, 8, 7205, DOI: 10.1038/s41598-018-25357-0, PMID: 29739984"
10.1111/resp.12920,10.1111/resp.12920,72.54061,"Tzouvelekis, A. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis, Respirology (Carlton, Vic.), 2017, 22, 486, 493, DOI: 10.1111/resp.12920"
10.1074/mcp.m111.014647,10.3410/f.721942476.793511151,74.07095,"Naba, A. The matrisome: in silico definition and, in vivo characterization by proteomics of normal and tumor extracellular matrices, Molecular & cellular proteomics: MCP, 2012, 11, M111, 014647, DOI: 10.1074/mcp.M111.014647, PMID: 22159717"
10.1093/nar/gkj109,10.1093/nar/gkj109,101.513176,"Stark, C. BioGRID: a general repository for interaction datasets, Nucleic acids research, 2006, 34, D535, 539, DOI: 10.1093/nar/gkj109, PMID: 16381927"
10.3389/fonc.2018.00225,10.3389/fonc.2018.00225,101.64018,"Gonzalez-Gonzalez, L, Alonso, J. Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression, Front Oncol, 2018, 8, 225, DOI: 10.3389/fonc.2018.00225, PMID: 29946533"
10.1038/nature10694,10.1038/nature10694,91.16126,"Malanchi, I. Interactions between cancer stem cells and their niche govern metastatic colonization, Nature, 2011, 481, 85, 89, DOI: 10.1038/nature10694, PMID: 22158103"
10.1002/path.4747,10.1002/path.4747,100.569695,"Wang, Z. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis, J Pathol, 2016, 239, 484, 495, DOI: 10.1002/path.4747, PMID: 27193093"
10.1007/s00441-007-0439-x,10.1007/s00441-007-0439-x,112.05756,"Yoshiba, N. Association of TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with periostin during mouse mandible development, Cell Tissue Res, 2007, 330, 133, 145, DOI: 10.1007/s00441-007-0439-x, PMID: 17602244"
10.1186/s12885-019-5768-0,10.1186/s12885-019-5768-0,84.0567,"Gobin, E. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential, BMC Cancer, 2019, 19, 581, DOI: 10.1186/s12885-019-5768-0, PMID: 31200666"
10.1042/bj20121558,10.1042/bj20121558,99.02143,"Frohlich, C. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins, The Biochemical journal, 2013, 452, 97, 109, DOI: 10.1042/bj20121558, PMID: 23458101"
10.1042/bj20100649,10.1042/bj20100649,85.13538,"Kveiborg, M. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2), The Biochemical journal, 2010, 430, 79, 86, DOI: 10.1042/bj20100649, PMID: 20533908"
10.1016/j.ydbio.2009.10.026,10.1016/j.ydbio.2009.10.026,102.258804,"Rozario, T, DeSimone, DW. The extracellular matrix in development and morphogenesis: a dynamic view, Developmental biology, 2010, 341, 126, 140, DOI: 10.1016/j.ydbio.2009.10.026, PMID: 19854168"
10.1016/j.canlet.2014.12.011,10.1016/j.canlet.2014.12.011,87.87802,"Raglow, Z, Thomas, SM. Tumor matrix protein collagen XIalpha1 in cancer, Cancer Lett, 2015, 357, 448, 453, DOI: 10.1016/j.canlet.2014.12.011, PMID: 25511741"
10.1242/dmm.004077,10.1242/dmm.004077,99.778694,"Cox, TR, Erler, JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer, Disease models & mechanisms, 2011, 4, 165, 178, DOI: 10.1242/dmm.004077, PMID: 21324931"
10.1096/fasebj.7.9.8330681,10.1096/fasebj.7.9.8330681,85.56572,"Lin, CQ, Bissell, MJ. Multi-faceted regulation of cell differentiation by extracellular matrix, FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 1993, 7, 737, 743, DOI: 10.1096/fasebj.7.9.8330681, PMID: 8330681"
10.1186/1471-213x-8-90,10.1186/1471-213x-8-90,90.997536,"Ma, W. Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells, BMC developmental biology, 2008, 8, 90, DOI: 10.1186/1471-213x-8-90, PMID: 18808690"
10.1089/wound.2013.0485,10.1089/wound.2013.0485,126.601685,"Xue, M, Jackson, CJ. Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring, Advances in wound care, 2015, 4, 119, 136, DOI: 10.1089/wound.2013.0485, PMID: 25785236"
10.1038/284067a0,10.1038/284067a0,87.073265,"Liotta, LA. Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature, 1980, 284, 67, 68, DOI: 10.1038/284067a0, PMID: 6243750"
10.1016/j.yexcr.2017.08.018,10.1016/j.yexcr.2017.08.018,118.4966,"Hartman, CD, Isenberg, BC, Chua, SG, Wong, JY. Extracellular matrix type modulates cell migration on mechanical gradients, Experimental cell research, 2017, 359, 361, 366, DOI: 10.1016/j.yexcr.2017.08.018, PMID: 28821395"
10.1016/j.matbio.2015.04.005,10.1016/j.matbio.2015.04.005,115.45014,"Apte, SS, Parks, WC. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future, Matrix biology: journal of the International Society for Matrix Biology, 2015, 44-46, 1, 6, DOI: 10.1016/j.matbio.2015.04.005, PMID: 25916966"
10.1016/j.matbio.2015.01.019,10.1016/j.matbio.2015.01.019,132.78085,"Shay, G, Lynch, CC, Fingleton, B. Moving targets: Emerging roles for MMPs in cancer progression and metastasis, Matrix biology: journal of the International Society for Matrix Biology, 2015, 44-46, 200, 206, DOI: 10.1016/j.matbio.2015.01.019, PMID: 25652204"
10.1074/jbc.m001271200,10.1074/jbc.m001271200,111.85336,"Caterina, JJ. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation, The Journal of biological chemistry, 2000, 275, 26416, 26422, DOI: 10.1074/jbc.M001271200, PMID: 10827176"
10.1016/j.bbamcr.2010.01.003,10.1016/j.bbamcr.2010.01.003,103.3963,"Brew, K, Nagase, H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity, Biochimica et biophysica acta, 2010, 1803, 55, 71, DOI: 10.1016/j.bbamcr.2010.01.003, PMID: 20080133"
10.1002/neu.20205,10.1002/neu.20205,122.34187,"Jaworski, DM, Soloway, P, Caterina, J, Falls, WA. Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits, J Neurobiol, 2006, 66, 82, 94, DOI: 10.1002/neu.20205, PMID: 16216006"
10.1016/j.brainres.2005.05.057,10.1016/j.brainres.2005.05.057,133.13815,"Jaworski, DM, Boone, J, Caterina, J, Soloway, P, Falls, WA. Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice, Brain Res, 2005, 1051, 81, 89, DOI: 10.1016/j.brainres.2005.05.057, PMID: 15979591"
10.1158/1541-7786.mcr-09-0523,10.1158/1541-7786.mcr-09-0523,151.46672,"Shen, Q, Lee, ES, Pitts, RL, Wu, MH, Yuan, SY. Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells, Molecular cancer research: MCR, 2010, 8, 939, 951, DOI: 10.1158/1541-7786.Mcr-09-0523, PMID: 20571065"
10.1371/journal.pone.0136797,10.1371/journal.pone.0136797,153.0286,"Valacca, C, Tassone, E, Mignatti, P. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis, PloS one, 2015, 10, e0136797, DOI: 10.1371/journal.pone.0136797, PMID: 26331622"
